Syndromic disease
MONDO:0002254A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.
Also known as: cluster, symptom, clusters, symptom, symptom cluster, symptom clusters, syndrome, syndrome associated with disease or disorder, syndromes, syndromic disease
7133 clinical trials for this condition and its sub-types, 25 tagged with Syndromic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Syndromic disease
-
Neoplastic syndrome 1 trial · 1,430 incl. sub-types
11 sub-types
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Myelodysplastic syndrome 653 trials · 671 incl. sub-types Sub-types →
- Ectopic ACTH secretion syndrome 15 trials
- Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types Sub-types →
- Ectopic hormone secretion syndrome associated with neoplasia 0 trials · 5 incl. sub-types Sub-types →
- Tumor lysis syndrome 3 trials
- Zollinger-Ellison syndrome 2 trials
- Pancoast syndrome 1 trial
- Carney triad 0 trials
- Meigs syndrome 0 trials
- Growing teratoma syndrome 0 trials
-
Obstructive sleep apnea syndrome 516 trials · 517 incl. sub-types
1 sub-type
- Complex sleep apnea 1 trial
-
Acute respiratory distress syndrome 298 trials · 417 incl. sub-types
2 sub-types
- Adult acute respiratory distress syndrome 246 trials
- Pediatric acute respiratory distress syndrome 14 trials · 123 incl. sub-types Sub-types →
-
Abdominal obesity-metabolic syndrome 301 trials · 357 incl. sub-types
5 sub-types
- Metabolic syndrome X 338 trials
- LIPE-related familial partial lipodystrophy 0 trials
- Abdominal obesity-metabolic syndrome 3 0 trials
- Abdominal obesity-metabolic syndrome 4 0 trials
- Abdominal obesity-metabolic syndrome quantitative trait locus 2 0 trials
-
Acute coronary syndrome 298 trials
-
Fibromyalgia 279 trials
-
Dry eye syndrome 253 trials · 254 incl. sub-types
1 sub-type
- Xerophthalmia 2 trials
-
Toxic shock syndrome 224 trials
2 sub-types
-
Irritable bowel syndrome 221 trials
-
Autoinflammatory syndrome 21 trials · 207 incl. sub-types
37 sub-types
- Sarcoidosis 61 trials · 84 incl. sub-types Sub-types →
- Periodic fever syndrome 2 trials · 25 incl. sub-types Sub-types →
- Systemic-onset juvenile idiopathic arthritis 25 trials
- Type 1 interferonopathy 4 trials · 21 incl. sub-types Sub-types →
- Autoinflammatory syndrome of childhood 0 trials · 19 incl. sub-types Sub-types →
- VEXAS syndrome 18 trials
- Adult-onset Still disease 12 trials
- Pyoderma gangrenosum 10 trials Sub-types →
- Idiopathic recurrent pericarditis 8 trials
- PFAPA syndrome 6 trials
- Chronic recurrent multifocal osteomyelitis 3 trials · 4 incl. sub-types Sub-types →
- SAPHO syndrome 3 trials
- Schnitzler syndrome 1 trial
- Cherubism 1 trial Sub-types →
- CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome 0 trials
- F12-associated cold autoinflammatory syndrome 0 trials
- PAPASH syndrome 0 trials
- Pelger-Huet-like anomaly and episodic fever with abdominal pain 0 trials
- SAMD9L-associated autoinflammatory syndrome 0 trials
- Sharpin-related autoinflammatory syndrome 0 trials
- Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation 0 trials
- Autoinflammatory disease, X-linked 0 trials
- Autoinflammatory disease, multisystem, with immune dysregulation, X-linked 0 trials Sub-types →
- Autoinflammatory disease, systemic, with vasculitis 0 trials
- Autoinflammatory syndrome with immunodeficiency 0 trials
- Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
- Autoinflammatory syndrome, familial, Behcet-like 0 trials Sub-types →
- Autoinflammatory syndrome due to TBK1 deficiency 0 trials
- Early-onset pulmonary and cutaneous vasculitis 0 trials
- Granulomatous autoinflammatory syndrome of childhood 0 trials
- Infantile onset panniculitis with uveitis and systemic granulomatosis 0 trials
- Magic syndrome 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Neonatal-onset severe multisystemic autoinflammatory disease with increased IL18 0 trials
- Psoriasis 14, pustular 0 trials
- Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome 0 trials
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials
-
Psoriatic arthritis 188 trials · 201 incl. sub-types
1 sub-type
-
Polycystic ovary syndrome 200 trials
-
Sjogren syndrome 166 trials
-
Progressive supranuclear palsy 73 trials · 77 incl. sub-types
4 sub-types
- Supranuclear palsy, progressive, 1 5 trials
- Atypical progressive supranuclear palsy syndrome 1 trial · 4 incl. sub-types Sub-types →
- Supranuclear palsy, progressive, 2 0 trials
- Supranuclear palsy, progressive, 3 0 trials
-
Syndromic dyslipidemia 0 trials · 73 incl. sub-types
29 sub-types
- CHILD syndrome 37 trials
- Smith-Lemli-Opitz syndrome 6 trials
- Cerebrotendinous xanthomatosis 6 trials
- Familial lipoprotein lipase deficiency 6 trials
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- GM1 gangliosidosis type 1 3 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Apparent mineralocorticoid excess 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Peroxisome biogenesis disorder due to PEX5 defect in the PEX7-binding domain 0 trials · 1 incl. sub-types Sub-types →
- Rhizomelic chondrodysplasia punctata type 1 1 trial
- CHIME syndrome 0 trials
- Krabbe disease due to saposin A deficiency 0 trials
- PHARC syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hyperlipoproteinemia, type 1D 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Lipoprotein glomerulopathy 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Sitosterolemia 0 trials Sub-types →
-
Nephrotic syndrome 47 trials · 71 incl. sub-types
4 sub-types
- Idiopathic nephrotic syndrome 13 trials · 24 incl. sub-types Sub-types →
- Familial nephrotic syndrome 0 trials · 22 incl. sub-types Sub-types →
- Steroid-resistant nephrotic syndrome 5 trials · 15 incl. sub-types Sub-types →
- Nephrotic syndrome ocular anomalies 0 trials
-
Cushing syndrome 42 trials · 66 incl. sub-types
2 sub-types
- Endogenous Cushing syndrome 3 trials · 38 incl. sub-types Sub-types →
- Exogenous Cushing syndrome 1 trial
-
Myotonic syndrome 11 trials · 61 incl. sub-types
5 sub-types
- Myotonic dystrophy 56 trials · 57 incl. sub-types Sub-types →
- Nondystrophic myotonia 4 trials
- Laryngospasm, severe neonatal episodic 1 trial
- Paramyotonia congenita of Von Eulenburg 1 trial
- Potassium-aggravated myotonia 0 trials Sub-types →
-
Antiphospholipid syndrome 58 trials · 59 incl. sub-types
4 sub-types
- Primary antiphospholipid syndrome 4 trials
- Catastrophic antiphospholipid syndrome 1 trial
- Familial antiphospholipid syndrome 0 trials
- Secondary antiphospholipid syndrome 0 trials Sub-types →
-
Substance withdrawal syndrome 30 trials · 59 incl. sub-types
3 sub-types
- Neonatal abstinence syndrome 18 trials
- Alcohol withdrawal 11 trials · 13 incl. sub-types Sub-types →
- Baclofen withdrawal syndrome 0 trials
-
Hemophagocytic syndrome 38 trials · 58 incl. sub-types
2 sub-types
- Secondary hemophagocytic lymphohistiocytosis 15 trials · 24 incl. sub-types Sub-types →
- Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
-
Multiple organ dysfunction syndrome 50 trials
-
Hypereosinophilic syndrome 19 trials · 49 incl. sub-types
8 sub-types
- Pulmonary eosinophilia 30 trials Sub-types →
- Idiopathic hypereosinophilic syndrome 1 trial Sub-types →
- Secondary hypereosinophilic syndrome 0 trials · 1 incl. sub-types Sub-types →
- Disseminated eosinophilic collagen disease 0 trials
- Eosinophilia-myalgia syndrome 0 trials
- Episodic angioedema with eosinophilia 0 trials
- Hypereosinophilia of undetermined significance 0 trials
- Primary hypereosinophilic syndrome 0 trials
-
Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types
25 sub-types
- Ehlers-Danlos syndrome, hypermobility type 15 trials
- Joint laxity, familial 14 trials
- Ehlers-Danlos syndrome, vascular type 6 trials Sub-types →
- Bethlem myopathy 2 0 trials
- COL1A1-related Ehlers-Danlos syndrome 0 trials Sub-types →
- COL1A2-related Ehlers-Danlos syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome due to tenascin-X deficiency 0 trials
- Ehlers-Danlos syndrome, Beasley-Cohen type 0 trials
- Ehlers-Danlos syndrome, arthrochalasia type 0 trials Sub-types →
- Ehlers-Danlos syndrome, autosomal dominant, type unspecified 0 trials
- Ehlers-Danlos syndrome, classic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, classic-like, 2 0 trials
- Ehlers-Danlos syndrome, classic-like, 3 0 trials
- Ehlers-Danlos syndrome, dermatosparaxis type 0 trials
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Ehlers-Danlos syndrome, periodontitis type 0 trials Sub-types →
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, vascular-like type 0 trials
- Ehlers-Danlos/osteogenesis imperfecta syndrome 0 trials Sub-types →
- X-linked Ehlers-Danlos syndrome 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types
120 sub-types
- Dyskeratosis congenita 12 trials Sub-types →
- CTSC-related disorder 0 trials · 11 incl. sub-types Sub-types →
- Cardiofaciocutaneous syndrome 7 trials Sub-types →
- Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome 4 trials
- Incontinentia pigmenti 3 trials
- Ectodermal dysplasia WNT10A related 0 trials · 2 incl. sub-types Sub-types →
- Trichothiodystrophy 2 trials Sub-types →
- Cronkhite-Canada syndrome 1 trial
- Ellis-van Creveld syndrome 1 trial Sub-types →
- Cartilage-hair hypoplasia 1 trial Sub-types →
- Hypohidrotic ectodermal dysplasia 1 trial Sub-types →
- Trichorhinophalangeal syndrome 0 trials · 1 incl. sub-types Sub-types →
- ADULT syndrome 0 trials
- AREDYLD syndrome 0 trials
- Ackerman syndrome 0 trials
- Barber-Say syndrome 0 trials
- Bartsocas-Papas syndrome 1 0 trials
- Brunoni syndrome 0 trials
- Böök syndrome 0 trials
- CHIME syndrome 0 trials
- Clouston syndrome 0 trials
- Curly hair - acral keratoderma - caries syndrome 0 trials
- Dahlberg-Borer-Newcomer syndrome 0 trials
- Dubowitz syndrome 0 trials
- EEM syndrome 0 trials
- Fontaine progeroid syndrome 0 trials
- Fried's tooth and nail syndrome 0 trials
- GAPO syndrome 0 trials
- Ito hypomelanosis 0 trials
- Johnson neuroectodermal syndrome 0 trials
- KID syndrome 0 trials Sub-types →
- Lelis syndrome 0 trials
- Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome 0 trials
- Marshall syndrome 0 trials
- Naegeli-Franceschetti-Jadassohn syndrome 0 trials
- Rapp-Hodgkin syndrome 0 trials
- Schinzel-Giedion syndrome 0 trials
- Stern-Lubinsky-Durrie syndrome 0 trials
- Teebi-Shaltout syndrome 0 trials
- Toriello-Lacassie-Droste syndrome 0 trials
- Acrofacial dysostosis, Weyers type 0 trials
- Alopecia - contractures - dwarfism - intellectual disability syndrome 0 trials
- Alves Castelo dos Santos syndrome 0 trials
- Amelocerebrohypohidrotic syndrome 0 trials
- Ameloonychohypohidrotic syndrome 0 trials
- Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome 0 trials Sub-types →
- Anonychia with flexural pigmentation 0 trials
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma 0 trials
- Arthrogryposis-ectodermal dysplasia-other anomalies syndrome 0 trials
- Autosomal dominant palmoplantar keratoderma and congenital alopecia 0 trials
- Autosomal dominant trichoodontoonychodysplasia-syndactyly 0 trials
- Autosomal recessive palmoplantar keratoderma and congenital alopecia 0 trials
- Blepharocheilodontic syndrome 0 trials Sub-types →
- Cataract-hypertrichosis-intellectual disability syndrome 0 trials
- Cerebellar ataxia-ectodermal dysplasia syndrome 0 trials
- Chondroectodermal dysplasia with night blindness 0 trials
- Choroidal atrophy-alopecia syndrome 0 trials
- Circumscribed palmoplantar hypokeratosis 0 trials
- Cleft lip/palate-ectodermal dysplasia syndrome 0 trials
- Conductive deafness-ptosis-skeletal anomalies syndrome 0 trials
- Congenital hypotrichosis with juvenile macular dystrophy 0 trials
- Contractures-ectodermal dysplasia-cleft lip/palate syndrome 0 trials
- Cranioectodermal dysplasia 0 trials Sub-types →
- Dermatoosteolysis, Kirghizian type 0 trials
- Dermatopathia pigmentosa reticularis 0 trials
- Dermo-odonto dysplasia 0 trials
- Dermotrichic syndrome 0 trials
- Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type 0 trials
- Ectodermal dysplasia 13, hair/tooth type 0 trials
- Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis 0 trials
- Ectodermal dysplasia 15, hypohidrotic/hair type 0 trials
- Ectodermal dysplasia 17 with or without limb malformations 0 trials
- Ectodermal dysplasia 5, hair/nail type 0 trials
- Ectodermal dysplasia Bartalos type 0 trials
- Ectodermal dysplasia alopecia preaxial polydactyly 0 trials
- Ectodermal dysplasia arthrogryposis diabetes mellitus 0 trials
- Ectodermal dysplasia blindness 0 trials
- Ectodermal dysplasia margarita type 0 trials
- Ectodermal dysplasia neurosensory deafness 0 trials
- Ectodermal dysplasia with natal teeth, Turnpenny type 0 trials
- Ectodermal dysplasia, trichoodontoonychial type 0 trials
- Ectodermal dysplasia-blindness syndrome 0 trials
- Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome 0 trials
- Ectodermal dysplasia-sensorineural deafness syndrome 0 trials
- Ectodermal dysplasia-syndactyly syndrome 0 trials Sub-types →
- Epidermolysis bullosa simplex due to plakophilin deficiency 0 trials
- Focal facial dermal dysplasia 0 trials Sub-types →
- Gingival fibromatosis-hypertrichosis syndrome 0 trials
- Hidrotic ectodermal dysplasia, Christianson-Fourie type 0 trials
- Hidrotic ectodermal dysplasia, Halal type 0 trials
- Hypertrichosis cubiti-short stature syndrome 0 trials
- Hypertrichosis lanuginosa congenita 0 trials Sub-types →
- Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome 0 trials
- Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome 0 trials
- Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome 0 trials
- Jones hersh yusk syndrome 0 trials
- Limb-mammary syndrome 0 trials
- Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies 0 trials
- Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome 0 trials
- Oculodentodigital dysplasia 0 trials Sub-types →
- Oculoosteocutaneous syndrome 0 trials
- Oculotrichodysplasia 0 trials
- Odonto-onycho dysplasia-alopecia syndrome 0 trials
- Odonto-tricho-ungual-digito-palmar syndrome 0 trials
- Odontomicronychial dysplasia 0 trials
- Odontotrichomelic syndrome 0 trials
- Pili torti-onychodysplasia syndrome 0 trials
- Pilodental dysplasia-refractive errors syndrome 0 trials
- Pure hair and nail ectodermal dysplasia 0 trials Sub-types →
- Scalp-ear-nipple syndrome 0 trials
- Taurodontia-absent teeth-sparse hair syndrome 0 trials
- Tooth and nail syndrome 0 trials
- Tricho-dento-osseous syndrome 0 trials
- Tricho-oculo-dermo-vertebral syndrome 0 trials
- Tricho-retino-dento-digital syndrome 0 trials
- Trichodental syndrome 0 trials
- Trichodermodysplasia-dental alterations syndrome 0 trials
- Trichodysplasia-amelogenesis imperfecta syndrome 0 trials
- Trichomegaly-retina pigmentary degeneration-dwarfism syndrome 0 trials
- Trichoodontoonychial dysplasia 0 trials
-
Alpha 1-antitrypsin deficiency 44 trials
-
Tourette syndrome 41 trials
-
Guillain-Barre syndrome 23 trials · 39 incl. sub-types
11 sub-types
- Polyneuropathy, inflammatory demyelinating, chronic 15 trials
- Guillain-Barre syndrome, familial 1 trial
- Acute inflammatory demyelinating polyradiculoneuropathy 1 trial
- Autoimmune autonomic ganglionopathy 1 trial
- Acute motor and sensory axonal neuropathy 0 trials
- Acute motor axonal neuropathy 0 trials
- Acute pure sensory neuropathy 0 trials
- Acute sensory ataxic neuropathy 0 trials
- Facial diplegia with paresthesias 0 trials
- Paraparetic variant of Guillain-Barre syndrome 0 trials
- Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome 0 trials
-
Type 2 collagenopathy 0 trials · 39 incl. sub-types
14 sub-types
- Dysplasia of the proximal femoral epiphyses 0 trials · 36 incl. sub-types Sub-types →
- Stickler syndrome type 1 3 trials Sub-types →
- Kniest dysplasia 0 trials
- Achondrogenesis type II 0 trials
- Hypochondrogenesis 0 trials
- Multiple epiphyseal dysplasia, Beighton type 0 trials
- Platyspondylic dysplasia, Torrance type 0 trials
- Spondyloepimetaphyseal dysplasia, Strudwick type 0 trials
- Spondyloepiphyseal dysplasia congenita 0 trials
- Spondyloepiphyseal dysplasia with metatarsal shortening 0 trials
- Spondyloepiphyseal dysplasia, Stanescu type 0 trials
- Spondylometaphyseal dysplasia, 'corner fracture' type 0 trials
- Spondylometaphyseal dysplasia, Schmidt type 0 trials
- Spondyloperipheral dysplasia 0 trials
-
Syndromic intellectual disability 2 trials · 38 incl. sub-types
17 sub-types
- Autosomal dominant syndromic intellectual disability 0 trials · 15 incl. sub-types Sub-types →
- X-linked syndromic intellectual disability 0 trials · 12 incl. sub-types Sub-types →
- Smith-Magenis syndrome 5 trials
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Autosomal recessive syndromic intellectual disability 0 trials · 1 incl. sub-types Sub-types →
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- 2p25.3 microduplication syndrome 0 trials
- 3q27.3 microdeletion syndrome 0 trials
- 7p22.1 microduplication syndrome 0 trials
- 9p13 microdeletion syndrome 0 trials
- 9q31.1q31.3 microdeletion syndrome 0 trials
- 9q33.3q34.11 microdeletion syndrome 0 trials
- AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0 trials
- CK syndrome 0 trials
- Aplasia cutis-enamel dysplasia syndrome 0 trials
- Intellectual disability, Buenos-Aires type 0 trials
- Intellectual disability, Wolff type 0 trials
-
Behcet disease 37 trials
-
Syndromic agammaglobulinemia 7 trials · 37 incl. sub-types
3 sub-types
- Common variable immunodeficiency 29 trials · 31 incl. sub-types Sub-types →
- Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome 0 trials
- Transient hypogammaglobulinemia 0 trials Sub-types →
-
X-linked ichthyosis syndrome 0 trials · 37 incl. sub-types
2 sub-types
- CHILD syndrome 37 trials
- Syndromic recessive X-linked ichthyosis 0 trials
-
Fragile X syndrome 34 trials
4 sub-types
- Fragile X syndrome type 1 0 trials
- Fragile X syndrome type 2 0 trials
- Fragile X syndrome type 3 0 trials
- Symptomatic form of fragile X syndrome in female carrier 0 trials
-
Primary ciliary dyskinesia 34 trials
59 sub-types
- Primary ciliary dyskinesia 1 6 trials
- CFAP46-related primary ciliary dyskinesia 0 trials
- Stromme syndrome 0 trials
- Ciliary discoordination due to random ciliary orientation 0 trials
- Ciliary dyskinesia with defective radial spokes 0 trials
- Ciliary dyskinesia with excessively long cilia 0 trials
- Ciliary dyskinesia with transposition of ciliary microtubules 0 trials
- Ciliary dyskinesia, primary, 36, X-linked 0 trials
- Ciliary dyskinesia, primary, 37 0 trials
- Ciliary dyskinesia, primary, 38 0 trials
- Ciliary dyskinesia, primary, 39 0 trials
- Ciliary dyskinesia, primary, 40 0 trials
- Ciliary dyskinesia, primary, 41 0 trials
- Ciliary dyskinesia, primary, 42 0 trials
- Ciliary dyskinesia, primary, 43 0 trials
- Ciliary dyskinesia, primary, 44 0 trials
- Ciliary dyskinesia, primary, 45 0 trials
- Ciliary dyskinesia, primary, 46 0 trials
- Ciliary dyskinesia, primary, 47, and lissencephaly 0 trials
- Ciliary dyskinesia, primary, 48, without situs inversus 0 trials
- Ciliary dyskinesia, primary, 49, without situs inversus 0 trials
- Ciliary dyskinesia, primary, 50 0 trials
- Ciliary dyskinesia, primary, 51 0 trials
- Ciliary dyskinesia, primary, 52 0 trials
- Ciliary dyskinesia, primary, 53 0 trials
- Ciliary dyskinesia, primary, 54 0 trials
- Primary ciliary dyskinesia 10 0 trials
- Primary ciliary dyskinesia 11 0 trials
- Primary ciliary dyskinesia 12 0 trials
- Primary ciliary dyskinesia 13 0 trials
- Primary ciliary dyskinesia 14 0 trials
- Primary ciliary dyskinesia 15 0 trials
- Primary ciliary dyskinesia 16 0 trials
- Primary ciliary dyskinesia 17 0 trials
- Primary ciliary dyskinesia 18 0 trials
- Primary ciliary dyskinesia 19 0 trials
- Primary ciliary dyskinesia 2 0 trials
- Primary ciliary dyskinesia 20 0 trials
- Primary ciliary dyskinesia 21 0 trials
- Primary ciliary dyskinesia 22 0 trials
- Primary ciliary dyskinesia 23 0 trials
- Primary ciliary dyskinesia 24 0 trials
- Primary ciliary dyskinesia 25 0 trials
- Primary ciliary dyskinesia 26 0 trials
- Primary ciliary dyskinesia 27 0 trials
- Primary ciliary dyskinesia 28 0 trials
- Primary ciliary dyskinesia 29 0 trials
- Primary ciliary dyskinesia 3 0 trials
- Primary ciliary dyskinesia 30 0 trials
- Primary ciliary dyskinesia 32 0 trials
- Primary ciliary dyskinesia 33 0 trials
- Primary ciliary dyskinesia 34 0 trials
- Primary ciliary dyskinesia 35 0 trials
- Primary ciliary dyskinesia 4 0 trials
- Primary ciliary dyskinesia 5 0 trials
- Primary ciliary dyskinesia 6 0 trials
- Primary ciliary dyskinesia 7 0 trials
- Primary ciliary dyskinesia 8 0 trials
- Primary ciliary dyskinesia 9 0 trials
-
Dialysis disequilibrium syndrome 33 trials
-
Exfoliation syndrome 32 trials
-
Prader-Willi syndrome 31 trials
5 sub-types
-
Rett syndrome 31 trials
-
Complex regional pain syndrome type 1 31 trials
-
Acute chest syndrome 30 trials
-
Polymyalgia rheumatica 30 trials
-
Syndromic congenital heart disease 0 trials · 30 incl. sub-types
8 sub-types
- NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types Sub-types →
- Hypoplastic left heart syndrome 9 trials Sub-types →
- Left ventricular noncompaction 3 trials · 4 incl. sub-types Sub-types →
- Dextrocardia 1 trial
- Char syndrome 0 trials
- Atrial septal defect, coronary sinus type 0 trials
- Congenital heart disease with heterotaxy syndrome 0 trials
- Scimitar syndrome 0 trials
-
Long QT syndrome 22 trials · 29 incl. sub-types
1 sub-type
- Familial long QT syndrome 1 trial · 11 incl. sub-types Sub-types →
-
Turner syndrome 28 trials
3 sub-types
- Turner syndrome due to structural X chromosome anomalies 0 trials
- Mixed gonadal dysgenesis 0 trials
- Monosomy X 0 trials Sub-types →
-
Corticobasal degeneration disorder 28 trials
-
Familial developmental dysphasia 28 trials
-
Takayasu arteritis 27 trials
-
Posterior leukoencephalopathy syndrome 27 trials
-
Lennox-Gastaut syndrome 26 trials · 27 incl. sub-types
3 sub-types
-
Piriformis syndrome 25 trials
-
Mucopolysaccharidosis type 2 24 trials
2 sub-types
-
Post-cardiac arrest syndrome 24 trials
-
Noonan syndrome 21 trials · 24 incl. sub-types
14 sub-types
- Noonan syndrome 3 2 trials
- Noonan syndrome 5 1 trial
- Noonan syndrome 1 0 trials
- Noonan syndrome 10 0 trials
- Noonan syndrome 11 0 trials
- Noonan syndrome 13 0 trials
- Noonan syndrome 14 0 trials
- Noonan syndrome 2 0 trials
- Noonan syndrome 4 0 trials
- Noonan syndrome 6 0 trials
- Noonan syndrome 7 0 trials
- Noonan syndrome 8 0 trials
- Noonan syndrome 9 0 trials
- Noonan syndrome 12 0 trials
-
Central sleep apnea syndrome 21 trials · 23 incl. sub-types
5 sub-types
- Central sleep apnea caused by high altitude 1 trial
- Central sleep apnea due to periodic breathing 1 trial
- Complex sleep apnea 1 trial
- Drug induced central sleep apnea 1 trial
- Primary central sleep apnea syndrome 0 trials
-
Sick sinus syndrome 22 trials
1 sub-type
- Familial sick sinus syndrome 0 trials Sub-types →
-
Syndromic craniosynostosis 1 trial · 22 incl. sub-types
40 sub-types
- Acrocephalosyndactyly 0 trials · 13 incl. sub-types Sub-types →
- Crouzon syndrome-acanthosis nigricans syndrome 4 trials
- Antley-Bixler syndrome 2 trials Sub-types →
- Muenke syndrome 2 trials
- Crouzon syndrome 1 trial Sub-types →
- Shprintzen-Goldberg syndrome 1 trial
- Pseudoaminopterin syndrome 1 trial
- Baller-Gerold syndrome 0 trials
- Beare-Stevenson cutis gyrata syndrome 0 trials
- C syndrome 0 trials
- Curry-Jones syndrome 0 trials
- Hunter-McAlpine craniosynostosis 0 trials
- Lowry-MacLean syndrome 0 trials
- Summitt syndrome 0 trials
- TCF12-related craniosynostosis 0 trials
- Weiss-Kruszka syndrome 0 trials
- X-linked intellectual disability-plagiocephaly syndrome 0 trials
- Acrocephalopolydactyly 0 trials
- Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0 trials
- Cardiocranial syndrome, Pfeiffer type 0 trials
- Cloverleaf skull-asphyxiating thoracic dysplasia syndrome 0 trials
- Cloverleaf skull-multiple congenital anomalies syndrome 0 trials
- Cranioectodermal dysplasia 0 trials Sub-types →
- Craniomicromelic syndrome 0 trials
- Craniosynostosis 2 0 trials
- Craniosynostosis 4 0 trials
- Craniosynostosis and dental anomalies 0 trials
- Craniosynostosis, Herrmann-Opitz type 0 trials
- Craniosynostosis, Philadelphia type 0 trials
- Craniosynostosis-anal anomalies-porokeratosis syndrome 0 trials
- Craniosynostosis-cataract syndrome 0 trials
- Craniosynostosis-fibular aplasia syndrome 0 trials
- Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome 0 trials
- Craniosynostosis-intracranial calcifications syndrome 0 trials
- Craniotelencephalic dysplasia 0 trials
- Familial scaphocephaly syndrome 0 trials Sub-types →
- Holoprosencephaly-craniosynostosis syndrome 0 trials
- Lethal occipital encephalocele-skeletal dysplasia syndrome 0 trials
- Osteosclerosis-developmental delay-craniosynostosis syndrome 0 trials
- Trigonocephaly-broad thumbs syndrome 0 trials
-
Marfan syndrome 21 trials
1 sub-type
- Neonatal Marfan syndrome 0 trials
-
Cardiovascular-kidney-metabolic syndrome 21 trials
-
Persian gulf syndrome 20 trials
-
Paraneoplastic syndrome 1 trial · 20 incl. sub-types
8 sub-types
- Paraneoplastic neurologic syndrome 1 trial · 15 incl. sub-types Sub-types →
- Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types Sub-types →
- Paraneoplastic hematological syndrome 0 trials · 9 incl. sub-types Sub-types →
- Paraneoplastic renal syndrome 0 trials · 3 incl. sub-types Sub-types →
- Bilateral diffuse uveal melanocytic proliferation disease 0 trials
- Paraneoplastic cutaneous syndrome 0 trials Sub-types →
- Paraneoplastic gastrointestinal syndrome 0 trials
- Paraneoplastic rheumatic syndrome 0 trials
-
Angelman syndrome 19 trials
-
Evans syndrome 19 trials
-
Atypical hemolytic-uremic syndrome 19 trials
4 sub-types
-
Dumping syndrome 19 trials
-
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types
3 sub-types
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 19 trials
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0 trials Sub-types →
- Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 0 trials
-
Infantile spasms 8 trials · 19 incl. sub-types
8 sub-types
- Developmental and epileptic encephalopathy, 2 10 trials
- Developmental and epileptic encephalopathy, 1 2 trials
- Developmental and epileptic encephalopathy, 12 0 trials
- Developmental and epileptic encephalopathy, 15 0 trials
- Developmental and epileptic encephalopathy, 27 0 trials
- Developmental and epileptic encephalopathy, 30 0 trials
- Developmental and epileptic encephalopathy, 40 0 trials
- Developmental and epileptic encephalopathy, 5 0 trials
-
Williams syndrome 18 trials
-
Cardio-renal syndrome 18 trials
-
Complex regional pain syndrome type 2 18 trials
-
Alport syndrome 17 trials · 18 incl. sub-types
5 sub-types
- X-linked Alport syndrome 3 trials
- Autosomal recessive Alport syndrome 2 trials
- Alport syndrome 3b, autosomal recessive 0 trials
- Autosomal dominant Alport syndrome 0 trials
- Digenic Alport syndrome 0 trials
-
Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types
4 sub-types
- Mucopolysaccharidosis type 3A 7 trials
- Mucopolysaccharidosis type 3B 6 trials
- Mucopolysaccharidosis type 3C 2 trials
- Mucopolysaccharidosis type 3D 0 trials
-
Fetal alcohol syndrome 17 trials
-
Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types
16 sub-types
- Progressive familial intrahepatic cholestasis type 1 4 trials
- Progressive familial intrahepatic cholestasis type 2 4 trials
- Cholestasis, progressive familial intrahepatic, 4 2 trials
- Progressive familial intrahepatic cholestasis type 3 2 trials
- Cholestasis, progressive familial intrahepatic, 5 1 trial
- Cholestasis, progressive familial intrahepatic, 6 1 trial
- Hereditary North American Indian childhood cirrhosis 1 trial
- MYO5B-related progressive familial intrahepatic cholestasis 0 trials
- Benign recurrent intrahepatic cholestasis type 1 0 trials
- Cholestasis, progressive familial intrahepatic, 10 0 trials
- Cholestasis, progressive familial intrahepatic, 11 0 trials
- Cholestasis, progressive familial intrahepatic, 12 0 trials
- Cholestasis, progressive familial intrahepatic, 13 0 trials
- Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss 0 trials
- Cholestasis, progressive familial intrahepatic, 8 0 trials
- Cholestasis, progressive familial intrahepatic, 9 0 trials
-
Usher syndrome 14 trials · 16 incl. sub-types
5 sub-types
- Usher syndrome type 1 0 trials · 3 incl. sub-types Sub-types →
- Usher syndrome type 2 2 trials · 3 incl. sub-types Sub-types →
- Usher syndrome type 3 0 trials Sub-types →
- Usher syndrome, type 4 0 trials
- Retinitis pigmentosa-deafness syndrome 0 trials
-
Alagille syndrome 15 trials
3 sub-types
-
Netherton syndrome 15 trials
-
Arts syndrome 14 trials
-
Erdheim-Chester disease 14 trials
-
Compartment syndrome 14 trials
2 sub-types
- Anterior compartment of tibia syndrome 1 trial
- Neonatal compartment syndrome 0 trials
-
Fetal cytomegalovirus syndrome 14 trials
-
MELAS syndrome 13 trials · 14 incl. sub-types
10 sub-types
- MELAS syndrome caused by mutation in MTTL1 1 trial
- MELAS syndrome caused by mutation in MTND1 0 trials
- MELAS syndrome caused by mutation in MTND5 0 trials
- MELAS syndrome caused by mutation in MTND6 0 trials
- MELAS syndrome caused by mutation in MTTC 0 trials
- MELAS syndrome caused by mutation in MTTH 0 trials
- MELAS syndrome caused by mutation in MTTK 0 trials
- MELAS syndrome caused by mutation in MTTQ 0 trials
- MELAS syndrome caused by mutation in MTTS1 0 trials
- MELAS syndrome caused by mutation in MTTS2 0 trials
-
HELLP syndrome 13 trials
-
Hepatorenal syndrome 13 trials
-
Familial chylomicronemia syndrome 11 trials · 13 incl. sub-types
5 sub-types
-
Stiff-person syndrome 12 trials
3 sub-types
- Classic stiff person syndrome 0 trials
- Focal stiff limb syndrome 0 trials
- Progressive encephalomyelitis with rigidity and myoclonus 0 trials
-
Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types
4 sub-types
- Chediak-Higashi syndrome 9 trials
- Hermansky-Pudlak syndrome 4 trials Sub-types →
- Griscelli syndrome 2 trials · 3 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome, Cross type 0 trials
-
Simpson-Golabi-Behmel syndrome 11 trials
2 sub-types
- Simpson-Golabi-Behmel syndrome type 1 0 trials
- Simpson-Golabi-Behmel syndrome type 2 0 trials
-
Thoracic outlet syndrome 11 trials
3 sub-types
- Arterial thoracic outlet syndrome 0 trials
- Neurogenic thoracic outlet syndrome 0 trials
- Venous thoracic outlet syndrome 0 trials
-
Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types
4 sub-types
- Autoimmune polyendocrine syndrome type 1 8 trials
- Autoimmune polyendocrinopathy type 2 1 trial
- Autoimmune polyendocrinopathy type 3 1 trial
- Autoimmune polyendocrinopathy type 4 0 trials
-
Syndromic microphthalmia 0 trials · 11 incl. sub-types
19 sub-types
- Matthew-Wood syndrome 5 trials
- Anophthalmia/microphthalmia-esophageal atresia syndrome 4 trials
- COFS syndrome 1 trial Sub-types →
- MMEP syndrome 1 trial
- Behrens Baumann dust syndrome 0 trials
- RAB18 deficiency 0 trials Sub-types →
- X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0 trials
- Colobomatous microphthalmia-rhizomelic dysplasia syndrome 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Microphthalmia microtia fetal akinesia 0 trials
- Microphthalmia with brain and digit anomalies 0 trials
- Microphthalmia, Lenz type 0 trials
- Microphthalmia, syndromic 1 0 trials
- Microphthalmia, syndromic 11 0 trials
- Microphthalmia, syndromic 12 0 trials
- Microphthalmia, syndromic 2 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Oculoauricular syndrome 0 trials
- Syndromic microphthalmia type 5 0 trials
-
Brugada syndrome 10 trials
9 sub-types
- Brugada syndrome 1 0 trials
- Brugada syndrome 2 0 trials
- Brugada syndrome 3 0 trials
- Brugada syndrome 4 0 trials
- Brugada syndrome 5 0 trials
- Brugada syndrome 6 0 trials
- Brugada syndrome 7 0 trials
- Brugada syndrome 8 0 trials
- Brugada syndrome 9 0 trials
-
Marinesco-Sjogren syndrome 10 trials
-
Phelan-McDermid syndrome 10 trials
2 sub-types
-
Post-infectious syndrome 5 trials · 10 incl. sub-types
3 sub-types
- KSHV inflammatory cytokine syndrome 4 trials
- Zika virus congenital syndrome 1 trial
- TORCH syndrome 0 trials
-
Mucopolysaccharidosis type 4 2 trials · 10 incl. sub-types
3 sub-types
- Mucopolysaccharidosis type 4A 8 trials
- Morquio syndrome C 0 trials
- Mucopolysaccharidosis type 4B 0 trials
-
Stevens-Johnson syndrome 9 trials
-
Burning mouth syndrome 9 trials
1 sub-type
- Burning mouth syndrome type 3 0 trials
-
Calciphylaxis 9 trials
2 sub-types
- Calciphylaxis cutis 0 trials
- Visceral calciphylaxis 0 trials
-
Hand-foot syndrome 9 trials
-
Mayer-Rokitansky-Kuster-Hauser syndrome 8 trials · 9 incl. sub-types
2 sub-types
-
Sickle cell-beta-thalassemia disease syndrome 5 trials · 9 incl. sub-types
2 sub-types
- Sickle cell-beta zero-thalassemia 6 trials
- Sickle cell-beta plus-thalassemia 5 trials
-
Leriche syndrome 8 trials
-
Breast implant illness 8 trials
-
Mucopolysaccharidosis type 6 8 trials
2 sub-types
-
Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types
2 sub-types
- Zellweger spectrum disorders 6 trials · 7 incl. sub-types Sub-types →
- Non-Zellweger spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
-
IRF6-related condition 0 trials · 8 incl. sub-types
2 sub-types
- Van der Woude syndrome 8 trials Sub-types →
- Popliteal pterygium syndrome 0 trials Sub-types →
-
Silver-Russell syndrome 7 trials
11 sub-types
- Russell-silver syndrome, X-linked 0 trials
- Silver-Russell syndrome 1 0 trials
- Silver-Russell syndrome 3 0 trials
- Silver-Russell syndrome 5 0 trials
- Silver-Russell syndrome due to 11p15 microduplication 0 trials
- Silver-Russell syndrome due to 7p11.2p13 microduplication 0 trials
- Silver-Russell syndrome due to an imprinting defect of 11p15 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7 0 trials
- Silver-russell syndrome 2 0 trials
- Silver-russell syndrome 4 0 trials
-
Wolfram syndrome 7 trials
3 sub-types
- Wolfram syndrome 1 1 trial
- Wolfram syndrome 2 0 trials
- Wolfram syndrome, mitochondrial form 0 trials
-
Cystinuria 7 trials
2 sub-types
- Cystinuria type A 0 trials
- Cystinuria type B 0 trials
-
Miliaria 7 trials
8 sub-types
- Infantile miliaria 0 trials
- Miliaria alba 0 trials
- Miliaria crystallina 0 trials
- Miliaria papulosa 0 trials
- Miliaria profunda 0 trials
- Miliaria pustulosa 0 trials
- Miliaria rubra 0 trials
- Miliaria vesiculosa 0 trials
-
Bardet-Biedl syndrome 6 trials · 7 incl. sub-types
22 sub-types
- Bardet-Biedl syndrome 1 1 trial
- Bardet-Biedl syndrome 10 0 trials
- Bardet-Biedl syndrome 11 0 trials
- Bardet-Biedl syndrome 12 0 trials
- Bardet-Biedl syndrome 13 0 trials
- Bardet-Biedl syndrome 14 0 trials
- Bardet-Biedl syndrome 15 0 trials
- Bardet-Biedl syndrome 16 0 trials
- Bardet-Biedl syndrome 17 0 trials
- Bardet-Biedl syndrome 18 0 trials
- Bardet-Biedl syndrome 19 0 trials
- Bardet-Biedl syndrome 2 0 trials
- Bardet-Biedl syndrome 20 0 trials
- Bardet-Biedl syndrome 22 0 trials
- Bardet-Biedl syndrome 3 0 trials
- Bardet-Biedl syndrome 4 0 trials
- Bardet-Biedl syndrome 5 0 trials
- Bardet-Biedl syndrome 6 0 trials
- Bardet-Biedl syndrome 7 0 trials
- Bardet-Biedl syndrome 8 0 trials
- Bardet-Biedl syndrome 9 0 trials
- Bardet-biedl syndrome 21 0 trials
-
Complex hereditary spastic paraplegia 1 trial · 7 incl. sub-types
50 sub-types
- Spastic paraplegia, optic atropy, and neuropathy 3 trials
- Hereditary spastic paraplegia 11 1 trial
- Hereditary spastic paraplegia 15 1 trial
- Hereditary spastic paraplegia 26 1 trial
- Hereditary spastic paraplegia 63 1 trial
- MASA syndrome 0 trials
- Troyer syndrome 0 trials
- Autosomal dominant complex spastic paraplegia 0 trials Sub-types →
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Autosomal recessive complex spastic paraplegia type 9B 0 trials
- Autosomal recessive spastic paraplegia type 59 0 trials
- Autosomal recessive spastic paraplegia type 60 0 trials
- Autosomal recessive spastic paraplegia type 66 0 trials
- Autosomal recessive spastic paraplegia type 67 0 trials
- Autosomal recessive spastic paraplegia type 68 0 trials
- Autosomal recessive spastic paraplegia type 69 0 trials
- Autosomal recessive spastic paraplegia type 70 0 trials
- Autosomal recessive spastic paraplegia type 76 0 trials
- Autosomal recessive spastic paraplegia type 78 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Glutamate pyruvate transaminase 2 deficiency 0 trials
- Hereditary sensory and autonomic neuropathy with spastic paraplegia 0 trials
- Hereditary spastic paraplegia 18 0 trials Sub-types →
- Hereditary spastic paraplegia 23 0 trials
- Hereditary spastic paraplegia 24 0 trials
- Hereditary spastic paraplegia 25 0 trials
- Hereditary spastic paraplegia 27 0 trials
- Hereditary spastic paraplegia 32 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hereditary spastic paraplegia 43 0 trials
- Hereditary spastic paraplegia 44 0 trials
- Hereditary spastic paraplegia 45 0 trials
- Hereditary spastic paraplegia 46 0 trials
- Hereditary spastic paraplegia 49 0 trials
- Hereditary spastic paraplegia 53 0 trials
- Hereditary spastic paraplegia 54 0 trials
- Hereditary spastic paraplegia 55 0 trials
- Hereditary spastic paraplegia 57 0 trials
- Hereditary spastic paraplegia 61 0 trials
- Hereditary spastic paraplegia 64 0 trials
- Hereditary spastic paraplegia 74 0 trials
- Hereditary spastic paraplegia 75 0 trials
- Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome 0 trials
- Maternally-inherited spastic paraplegia 0 trials
- Spastic ataxia 2 0 trials
- Spastic paraplegia 84, autosomal recessive 0 trials
- Spastic paraplegia 85, autosomal recessive 0 trials
- Spastic paraplegia 86, autosomal recessive 0 trials
- Spastic paraplegia-glaucoma-intellectual disability syndrome 0 trials
- Spastic paraplegia-severe developmental delay-epilepsy syndrome 0 trials
-
Duane retraction syndrome 6 trials
4 sub-types
- Duane retraction syndrome 2 0 trials
- Duane retraction syndrome 3 with or without deafness 0 trials
- Duane retraction syndrome with congenital deafness 0 trials
- Duane syndrome type 1 0 trials
-
Hurler syndrome 6 trials
-
Loeys-Dietz syndrome 6 trials
6 sub-types
- Loeys-Dietz syndrome 1 0 trials
- Loeys-Dietz syndrome 2 0 trials
- Loeys-Dietz syndrome 4 0 trials
- Loeys-Dietz syndrome 6 0 trials
- Rienhoff syndrome 0 trials
- Aneurysm-osteoarthritis syndrome 0 trials
-
Angioosteohypertrophic syndrome 6 trials
-
Carcinoid syndrome 6 trials
1 sub-type
- Carcinoid crisis 0 trials
-
Tethered spinal cord syndrome 6 trials
-
DICER1-related tumor predisposition 1 trial · 6 incl. sub-types
2 sub-types
-
Neonatal aspiration syndrome 1 trial · 6 incl. sub-types
2 sub-types
- Meconium aspiration syndrome 5 trials
- Massive neonatal aspiration syndrome 0 trials
-
Growth hormone insensitivity syndrome 0 trials · 6 incl. sub-types
6 sub-types
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Laron syndrome 0 trials
- Short stature due to partial GHR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
-
CLOVES syndrome 5 trials
-
Eisenmenger syndrome 5 trials
-
IMAGe syndrome 5 trials
-
Kearns-Sayre syndrome 5 trials
-
MERRF syndrome 5 trials
-
McCune-Albright syndrome 5 trials
-
Menkes disease 5 trials
-
Shwachman-Diamond syndrome 5 trials
3 sub-types
- DNAJC21-related Shwachman Diamond syndrome 0 trials
- Shwachman-Diamond syndrome 1 0 trials
- Shwachman-Diamond syndrome 2 0 trials
-
4 sub-types
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3 0 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 0 trials
-
Congenital myasthenic syndrome 5 trials
8 sub-types
- Postsynaptic congenital myasthenic syndrome 0 trials · 2 incl. sub-types Sub-types →
- Presynaptic congenital myasthenic syndrome 0 trials · 1 incl. sub-types Sub-types →
- Congenital myasthenic syndrome 15 0 trials
- Congenital myasthenic syndrome 5 0 trials
- Congenital myasthenic syndrome with tubular aggregates 0 trials Sub-types →
- Myasthenia, congenital, refractory to acetylcholinesterase inhibitors 0 trials
- Myasthenic syndrome, congenital, 22 0 trials
- Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive 0 trials
-
Craniofacial microsomia 5 trials
2 sub-types
- Craniofacial microsomia 1 0 trials
- Craniofacial microsomia 2 0 trials
-
Pelvis syndrome 5 trials
-
Cornelia de Lange syndrome 4 trials · 5 incl. sub-types
6 sub-types
- Cornelia de Lange syndrome 1 1 trial
- Cornelia de Lange syndrome 2 0 trials
- Cornelia de Lange syndrome 3 0 trials
- Cornelia de Lange syndrome 4 0 trials
- Cornelia de Lange syndrome 5 0 trials
- Cornelia de Lange syndrome 6 0 trials
-
Boerhaave syndrome 4 trials
-
CHARGE syndrome 4 trials
1 sub-type
- CHD7-related CHARGE syndrome 0 trials
-
Fanconi renotubular syndrome 4 trials
4 sub-types
- Deal Barratt Dillon syndrome 0 trials
- Acquired Fanconi syndrome 0 trials Sub-types →
- Adult Fanconi syndrome 0 trials
- Inherited Fanconi renotubular syndrome 0 trials Sub-types →
-
SUNCT syndrome 4 trials
-
4 sub-types
-
Nephronophthisis 1 4 trials
-
Trisomy 13 4 trials
2 sub-types
- Complete trisomy 13 0 trials
- Mosaic trisomy 13 0 trials
-
Stickler syndrome 2 trials · 4 incl. sub-types
5 sub-types
- Stickler syndrome type 1 3 trials Sub-types →
- Stickler syndrome type 2 2 trials
- Stickler syndrome, type 4 0 trials
- Stickler syndrome, type 5 0 trials
- Stickler syndrome, type 6 0 trials
-
Kenny-Caffey syndrome 0 trials · 4 incl. sub-types
2 sub-types
-
Hypoplastic right heart syndrome 0 trials · 4 incl. sub-types
2 sub-types
-
Barre-Lieou syndrome 3 trials
-
Hutchinson-Gilford progeria syndrome 3 trials
-
Kallmann syndrome 3 trials
18 sub-types
- Hypogonadotropic hypogonadism 1 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 11 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 14 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 15 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 16 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 17 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 18 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 19 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 2 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 20 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 21 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 22 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 3 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 4 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 5 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 6 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 8 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 9 with or without anosmia 0 trials
-
3 sub-types
- LEOPARD syndrome 1 0 trials
- LEOPARD syndrome 2 0 trials
- LEOPARD syndrome 3 0 trials
-
Pearson syndrome 3 trials
-
Pitt-Hopkins syndrome 3 trials
-
Cannabinoid hyperemesis syndrome 3 trials
-
Facial hemiatrophy 3 trials
-
Oculocerebrorenal syndrome 3 trials
-
Ornithine translocase deficiency 3 trials
-
Triple-A syndrome 3 trials
-
Trisomy 18 3 trials
2 sub-types
- Complete trisomy 18 0 trials
- Mosaic trisomy 18 0 trials
-
Trisomy X 3 trials
-
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 1 trial · 3 incl. sub-types
4 sub-types
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 2 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 1 trial
- Inclusion body myopathy and brain white matter abnormalities 0 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 0 trials
-
Iridocorneal endothelial syndrome 1 trial · 3 incl. sub-types
3 sub-types
- Chandler syndrome 2 trials
- Cogan-Reese syndrome 0 trials
- Essential iris atrophy 0 trials
-
Aicardi syndrome 2 trials
-
Birt-Hogg-Dube syndrome 2 trials
2 sub-types
- Birt-Hogg-Dube syndrome 1 0 trials
- Birt-Hogg-Dube syndrome 2 0 trials
-
Charles bonnet syndrome 2 trials
-
Cri-du-chat syndrome 2 trials
-
Hurler-Scheie syndrome 2 trials
-
Joubert syndrome 2 trials
39 sub-types
- Joubert syndrome 1 0 trials
- Joubert syndrome 10 0 trials
- Joubert syndrome 11 0 trials
- Joubert syndrome 13 0 trials
- Joubert syndrome 14 0 trials
- Joubert syndrome 15 0 trials
- Joubert syndrome 16 0 trials
- Joubert syndrome 17 0 trials Sub-types →
- Joubert syndrome 18 0 trials
- Joubert syndrome 19 0 trials
- Joubert syndrome 2 0 trials
- Joubert syndrome 20 0 trials
- Joubert syndrome 21 0 trials
- Joubert syndrome 22 0 trials
- Joubert syndrome 23 0 trials
- Joubert syndrome 24 0 trials
- Joubert syndrome 25 0 trials
- Joubert syndrome 26 0 trials
- Joubert syndrome 27 0 trials
- Joubert syndrome 28 0 trials
- Joubert syndrome 29 0 trials
- Joubert syndrome 3 0 trials
- Joubert syndrome 30 0 trials
- Joubert syndrome 31 0 trials
- Joubert syndrome 32 0 trials
- Joubert syndrome 33 0 trials
- Joubert syndrome 34 0 trials
- Joubert syndrome 35 0 trials
- Joubert syndrome 36 0 trials
- Joubert syndrome 37 0 trials
- Joubert syndrome 38 0 trials
- Joubert syndrome 39 0 trials
- Joubert syndrome 40 0 trials
- Joubert syndrome 5 0 trials
- Joubert syndrome 6 0 trials
- Joubert syndrome 7 0 trials
- Joubert syndrome 8 0 trials
- Joubert syndrome 9 0 trials
- Joubert syndrome with renal defect 0 trials
-
Kabuki syndrome 2 trials
2 sub-types
- Kabuki syndrome 1 0 trials
- Kabuki syndrome 2 0 trials
-
Mobius syndrome 2 trials
1 sub-type
-
Poland syndrome 2 trials
-
Susac syndrome 2 trials
-
Werner syndrome 2 trials
-
Acrocallosal syndrome 2 trials
-
Cauda equina syndrome 2 trials
1 sub-type
-
Celiac trunk compression syndrome 2 trials
-
Congenital cardiovascular shunt 2 trials
-
Craniofacial and skeletal defects 2 trials
-
Dilated cardiomyopathy 1A 2 trials
-
Engraftment syndrome 2 trials
-
Gas bloat syndrome 2 trials
-
Hantavirus pulmonary syndrome 2 trials
-
Jaw-winking syndrome 2 trials
2 sub-types
- Marin-Amat syndrome 0 trials
- Inverse Marcus-Gunn phenomenon 0 trials
-
Nail-patella syndrome 2 trials
-
Polydactyly-myopia syndrome 2 trials
-
Superior mesenteric artery syndrome 2 trials
-
Superior vena cava syndrome 2 trials
-
Sweet syndrome 2 trials
-
Vertebral artery insufficiency 2 trials
-
Xeroderma pigmentosum-Cockayne syndrome complex 1 trial · 2 incl. sub-types
6 sub-types
- Xeroderma pigmentosum group F 1 trial
- Xeroderma pigmentosum group B 0 trials
- Xeroderma pigmentosum group D 0 trials
- Xeroderma pigmentosum group G 0 trials
- Xeroderma pigmentosum, type F/Cockayne syndrome 0 trials
- Xeroderma pigmentosum, type G/Cockayne syndrome 0 trials
-
Pallister-Hall syndrome 0 trials · 2 incl. sub-types
1 sub-type
-
Disappearing bone disease 0 trials · 2 incl. sub-types
2 sub-types
- Gorham-Stout disease 2 trials
- Acroosteolysis dominant type 0 trials
-
Short rib-polydactyly syndrome 0 trials · 2 incl. sub-types
4 sub-types
- Jeune syndrome 1 trial · 2 incl. sub-types Sub-types →
- Joubert syndrome with Jeune asphyxiating thoracic dystrophy 0 trials Sub-types →
- Cranioectodermal dysplasia 0 trials Sub-types →
- Short rib-polydactyly syndrome, Majewski type 0 trials Sub-types →
-
Aagenaes syndrome 1 trial
-
Adams-Stokes syndrome 1 trial
-
Alstrom syndrome 1 trial
-
Axenfeld-Rieger syndrome 1 trial
3 sub-types
- Axenfeld-Rieger syndrome type 3 1 trial
- Axenfeld-Rieger syndrome type 1 0 trials
- Axenfeld-Rieger syndrome type 2 0 trials
-
BNAR syndrome 1 trial
-
Capgras syndrome 1 trial
-
Caroli syndrome 1 trial
-
Coffin-Siris syndrome 1 trial
11 sub-types
- Coffin-Siris syndrome 1 0 trials
- Coffin-Siris syndrome 10 0 trials
- Coffin-Siris syndrome 11 0 trials
- Coffin-Siris syndrome 12 0 trials
- Coffin-Siris syndrome 5 0 trials
- Coffin-Siris syndrome 7 0 trials
- Coffin-Siris syndrome 8 0 trials
- Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
-
Currarino triad 1 trial
-
DNA ligase IV deficiency 1 trial
-
Denys-Drash syndrome 1 trial
-
Duane-radial ray syndrome 1 trial
2 sub-types
-
EEC syndrome 1 trial
-
Freeman-Sheldon syndrome 1 trial
1 sub-type
-
Fryns syndrome 1 trial
-
German syndrome 1 trial
-
Holmes-Adie syndrome 1 trial
-
5 sub-types
- Joubert syndrome 14 0 trials
- Joubert syndrome 16 0 trials
- Joubert syndrome 2 0 trials
- Joubert syndrome 5 0 trials
- Joubert syndrome 9 0 trials
-
Lesch-Nyhan syndrome 1 trial
1 sub-type
-
Liddle syndrome 1 trial
3 sub-types
- Liddle syndrome 1 0 trials
- Liddle syndrome 2 0 trials
- Liddle syndrome 3 0 trials
-
Meier-Gorlin syndrome 1 trial
9 sub-types
- Meier-Gorlin syndrome 1 0 trials
- Meier-Gorlin syndrome 2 0 trials
- Meier-Gorlin syndrome 3 0 trials
- Meier-Gorlin syndrome 4 0 trials
- Meier-Gorlin syndrome 5 0 trials
- Meier-Gorlin syndrome 6 0 trials
- Meier-Gorlin syndrome 7 0 trials
- Meier-Gorlin syndrome 8 0 trials
- Meier-Gorlin syndrome 9 0 trials
-
Potocki-Lupski syndrome 1 trial
-
Potter sequence 1 trial
-
RHYNS syndrome 1 trial
-
RNU4ATAC spectrum disorder 1 trial
3 sub-types
- Lowry-Wood syndrome 1 trial
- Roifman syndrome 1 trial
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
-
Reunion island Larsen syndrome 1 trial
-
Scheie syndrome 1 trial
-
Sotos syndrome 1 trial
-
Tolosa-Hunt syndrome 1 trial
-
Waardenburg syndrome 1 trial
5 sub-types
- Waardenburg syndrome type 1 1 trial
- Waardenburg syndrome type 2 1 trial Sub-types →
- Waardenburg syndrome type 3 0 trials
- Waardenburg syndrome, IIa 2F 0 trials
- Waardenburg-Shah syndrome 0 trials Sub-types →
-
Wernicke-Korsakoff syndrome 1 trial
1 sub-type
-
Acute radiation syndrome 1 trial
-
2 sub-types
-
Atlanto-axial fusion 1 trial
-
Bidirectional tachycardia 1 trial
-
Capillary leak syndrome 1 trial
-
Cleidocranial dysplasia 1 1 trial
-
Congenital amputation 1 trial
-
Craniofrontonasal syndrome 1 trial
-
Deafness-infertility syndrome 1 trial
-
Epidermal nevus syndrome 1 trial
-
Human HOXA1 syndromes 1 trial
1 sub-type
- Bosley-Salih-Alorainy syndrome 0 trials
-
Ichthyosis prematurity syndrome 1 trial
-
Levator syndrome 1 trial
-
Neuroleptic malignant syndrome 1 trial
-
Orofaciodigital syndrome I 1 trial
-
Palindromic rheumatism 1 trial
-
Postaxial acrofacial dysostosis 1 trial
-
Prune belly syndrome 1 trial
-
Septooptic dysplasia 1 trial
2 sub-types
- Congenital absence of septum pellucidum 0 trials
- Pagon stephan syndrome 0 trials
-
Subclavian steal syndrome 1 trial
-
Tarsal tunnel syndrome 1 trial
-
Thalidomide embryopathy 1 trial
-
Visceral heterotaxy 1 trial
19 sub-types
- Dextrocardia 1 trial
- Situs inversus 1 trial Sub-types →
- Heterotaxy, visceral, 1, X-linked 0 trials
- Heterotaxy, visceral, 10, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 11, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 12, autosomal 0 trials
- Heterotaxy, visceral, 13, autosomal 0 trials
- Heterotaxy, visceral, 14, autosomal 0 trials
- Heterotaxy, visceral, 2, autosomal 0 trials
- Heterotaxy, visceral, 3, autosomal 0 trials
- Heterotaxy, visceral, 4, autosomal 0 trials
- Heterotaxy, visceral, 5, autosomal 0 trials
- Heterotaxy, visceral, 6, autosomal 0 trials
- Heterotaxy, visceral, 7, autosomal 0 trials
- Heterotaxy, visceral, 8, autosomal 0 trials
- Heterotaxy, visceral, 9, autosomal, with male infertility 0 trials
- Laterality defects, autosomal dominant 0 trials
- Levocardia 0 trials
- Right atrial isomerism 0 trials
-
Meckel syndrome 0 trials · 1 incl. sub-types
14 sub-types
- Meckel syndrome, type 1 1 trial
- Meckel syndrome 13 0 trials
- Meckel syndrome, type 10 0 trials
- Meckel syndrome, type 11 0 trials
- Meckel syndrome, type 2 0 trials
- Meckel syndrome, type 3 0 trials
- Meckel syndrome, type 4 0 trials
- Meckel syndrome, type 5 0 trials
- Meckel syndrome, type 6 0 trials
- Meckel syndrome, type 8 0 trials
- Meckel syndrome, type 9 0 trials
- NPHP3-related Meckel-like syndrome 0 trials
- Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome 0 trials
- Meckel syndrome 14 0 trials
-
NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types
3 sub-types
- Thyroid cancer, nonmedullary, 1 1 trial
- Brain-lung-thyroid syndrome 0 trials
- Hereditary progressive chorea without dementia 0 trials
-
Seckel syndrome 0 trials · 1 incl. sub-types
12 sub-types
- Seckel syndrome 7 1 trial
- Seckel syndrome 1 0 trials
- Seckel syndrome 10 0 trials
- Seckel syndrome 11 0 trials
- Seckel syndrome 2 0 trials
- Seckel syndrome 4 0 trials
- Seckel syndrome 5 0 trials
- Seckel syndrome 6 0 trials
- Seckel syndrome 8 0 trials
- Seckel syndrome 9 0 trials
- Intrauterine growth retardation with increased mitomycin c sensitivity 0 trials
- Microcephaly 13, primary, autosomal recessive 0 trials
-
Microcephalic osteodysplastic primordial dwarfism types I and III 0 trials · 1 incl. sub-types
2 sub-types
-
3-M syndrome 0 trials
3 sub-types
- 3M syndrome 1 0 trials
- 3M syndrome 2 0 trials
- 3M syndrome 3 0 trials
-
48,XXXY syndrome 0 trials
-
48,XXYY syndrome 0 trials
-
48,XYYY syndrome 0 trials
-
49,XXXXY syndrome 0 trials
-
6q terminal deletion syndrome 0 trials
-
8p23.1 microdeletion syndrome 0 trials
-
AIDS dysmorphic syndrome 0 trials
-
ANE syndrome 0 trials
-
Abruzzo-Erickson syndrome 0 trials
-
Achard syndrome 0 trials
-
Achard-Thiers syndrome 0 trials
-
Achenbach syndrome 0 trials
-
Acrootoocular syndrome 0 trials
-
Ahumada Del Castillo syndrome 0 trials
-
Aksu von Stockhausen syndrome 0 trials
-
Al-Gazali syndrome 0 trials
-
Alfadhel syndrome 0 trials
-
Alice in Wonderland syndrome 0 trials
-
Alkuraya-Kucinskas syndrome 0 trials
-
Aloi Tomasini Isaia syndrome 0 trials
-
1 sub-type
-
Alsahan-Harris syndrome 0 trials
-
Apert-like polydactyly syndrome 0 trials
-
Armfield syndrome 0 trials
-
Arnold stickler bourne syndrome 0 trials
-
Atkin-Flaitz syndrome 0 trials
-
Ayme-Gripp syndrome 0 trials
-
BD syndrome 0 trials
-
BRESEK syndrome 0 trials
-
Bamforth-Lazarus syndrome 0 trials
-
2 sub-types
- Baraitser-Winter syndrome 1 0 trials
- Baraitser-winter syndrome 2 0 trials
-
Barnicoat Baraitser syndrome 0 trials
-
Bartter syndrome 0 trials
6 sub-types
- Bartter disease type 1 0 trials
- Bartter disease type 2 0 trials
- Bartter disease type 3 0 trials
- Bartter disease type 5 0 trials
- Bartter syndrome type 4 0 trials Sub-types →
- Bartter syndrome with hypocalcemia 0 trials
-
Basedow's coma 0 trials
-
Basilicata-Akhtar syndrome 0 trials
-
Beardwell syndrome 0 trials
-
Bencze syndrome 0 trials
-
Bernard-Soulier syndrome 0 trials
1 sub-type
-
Bloom syndrome 0 trials
-
Bonnemann-Meinecke-Reich syndrome 0 trials
-
Bonnevie-Ullrich syndrome 0 trials
-
Brown-Sequard syndrome 0 trials
-
Bruck syndrome 0 trials
2 sub-types
- Bruck syndrome 1 0 trials
- Bruck syndrome 2 0 trials
-
Brunsting-Perry syndrome 0 trials
-
Buschke-Ollendorff syndrome 0 trials
-
CADDS 0 trials
-
CEDNIK syndrome 0 trials
-
CODAS syndrome 0 trials
-
CREST syndrome 0 trials
-
3 sub-types
- Cataract 16 multiple types 0 trials Sub-types →
- Dilated cardiomyopathy 1II 0 trials
- Myofibrillar myopathy 2 0 trials
-
Camurati-Engelmann disease 0 trials
2 sub-types
- Camurati-Engelmann disease type 1 0 trials
- Camurati-Engelmann disease type 2 0 trials
-
Cartwright Nelson Fryns syndrome 0 trials
-
Cerebrorenodigital syndrome 0 trials
-
Christian Demyer Franken syndrome 0 trials
-
Christian Johnson angenieta syndrome 0 trials
-
Christianson syndrome 0 trials
-
Cohen Lockood Wyborney syndrome 0 trials
-
Cole-Carpenter syndrome 0 trials
2 sub-types
- Cole-Carpenter syndrome 1 0 trials
- Cole-Carpenter syndrome 2 0 trials
-
Collins-Sakati syndrome 0 trials
-
Colver Steer Godman syndrome 0 trials
-
Combarros Calleja Leno syndrome 0 trials
-
Cormier Rustin Munnich syndrome 0 trials
-
Cortes Lacassie syndrome 0 trials
-
Cramp-fasciculation syndrome 0 trials
-
Crandall syndrome 0 trials
-
Crigler-Najjar syndrome 0 trials
2 sub-types
- Crigler-Najjar syndrome type 1 0 trials
- Crigler-Najjar syndrome type 2 0 trials
-
Czeizel-Losonci syndrome 0 trials
-
DOORS syndrome 0 trials
-
Davenport-Donlan syndrome 0 trials
-
Davis Lafer syndrome 0 trials
-
Dennis-Fairhurst-Moore syndrome 0 trials
-
Diamond-Blackfan anemia 2 0 trials
-
Donohue syndrome 0 trials
-
Drachtman Weinblatt Sitarz syndrome 0 trials
-
Dubin-Johnson syndrome 0 trials
-
Duker-Weiss-Siber syndrome 0 trials
-
Dursun syndrome 0 trials
-
Dyggve-Melchior-Clausen disease 0 trials
1 sub-type
-
EDICT syndrome 0 trials
-
Eagle syndrome 0 trials
-
Elliott ludman Teebi syndrome 0 trials
-
Elsahy-Waters syndrome 0 trials
-
Engelhard Yatziv syndrome 0 trials
-
FG syndrome 0 trials
6 sub-types
- Aarskog-Scott syndrome, X-linked 0 trials
- FG syndrome 1 0 trials
- FG syndrome 2 0 trials
- FG syndrome 3 0 trials
- FG syndrome 4 0 trials
- FG syndrome 5 0 trials
-
FICUS syndrome 0 trials
-
FRAXF syndrome 0 trials
-
Fanconi-like syndrome 0 trials
1 sub-type
-
Faye-Petersen-Ward-Carey syndrome 0 trials
-
Feingold syndrome 0 trials
2 sub-types
- Feingold syndrome type 1 0 trials
- Feingold syndrome type 2 0 trials
-
Feingold trainer syndrome 0 trials
-
Felty syndrome 0 trials
-
Finnish type amyloidosis 0 trials
-
Fitz-Hugh-Curtis syndrome 0 trials
-
Fliedner-Zweier syndrome 0 trials
-
Frank-Ter Haar syndrome 0 trials
-
Fraser Jequier Chen syndrome 0 trials
-
Fraser syndrome 0 trials
3 sub-types
- Fraser syndrome 1 0 trials
- Fraser syndrome 2 0 trials
- Fraser syndrome 3 0 trials
-
Frasier syndrome 0 trials
-
Freiberg disease 0 trials
-
Friedman Goodman syndrome 0 trials
-
Froelich syndrome 0 trials
-
Fryns Fabry Remans syndrome 0 trials
-
Fryns Smeets Thiry syndrome 0 trials
-
Fuchs heterochromic iridocyclitis 0 trials
-
Fukuda-Miyanomae-Nakata syndrome 0 trials
-
Fuqua Berkovitz syndrome 0 trials
-
GMS syndrome 0 trials
-
Galloway-Mowat syndrome 0 trials
10 sub-types
- Galloway-Mowat syndrome 1 0 trials
- Galloway-Mowat syndrome 10 0 trials
- Galloway-Mowat syndrome 2, X-linked 0 trials
- Galloway-Mowat syndrome 3 0 trials
- Galloway-Mowat syndrome 4 0 trials
- Galloway-Mowat syndrome 5 0 trials
- Galloway-Mowat syndrome 6 0 trials
- Galloway-Mowat syndrome 7 0 trials
- Galloway-Mowat syndrome 8 0 trials
- Galloway-Mowat syndrome 9 0 trials
-
Gamstorp-Wohlfart syndrome 0 trials
-
Garret-Tripp syndrome 0 trials
-
Ghose-Sachdev-Kumar syndrome 0 trials
-
Gilbert syndrome 0 trials
-
Gitelman syndrome 0 trials
-
Goldberg-Shprintzen syndrome 0 trials
-
Greig cephalopolysyndactyly syndrome 0 trials
1 sub-type
-
Grisel syndrome 0 trials
-
Grubben-de Cock-Borghgraef syndrome 0 trials
-
Guillouet-Gordon syndrome 0 trials
-
Guttmacher syndrome 0 trials
-
HEC syndrome 0 trials
-
Hartsfield-Bixler-Demyer syndrome 0 trials
-
Hennekam syndrome 0 trials
3 sub-types
-
Hernández-Aguirre Negrete syndrome 0 trials
-
Ho-Kaufman-McAlister syndrome 0 trials
-
Holzgreve-Wagner-Rehder syndrome 0 trials
-
Houge-Janssens syndrome 0 trials
4 sub-types
- Houge-Janssens syndrome 1 0 trials
- Houge-Janssens syndrome 2 0 trials
- Houge-Janssens syndrome 3 0 trials
- Houge-Janssens syndrome 4 0 trials
-
Hoxha-Aliu syndrome 0 trials
-
Hughes-Stovin syndrome 0 trials
-
ICHAD syndrome 0 trials
-
IFAP syndrome 0 trials
2 sub-types
- IFAP syndrome 1, with or without BRESHECK syndrome 0 trials
- IFAP syndrome 2 0 trials
-
Imerslund-Grasbeck syndrome 0 trials
2 sub-types
- Imerslund-Grasbeck syndrome type 1 0 trials
- Imerslund-Grasbeck syndrome type 2 0 trials
-
Jaberi-Elahi syndrome 0 trials
-
Jacobsen syndrome 0 trials
-
Jaffer-Beighton syndrome 0 trials
-
Joubert syndrome with ocular defect 0 trials
5 sub-types
- Joubert syndrome 14 0 trials
- Joubert syndrome 15 0 trials
- Joubert syndrome 20 0 trials
- Joubert syndrome 28 0 trials
- Joubert syndrome 3 0 trials
-
Judge Misch wright syndrome 0 trials
-
KINSSHIP syndrome 0 trials
-
Kashani-Strom-Utley syndrome 0 trials
-
Kasznica-Carlson-Coppedge syndrome 0 trials
-
Kleine-Levin syndrome 0 trials
-
Kluver-Bucy syndrome 0 trials
-
Kocher-debre-Semelaigne syndrome 0 trials
-
Koone-Rizzo-Elias syndrome 0 trials
-
Kousseff syndrome 0 trials
-
Kozlowski Brown Hardwick syndrome 0 trials
-
Kozlowski Ouvrier syndrome 0 trials
-
Kozlowski Warren Fisher syndrome 0 trials
-
Krauss Herman Holmes syndrome 0 trials
-
Krieble Bixler syndrome 0 trials
-
Kuster Majewski Hammerstein syndrome 0 trials
-
Kuster syndrome 0 trials
-
Landau-Kleffner syndrome 0 trials
-
Landy-Donnai syndrome 0 trials
-
Laugier-Hunziker syndrome 0 trials
-
Laurence-Moon syndrome 0 trials
-
Laurence-Prosser-Rocker syndrome 0 trials
-
Leigh syndrome, mitochondrial 0 trials
-
Lenz-Majewski hyperostotic dwarfism 0 trials
-
Li-Takada-Miyake syndrome 0 trials
-
Liberfarb syndrome 0 trials
-
Long-Olsen-Distelmaier syndrome 0 trials
-
Lopes-Maciel-Rodan syndrome 0 trials
-
Lowe-Kohn-Cohen syndrome 0 trials
-
Lown-Ganong-Levine syndrome 0 trials
-
Lui-Jee-Baron syndrome 0 trials
-
Luscan-Lumish syndrome 0 trials
-
MEDNIK syndrome 0 trials
-
MIRAGE syndrome 0 trials
-
Mallory-Weiss syndrome 0 trials
-
Marinesco-Sjogren-like syndrome 0 trials
-
Marshall-Smith syndrome 0 trials
-
Mauriac syndrome 0 trials
-
Meacham syndrome 0 trials
-
Meester-Loeys syndrome 0 trials
-
Melhem-Fahl syndrome 0 trials
-
Melkersson-Rosenthal syndrome 0 trials
-
Mietens syndrome 0 trials
-
Mikati-Najjar-Sahli syndrome 0 trials
-
Miller Fisher syndrome 0 trials
-
Miller-Dieker lissencephaly syndrome 0 trials
-
Milner-Khallouf-Gibson syndrome 0 trials
-
NDUFB11-related disorders 0 trials
2 sub-types
-
Nager acrofacial dysostosis 0 trials
-
Nathalie syndrome 0 trials
-
Neu-Laxova syndrome 0 trials
3 sub-types
- Neu-Laxova syndrome 1 0 trials
- Neu-Laxova syndrome 2 0 trials
- Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency 0 trials
-
Norman-Roberts syndrome 0 trials
-
Opitz G/BBB syndrome 0 trials
1 sub-type
- X-linked Opitz G/BBB syndrome 0 trials
-
PAGOD syndrome 0 trials
-
PCWH syndrome 0 trials
-
PEHO syndrome 0 trials
-
Pallister-W syndrome 0 trials
-
Pan-Chung-Bellen syndrome 0 trials
-
Parana hard-skin syndrome 0 trials
-
Parinaud syndrome 0 trials
-
Pavone Fiumara Rizzo syndrome 0 trials
-
Pendred syndrome 0 trials
-
Perlman syndrome 0 trials
-
Perry syndrome 0 trials
-
Peters plus syndrome 0 trials
-
Pfeiffer Tietze Welte syndrome 0 trials
-
Plummer-Vinson syndrome 0 trials
-
Potocki-Shaffer syndrome 0 trials
-
Primrose syndrome 0 trials
-
Qazi Markouizos syndrome 0 trials
-
Rabson-Mendenhall syndrome 0 trials
-
Rahman syndrome 0 trials
-
Reye syndrome 0 trials
-
Roberts-SC phocomelia syndrome 0 trials
-
Robinow syndrome 0 trials
3 sub-types
-
Roussy-Levy syndrome 0 trials
-
Rubinstein Taybi like syndrome 0 trials
-
Ruvalcaba syndrome 0 trials
-
Ruzicka-Goerz-Anton syndrome 0 trials
-
SCARF syndrome 0 trials
-
SHORT syndrome 0 trials
-
STAD syndrome 0 trials
-
Saal-Bulas syndrome 0 trials
-
Sackey-Sakati-Aur syndrome 0 trials
-
Sammartino-Decreccio syndrome 0 trials
-
Samson-Gardner syndrome 0 trials
-
Samson-Viljoen syndrome 0 trials
-
Sanderson-Fraser syndrome 0 trials
-
Sandhaus-Ben-Ami syndrome 0 trials
-
Sandifer syndrome 0 trials
-
Saul-Wilkes-Stevenson syndrome 0 trials
-
Say-Barber-Miller syndrome 0 trials
-
Schilbach-Rott syndrome 0 trials
-
Schlegelberger-Grote syndrome 0 trials
-
Schmid metaphyseal chondrodysplasia 0 trials
-
Schwartz-Jampel syndrome 0 trials
2 sub-types
- Schwartz-Jampel syndrome type 1 0 trials
- Stüve-Wiedemann syndrome 1 0 trials
-
Sheehan syndrome 0 trials
-
Sillence syndrome 0 trials
-
Skraban-Deardorff syndrome 0 trials
-
Slti-Salem syndrome 0 trials
-
Stankiewicz-Isidor syndrome 0 trials
-
Sweeney-Cox syndrome 0 trials
-
Tan-Almurshedi syndrome 0 trials
-
Tayoun-Maawali syndrome 0 trials
-
Tietze syndrome 0 trials
-
Townes-Brocks syndrome 0 trials
2 sub-types
- Townes-Brocks syndrome 1 0 trials
- Townes-Brocks syndrome 2 0 trials
-
Treacher-Collins syndrome 0 trials
4 sub-types
- Treacher Collins syndrome 1 0 trials
- Treacher Collins syndrome 2 0 trials
- Treacher Collins syndrome 3 0 trials
- Treacher Collins syndrome 4 0 trials
-
VACTERL with hydrocephalus 0 trials
1 sub-type
-
VACTERL/vater association 0 trials
1 sub-type
-
Ververi-Brady syndrome 0 trials
2 sub-types
- Ververi-Brady syndrome 1 0 trials
- Ververi-Brady syndrome 2 0 trials
-
Vici syndrome 0 trials
-
Waterhouse-Friderichsen syndrome 0 trials
-
Weaver syndrome 0 trials
-
Weill-Marchesani syndrome 0 trials
4 sub-types
- Weill-Marchesani 4 syndrome, recessive 0 trials
- Weill-Marchesani syndrome 1 0 trials
- Weill-Marchesani syndrome 2, dominant 0 trials
- Weill-Marchesani syndrome 3 0 trials
-
Wiedemann-Rautenstrauch syndrome 0 trials
-
Wildervanck syndrome 0 trials
-
Wissler syndrome 0 trials
-
Wolcott-Rallison syndrome 0 trials
-
Wolf-Hirschhorn syndrome 0 trials
-
X-linked corneal dermoid 0 trials
-
X-linked mandibulofacial dysostosis 0 trials
-
XFE progeroid syndrome 0 trials
-
Yuksel-Vogel-Bauer syndrome 0 trials
-
Yunis-Varon syndrome 0 trials
-
Zadik-Barak-Levin syndrome 0 trials
-
Zazam Sheriff Phillips syndrome 0 trials
-
Zerres Rietschel Majewski syndrome 0 trials
-
Zinner syndrome 0 trials
-
Ablepharon macrostomia syndrome 0 trials
-
Achalasia-alacrima syndrome 0 trials
-
Acrofrontofacionasal dysostosis 2 0 trials
-
Aglossia and situs inversus 0 trials
-
Agnathia-microstomia-synotia 0 trials
-
Agyria pachygyria polymicrogyria 0 trials
-
Agyria-pachygyria type 1 0 trials
-
4 sub-types
-
Alpha-mannosidosis type 1 0 trials
-
Aluminosis 0 trials
-
Angioosteohypotrophic syndrome 0 trials
-
Aniridia-absent patella syndrome 0 trials
-
Ankle defects short stature 0 trials
-
Annular constricting bands 0 trials
-
Anophthalmia plus syndrome 0 trials
-
Anotia facial palsy cardiac defect 0 trials
-
Anterior spinal artery syndrome 0 trials
-
Aortic dissection lentiginosis 0 trials
-
Arakawa syndrome 2 0 trials
-
Arena syndrome 0 trials
-
Asternia 0 trials
-
Ataxia - telangiectasia variant 0 trials
-
Atrophoderma of Pierini and Pasini 0 trials
-
Auroneurodental syndrome 0 trials
-
Autosomal dominant cataract 0 trials
1 sub-type
-
2 sub-types
-
1 sub-type
-
Axial mesodermal dysplasia spectrum 0 trials
-
Baetz-greenwalt syndrome 0 trials
-
Bagatelle Cassidy syndrome 0 trials
-
Baker Vinters syndrome 0 trials
-
Basilar artery insufficiency 0 trials
-
Benign exophthalmos syndrome 0 trials
-
Bhaskar jagannathan syndrome 0 trials
-
Bobble-head doll syndrome 0 trials
-
Brachydactyly anonychia 0 trials
-
Brachydactyly tibial hypoplasia 0 trials
-
Brachydactyly type A2 0 trials
-
Brain malformation renal syndrome 0 trials
-
Branchio-oto-renal syndrome 0 trials
2 sub-types
- Branchiootorenal syndrome 1 0 trials
- Branchiootorenal syndrome 2 0 trials
-
Branchiootic syndrome 0 trials
3 sub-types
- Branchiootic syndrome 1 0 trials
- Branchiootic syndrome 2 0 trials
- Branchiootic syndrome 3 0 trials
-
Brittle bone syndrome lethal type 0 trials
-
Bronchiectasis oligospermia 0 trials
-
Bruyn scheltens syndrome 0 trials
-
Burn goodship syndrome 0 trials
-
Campomelia, Cumming type 0 trials
-
Camptodactyly vertebral fusion 0 trials
-
Camptomelic syndrome, long-limb type 0 trials
-
Carbon baby syndrome 0 trials
-
Cardiocutaneous syndrome 0 trials
-
Cardioectodermal syndrome 0 trials
2 sub-types
- Naxos disease 0 trials
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma 0 trials
-
Cardioencephalomyopathy 0 trials
-
Cardiofacial syndrome short limbs 0 trials
-
Cardiomyopathy diabetes deafness 0 trials
-
Cardiomyopathy spherocytosis 0 trials
-
Carpo tarsal osteolysis recessive 0 trials
-
Cat-eye syndrome 0 trials
-
Cataract - microcornea syndrome 0 trials
-
Cataract skeletal anomalies 0 trials
-
Cataract-glaucoma syndrome 0 trials
-
Caudal duplication 0 trials
-
1 sub-type
- Familial caudal dysgenesis 0 trials Sub-types →
-
Cennamo gangemi syndrome 0 trials
-
Cerebellar agenesis 0 trials
-
Cerebello-olivary atrophy 0 trials
-
Cerebrocostomandibular syndrome 0 trials
-
Childhood aortic valve stenosis 0 trials
-
Chondrodysplasia 0 trials
3 sub-types
-
Choreoacanthocytosis amyotrophic 0 trials
-
Chromosome 13q14 deletion syndrome 0 trials
-
Chromosome 18p deletion syndrome 0 trials
-
Chromosome 18q deletion syndrome 0 trials
2 sub-types
-
Chromosome 3 duplication syndrome 0 trials
-
Ciliary dyskinesia-bronchiectasis 0 trials
-
Cleft lip palate-tetraphocomelia 0 trials
-
Cleft lip-retinopathy syndrome 0 trials
-
Cleft tongue 0 trials
-
Cleidorhizomelic syndrome 0 trials
-
Cloacal exstrophy 0 trials
-
Coarse face hypotonia constipation 0 trials
-
Coloboma porencephaly hydronephrosis 0 trials
-
Colonic malakoplakia 0 trials
-
Complement receptor deficiency 0 trials
-
Congenital acardia 0 trials
1 sub-type
- Holoacardius amorphus 0 trials
-
Congenital articular rigidity 0 trials
-
Congenital contractures 0 trials
-
Congenital cystic eye 0 trials
1 sub-type
-
2 sub-types
-
Congenital laryngeal web 0 trials
-
Congenital mumps 0 trials
-
Congenital vagal hyperreflexivity 0 trials
-
Congenital varicella syndrome 0 trials
-
Corneal crystals myopathy neuropathy 0 trials
-
Corneal-cerebellar syndrome 0 trials
-
Cortada Koussef Matsumoto syndrome 0 trials
-
Craniofaciocardiohepatic syndrome 0 trials
-
Craniosynostosis-scoliosis syndrome 0 trials
-
Crawfurd syndrome 0 trials
-
Cutis laxa osteoporosis 0 trials
-
De Sanctis-Cacchione syndrome 0 trials
-
Deafness goiter stippled epiphyses 0 trials
-
Deafness-hypogonadism syndrome 0 trials
-
Dermochondrocorneal dystrophy 0 trials
-
Dextrocardia with situs inversus 0 trials
-
Diabetes persistent mullerian ducts 0 trials
-
Die Smulders droog van dijk syndrome 0 trials
-
Diencephalic syndrome 0 trials
-
Dilated cardiomyopathy 1E 0 trials
-
Diomedi bernardi placidi syndrome 0 trials
-
Distal monosomy 13q 0 trials
-
Distal trisomy 14q 0 trials
-
Double discordia 0 trials
-
Duodenal atresia tetralogy of fallot 0 trials
-
Duplication of leg mirror foot 0 trials
-
Dupont sellier chochillon syndrome 0 trials
-
Dwarfism bluish sclerae 0 trials
-
Dyschondrosteosis-nephritis syndrome 0 trials
-
Dysmorphism cleft palate loose skin 0 trials
-
Dystonia-aphonia syndrome 0 trials
-
Ectrodactyly cardiopathy dysmorphism 0 trials
-
Ectrodactyly-polydactyly syndrome 0 trials
-
Empty sella syndrome 0 trials
-
Encephalocele anencephaly 0 trials
-
Enchondromatosis dwarfism deafness 0 trials
-
Epimetaphyseal dysplasia cataract 0 trials
-
Ermine phenotype 0 trials
-
Esophageal atresia coloboma talipes 0 trials
-
Estrogen resistance syndrome 0 trials
-
Euthyroid sick syndrome 0 trials
-
Even-plus syndrome 0 trials
-
Faciodigitogenital syndrome 0 trials
3 sub-types
- Aarskog-Scott syndrome, X-linked 0 trials
- Autosomal dominant Aarskog syndrome 0 trials
- Autosomal recessive faciodigitogenital syndrome 0 trials
-
1 sub-type
-
Feigenbaum Bergeron syndrome 0 trials
-
Ferro-cerebro-cutaneous syndrome 0 trials
-
Fetal akinesia deformation sequence 0 trials
5 sub-types
- Fetal akinesia deformation sequence 1 0 trials
- Fetal akinesia deformation sequence 2 0 trials
- Fetal akinesia deformation sequence 3 0 trials
- Fetal akinesia deformation sequence 4 0 trials
- Fetal akinesia syndrome, X-linked 0 trials
-
Fetal brain disruption sequence 0 trials
-
Fetal enterovirus syndrome 0 trials
-
Fetal hydantoin syndrome 0 trials
-
Fetal phenothiazine syndrome 0 trials
-
Fetal valproate syndrome 0 trials
-
Fibrogenesis imperfecta ossium 0 trials
-
Fibromatosis multiple non ossifying 0 trials
-
Fibula aplasia complex brachydactyly 0 trials
-
Foix chavany Marie syndrome 0 trials
-
Frontofacionasal dysplasia 0 trials
-
Genitopatellar syndrome 0 trials
-
Gershinibaruch Leibo syndrome 0 trials
-
Glaucoma-sleep apnea syndrome 0 trials
-
Goldstein hutt syndrome 0 trials
-
Gray platelet syndrome 0 trials
-
Green sandford davison syndrome 0 trials
-
Grix Blankenship Peterson syndrome 0 trials
-
Hand-foot-genital syndrome 0 trials
-
Heart-hand syndrome 0 trials
6 sub-types
- Carney complex - trismus - pseudocamptodactyly syndrome 0 trials
- Holt-Oram syndrome 0 trials Sub-types →
- Brachydactyly-long thumb syndrome 0 trials
- Heart-hand syndrome type 2 0 trials
- Heart-hand syndrome, Slovenian type 0 trials
- Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome 0 trials
-
Holoprosencephaly 0 trials
17 sub-types
- Alobar holoprosencephaly 0 trials Sub-types →
- Chromosome 1q41-q42 deletion syndrome 0 trials
- Holoprosencephaly 1 0 trials
- Holoprosencephaly 10 0 trials
- Holoprosencephaly 11 0 trials
- Holoprosencephaly 12 with or without pancreatic agenesis 0 trials
- Holoprosencephaly 13, X-linked 0 trials
- Holoprosencephaly 14 0 trials
- Holoprosencephaly 2 0 trials
- Holoprosencephaly 3 0 trials Sub-types →
- Holoprosencephaly 4 0 trials
- Holoprosencephaly 6 0 trials
- Holoprosencephaly 7 0 trials
- Holoprosencephaly 8 0 trials
- Lobar holoprosencephaly 0 trials Sub-types →
- Microform holoprosencephaly 0 trials Sub-types →
- Semilobar holoprosencephaly 0 trials
-
Hypotonia-cystinuria syndrome 0 trials
1 sub-type
-
Hypotrichosis-deafness syndrome 0 trials
-
2 sub-types
-
Ichthyosis linearis circumflexa 0 trials
-
Ichthyosis-cheek-eyebrow syndrome 0 trials
-
Ischio-vertebral syndrome 0 trials
-
Isotretinoin syndrome 0 trials
-
Laryngo-onycho-cutaneous syndrome 0 trials
-
Lateral medullary syndrome 0 trials
-
Le Marec-Bracq-Picaud syndrome 0 trials
-
Lethal multiple pterygium syndrome 0 trials
1 sub-type
-
Limb body wall complex 0 trials
-
Linkeropathy 0 trials
3 sub-types
- Desbuquois dysplasia 2 0 trials
- Spondylo-ocular syndrome 0 trials
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Loin pain hematuria syndrome 0 trials
-
Lymphedema-distichiasis syndrome 0 trials
-
5 sub-types
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 0 trials
-
Megalencephaly-polydactyly syndrome 0 trials
-
Merlob grunebaum reisner syndrome 0 trials
-
Methimazole embryofetopathy 0 trials
-
1 sub-type
- Bilateral generalized polymicrogyria 0 trials
-
Microcephaly and chorioretinopathy 1 0 trials
-
Monosomy 13q34 0 trials
-
3 sub-types
-
Mulibrey nanism 0 trials
-
Multicentric reticulohistiocytosis 0 trials
-
Multiple synostoses syndrome 0 trials
4 sub-types
- Multiple synostoses syndrome 1 0 trials
- Multiple synostoses syndrome 2 0 trials
- Multiple synostoses syndrome 3 0 trials
- Multiple synostoses syndrome 4 0 trials
-
Nodular neuronal heterotopia 0 trials
3 sub-types
- Periventricular nodular heterotopia 0 trials Sub-types →
- Sub-cortical nodular heterotopia 0 trials
- Subependymal nodular heterotopia 0 trials
-
Oculo digital syndrome 0 trials
-
Oculo-skeletal-renal syndrome 0 trials
-
Oculocerebrodental syndrome 0 trials
-
Oculomaxillofacial dysostosis 0 trials
1 sub-type
- Tessier number 4 facial cleft 0 trials
-
Oculovertebral syndrome 0 trials
-
2 sub-types
-
Osteoporosis-pseudoglioma syndrome 0 trials
-
Otopalatodigital syndrome type 1 0 trials
-
1 sub-type
-
Parkinsonism-dystonia, infantile 0 trials
3 sub-types
-
Pentasomy X 0 trials
-
Pfeiffer rockelein syndrome 0 trials
-
Piepkorn karp hickok syndrome 0 trials
-
Podder-tolmie syndrome 0 trials
-
Pointer syndrome 0 trials
-
Polydactyly-macrocephaly syndrome 0 trials
-
Ptosis-vocal cord paralysis syndrome 0 trials
-
Radio-digito-facial dysplasia 0 trials
-
Ragopathy 0 trials
-
Renal coloboma syndrome 0 trials
-
Renal cysts and diabetes syndrome 0 trials
-
Ring chromosome 10 0 trials
-
Ring chromosome 13 0 trials
-
Ruvalcaba churesigaew myhre syndrome 0 trials
-
Schisis association 0 trials
-
Shone complex 0 trials
-
Short stature contractures hypotonia 0 trials
-
Spina bifida-hypospadias syndrome 0 trials
-
Subcortical band heterotopia 0 trials
2 sub-types
-
Syndromic congenital sodium diarrhea 0 trials
-
Syndromic microspherophakia 0 trials
-
Syndromic orbital border hypoplasia 0 trials
-
Syngnathia multiple anomalies 0 trials
-
Tempi syndrome 0 trials
-
Tetrasomy 12p 0 trials
-
Thyrocerebrorenal syndrome 0 trials
-
Trigeminal trophic syndrome 0 trials
-
Ulnar hypoplasia-split foot syndrome 0 trials
-
Ulnar-mammary syndrome 0 trials
-
Van den Bosch syndrome 0 trials
-
Vitamin K-antagonist embryofetopathy 0 trials
-
Weinstein kliman scully syndrome 0 trials
-
Yellow nail syndrome 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1227 trials in this tab.
-
Rewriting the code: a One-Time gene fix for a rare immune disease?
Cure By invitation onlyThis trial tests a one-time gene therapy for WHIM syndrome, a rare inherited immune disorder that causes severe infections. Doctors collect a person's own blood stem cells, use base editing to correct the faulty CXCR4 gene, and return the edited cells to the body. The goal is to …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can a One-Time gene therapy fix the root cause of rett syndrome?
Cure By invitation onlyRett syndrome is a rare genetic disorder that mostly affects girls and stems from mutations in the MECP2 gene. This trial tests GCB-002, an experimental gene therapy given as a single injection into the spinal fluid, in 6 to 9 girls aged 2 to 10 who have a confirmed MECP2 mutatio…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
Can a calming drug make cord blood transplants safer?
Cure PausedResearchers are testing whether adding abatacept to standard immune-suppressing drugs can prevent severe graft-versus-host disease after a double umbilical cord blood transplant. The trial enrolls people with blood cancers such as leukemia, lymphoma, and myelodysplastic syndromes…
Phase 2 • Sponsor: Leland Metheny • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
Can a transplanted uterus make pregnancy possible for women born without one?
Cure OngoingThis trial tests whether a uterus transplanted from a living or deceased donor can allow women with uterine factor infertility to carry a pregnancy and give birth. The study plans to enroll 10 women who will receive a transplant, undergo embryo transfer, and attempt delivery, fol…
Sponsor: University of Pennsylvania • Aim: Cure
Last updated Aug 29, 2026 00:00 UTC
-
New drug could ease sleep apnea and help shed pounds
Disease control OngoingThis study tests a new medicine, maridebart cafraglutide, for adults with obstructive sleep apnea who are overweight or obese and already use a CPAP machine. The goal is to see if the drug can reduce breathing pauses during sleep and help with weight loss over 52 weeks. About 250…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail takes on glioblastoma in early trial
Disease control OngoingThis early-stage study tests whether adding an experimental drug called OKN-007 to standard chemoradiotherapy is safe and tolerable for people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 27 participants will receive the combination after surgery. The mai…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control By invitation onlyThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
Disease control OngoingThis Phase II trial tests whether combining lenvatinib and everolimus can shrink or slow advanced carcinoid tumors that cannot be removed by surgery. The study enrolls 36 adults with confirmed unresectable carcinoid tumors. Both drugs are taken orally and work by blocking enzymes…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to slow kidney failure in rare genetic disease
Disease control OngoingThis study tests an experimental drug called BAY 3401016 in 60 adults aged 18 to 45 with Alport syndrome, a rare genetic condition that damages kidneys, hearing, and eyes. The drug works by blocking a protein thought to cause kidney injury, with the goal of slowing the loss of ki…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new antibody drug called Hu8F4 in 72 people with advanced blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and see if it can slow or stop cancer growth. Researchers will also track how long patients live …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug duo targets hard-to-treat blood cancers
Disease control OngoingThis study tests a new drug, seclidemstat, combined with a standard drug, azacitidine, for people with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to find the best dose and see if the combination can shrink or control the cancer. About 2…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Platelet-Boosting drug help control a rare bone marrow disorder?
Disease control OngoingResearchers are observing how well eltrombopag works in adults with hypocellular myelodysplastic neoplasms, a bone marrow condition that lowers blood cell counts. The study follows patients in Italy who receive eltrombopag alone or with immunosuppressive therapy as part of routin…
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill hopes to boost blood in bone marrow disease
Disease control OngoingThis study tests an experimental drug, HT-6184, in adults with a bone marrow disorder called myelodysplastic syndrome (MDS) who have low red blood cell counts (anemia). The goal is to see if the drug can improve blood counts and reduce the need for transfusions. Participants take…
Phase 2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Cancer drug RVU120 gets extended trial for ongoing patients
Disease control By invitation onlyThis study offers continued RVU120 treatment to up to 10 patients with advanced solid tumors, acute myeloid leukemia, or high-risk myelodysplastic syndrome who are already benefiting from the drug in an earlier trial. The main goal is to monitor safety and see how long patients c…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Lifeline for ALK cancer patients: continued access to ceritinib
Disease control OngoingThis study offers continued treatment with the drug ceritinib to people with ALK-positive cancers who were already benefiting from it in a previous Novartis study. The main goal is to track safety and side effects over time. About 233 participants will receive the drug as long as…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for Post-Surgery sugar crashes: pasireotide under study
Disease control OngoingThis phase 2 trial tests the drug pasireotide in 93 adults who experience severe low blood sugar after weight-loss surgery. Participants receive either the drug or a placebo for 12 weeks, then all can receive the drug for 36 more weeks. The goal is to see if pasireotide can stabi…
Phase 2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink or slow the growth of these tumors. Participants take the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New camera could save hearts: OCTAVE trial tests smarter stent placement
Disease control By invitation onlyThis study tests whether using a special camera (OCT) inside the heart's arteries during a heart attack procedure leads to better outcomes than the standard X-ray method. About 3000 people having a heart attack will be randomly assigned to one of the two approaches. The goal is t…
Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple ketone drink reduce the need for surgery in FAP patients?
Disease control By invitation onlyThis study tests whether a daily ketone supplement (BHB) is safe and tolerable for people with Familial Adenomatous Polyposis (FAP), a genetic condition that causes many colon polyps and often leads to surgery. Twenty participants will take the supplement for two weeks to see if …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control OngoingThis early study is testing a new device called the ReNew Hip Implant in 15 people aged 14 to 64 with hip cartilage damage from conditions like osteoarthritis or hip impingement. The implant is surgically placed to repair the cartilage. Researchers are checking if it is safe and …
Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental drug TAK-243 targets tough blood cancers in early trial
Disease control OngoingThis early-phase study is testing a drug called TAK-243 in people whose acute myeloid leukemia or myelodysplastic syndrome has come back or is not responding to treatment. The goal is to find the best dose and check for side effects. The trial is currently on hold.
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a pill that starves tumors of oxygen help fight advanced cancer?
Disease control OngoingThis early-stage trial is testing an experimental drug called belzutifan in people with advanced solid tumors that have not responded to standard treatments. Belzutifan works by blocking a protein (HIF-2α) that tumors use to survive in low-oxygen conditions. The main goal is to f…
Phase 1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study tests aggressive BP management to protect heart and kidneys in cancer patients
Disease control OngoingThis phase II trial tests whether intensive blood pressure management (targeting systolic BP below 120 mmHg) is better than standard care (below 140 mmHg) for patients with advanced kidney or thyroid cancer starting anti-angiogenic TKI therapy. The study enrolls 61 participants a…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare inflammatory disease: pacritinib trial begins
Disease control OngoingThis study tests a drug called pacritinib for people with VEXAS syndrome, a rare genetic disease that causes severe inflammation. About 78 adults will receive either the drug or a placebo to see if it controls symptoms and reduces flare-ups. The goal is to find a safe and effecti…
Phase 2 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Smart inhalers track Fasenra's asthma control over full dosing cycle
Disease control By invitation onlyThis study tracks people with severe eosinophilic asthma who already take Fasenra (benralizumab) every 8 weeks. Participants use electronic monitors on their regular inhalers and a study-provided rescue inhaler (AirSupra) to see if asthma control stays steady throughout the dosin…
Phase 4 • Sponsor: Endeavor Health • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a supplement duo quiet PCOS-Linked inflammation?
Disease control OngoingResearchers are testing whether a daily combination of myo-inositol and folic acid can lower two markers of inflammation, NLR and CRP, in overweight women aged 25 to 35 with polycystic ovarian syndrome. The trial compares this supplement pair with metformin plus folic acid over t…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug targets Sugar-Coated proteins on cancer cells
Disease control OngoingResearchers are testing an experimental oral drug called PhOx430 in people with advanced solid tumors, including glioblastoma and triple-negative breast cancer. The trial has two parts: first, they give increasing doses to small groups to find a safe dose and watch for side effec…
Phase 1 • Sponsor: Phost'In Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a combination of two oral drugs, olaparib and ASTX727, in adults with advanced solid tumors that have mutations in genes like BRCA1, BRCA2, PALB2, ATM, or CHEK2. The main goals are to find the safest dose and to check for side effects. About 18 partic…
Phase 1 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail targets Hard-to-Treat MDS
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) plus a chemotherapy drug (azacitidine) in 99 people with myelodysplastic syndromes (MDS), a type of blood cancer. The goal is to see if the combination improves response rates, especially…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Nasal spray shows promise against deadly brain cancer
Disease control OngoingThis study tests a nasal spray drug called NEO100 (perillyl alcohol) in people with aggressive brain tumors (grade III or IV gliomas) that have come back or worsened. The trial has two phases: first to find the safest dose, then to see if it helps patients live longer. About 49 p…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Immunotherapy before surgery shows promise for certain colorectal cancers
Disease control OngoingThis trial is testing whether giving the immunotherapy drug pembrolizumab before surgery can improve outcomes for people with high-risk stage 2 or stage 3 colorectal cancer that has a specific genetic feature called mismatch repair deficiency. About 88 participants will receive p…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Real-World check: is talzenna safe for advanced breast cancer?
Disease control CancelledThis study will track 600 people in Korea with advanced breast cancer who are already being prescribed Talzenna. Researchers will watch for side effects and see how well the drug works in everyday medical practice, not in a strict research setting. The goal is to confirm the drug…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Experimental CART123 therapy targets tough blood cancers in early trial
Disease control OngoingThis early-phase trial tests a personalized cell therapy called CART123 for people with certain blood cancers (like AML or MDS) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to recognize and attack cancer cells. The main goa…
Early phase 1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail shows promise for tough childhood brain cancers
Disease control OngoingThis trial is testing whether adding hydroxychloroquine to two targeted cancer drugs (dabrafenib and trametinib) can help children and young adults with certain brain tumors that have come back or not responded to treatment. The study includes patients with specific genetic chang…
Phase 1/2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Blood cancer combo trial pulled before it even started
Disease control CancelledThis study was designed to test whether adding olutasidenib to standard chemotherapy drugs could help control certain blood cancers in people with an IDH1 gene mutation. The trial was withdrawn before enrolling any participants, so no results are available.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
Disease control CancelledThis phase 2 trial is testing whether combining an experimental drug called S-531011 with a precise radiation technique known as RadScopal can help control metastatic colorectal cancer that has not responded to prior treatments. The study enrolls about 30 adults with advanced dis…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can an oral drug calm psoriatic arthritis? phase 3 trial puts deucravacitinib to the test
Disease control OngoingResearchers are testing whether deucravacitinib, a daily oral drug, can reduce joint swelling, tenderness, and skin symptoms in people with active psoriatic arthritis. The trial enrolls adults who have not taken biologic drugs for their arthritis or who previously received a TNF …
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug DFV890 takes on Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new drug called DFV890 in about 62 adults with low-risk myelodysplastic syndromes, low-risk chronic myelomonocytic leukemia, or high-risk clonal cytopenia of undetermined significance. The main goals are to check the drug's safety, find the best dos…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a cancer drug help patients with rare gene changes?
Disease control OngoingThis phase 2 trial tests the drug olaparib in 14 adults with acute myeloid leukemia or myelodysplastic syndrome that has returned or not responded to treatment, and whose cancer has a specific change in the IDH gene. Olaparib is a pill that may block enzymes cancer cells need to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can tailoring bypass length improve weight loss surgery results?
Disease control By invitation onlyResearchers are studying how the length of bypassed intestine during gastric bypass affects weight loss, complications, and metabolic changes in people with severe obesity. Participants will have different lengths of intestine bypassed and will provide blood and stool samples bef…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
Disease control OngoingResearchers compare a very low calorie ketogenic diet with a Mediterranean-style low-calorie diet in 40 adults who have type 2 diabetes, obesity, and non-alcoholic fatty liver disease. Participants follow one of the two diets for several weeks. The study measures changes in weigh…
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New weekly shot aims to tame Sjögren's Flare-Ups
Disease control OngoingThis study tests an experimental drug called IMVT-1402 in 180 adults with moderate to severe Sjögren's disease. Participants receive either the drug or a placebo as a weekly injection under the skin for 24 weeks. The goal is to see if the drug can reduce overall disease activity …
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Phase 1/2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a website teach patients to tame gut pain and skip needless hospital tests?
Disease control OngoingUpper abdominal pain often comes from functional dyspepsia, irritable bowel syndrome, or uncomplicated gallstones. These conditions overlap and many patients do not know that tests and surgery may not help. Researchers are testing a personalized web-based education tool that expl…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for angelman syndrome: experimental drug enters Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called GTX-102 (apazunersen) in 60 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants range from 1 to 65 years old and are grouped by age and genetic type. The goal is to see if the drug …
Phase 2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New targeted radiation therapy tested for stubborn bone marrow cancer
Disease control PausedThis early-phase trial tests a drug called lintuzumab-Ac225 in 18 adults with high-risk myelodysplastic syndrome (MDS) that did not improve after standard treatment. The drug is an antibody that seeks out cancer cells and delivers a radioactive payload to kill them. The main goal…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to control angelman syndrome long-term
Disease control OngoingThis phase 3 trial tests the long-term safety of GTX-102 (apazunersen) in 255 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants have already completed an earlier GTX-102 study and will continue receiving the drug. The main g…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can focused radiation replace surgery for inherited pancreatic tumors?
Disease control OngoingPeople with MEN1 syndrome inherit a high risk of developing multiple pancreatic neuroendocrine tumors. Surgery is the only curative option but causes major complications. Researchers are testing high-dose, high-precision MR-guided radiotherapy to see if it can shrink these tumors…
Sponsor: J.M. de Laat • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis phase 3 trial tests crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare disease that causes blood clots and kidney damage. The drug is given first through a vein, then as a shot under the skin every four weeks. The goal is to see if it can stop d…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Cord blood stem cells aim to tame COVID-19 lung crisis
Disease control OngoingThis study tests whether infusions of cord blood stem cells can help people with moderate to critical COVID-19 pneumonia. The trial includes 65 adults with COVID-19-related acute respiratory distress syndrome (ARDS). Researchers will compare stem cell treatment plus standard care…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control OngoingThis Phase 3 study tests whether a daily pill combining obicetrapib and ezetimibe, or obicetrapib alone, can lower LDL (bad) cholesterol more than placebo in 300 people with type 2 diabetes or metabolic syndrome. Participants continue their standard cholesterol medications. The m…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Chilling the body to save the lungs: new trial for ARDS
Disease control OngoingThis study tests whether gently cooling the body (to 34-35°C) combined with muscle-paralyzing drugs can help people with severe lung injury (ARDS) recover. About 340 adults on ventilators will be randomly assigned to cooling plus paralytics or usual care. The main goal is to see …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New arthritis drug shows promise in Long-Term safety trial
Disease control By invitation onlyThis study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with psoriatic arthritis. About 1560 adults who finished an earlier study will receive the drug as a shot under the skin. Researchers will track side effects and how well the drug c…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental combo aims to outsmart relapsed blood cancers
Disease control OngoingThis early-stage trial tests whether adding the immunotherapy drug ipilimumab to the chemotherapy drug decitabine is safe and tolerable for people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back or stopped responding to treatment. About 54 p…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Sound waves open brain barrier to attack deadly tumor
Disease control PausedThis early study tests a combination approach for recurrent glioblastoma, an aggressive brain cancer. The treatment uses focused ultrasound (NaviFUS) to temporarily open the blood-brain barrier, allowing the drug Avastin (bevacizumab) to reach the tumor more effectively. Ten adul…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New enzyme therapy aims to reach the brain in MPS II
Disease control OngoingResearchers are testing tividenofusp alfa (DNL310), an experimental enzyme replacement therapy, against the standard treatment idursulfase in children and young adults with mucopolysaccharidosis type II (MPS II). The study includes participants with and without brain involvement,…
Phase 2/3 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can adding another drug improve MDS treatment?
Disease control OngoingThis study compares the standard drug azacitidine alone versus azacitidine combined with either lenalidomide or vorinostat in 282 patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see if any combination improves re…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug combo targets tough blood cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called SEA-CD70, alone or with standard drugs azacitidine and venetoclax, in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The main goal is to check safety and find the right dose. About 178 participants will b…
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Raspberry diet shows promise for gut health and metabolism
Disease control OngoingThis study looks at whether eating 2 cups of frozen raspberries daily for 8 weeks can improve blood sugar, cholesterol, and gut health in overweight or obese adults with early signs of metabolic syndrome. Researchers want to see if the berries' natural compounds help by changing …
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new enzyme therapy tame MPS II over time?
Disease control OngoingThis study tests the long-term safety and effects of JR-141, an enzyme replacement therapy, in people with mucopolysaccharidosis II (MPS II), a rare genetic disorder. Participants who completed an earlier JR-141 trial receive the drug again by IV infusion. Researchers track side …
Phase 2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame deadly fat levels in the blood
Disease control OngoingThis Phase 2 trial tests two experimental injections, HRS-7249 and SHR-1918, in 108 adults with severely high triglycerides who are at high risk of acute pancreatitis. The study aims to see if these drugs can safely lower fat levels in the blood and reduce the chance of a pancrea…
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a direct brain infusion slow sanfilippo syndrome?
Disease control OngoingThis trial tests an experimental enzyme replacement called GC1130A in children with Sanfilippo syndrome type A, a rare genetic disease that damages the brain. The enzyme is given through a small device placed under the scalp that delivers it directly into the fluid around the bra…
Phase 1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a small breathing hurdle ease sleep apnea?
Disease control CancelledThis study tests whether adding a mild expiratory resistance to the breathing circuit can improve ventilation and sleep in people with obstructive sleep apnea who also have expiratory flow limitation, a condition where exhaling is partially blocked. Researchers will compare real …
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug hope for rare kidney disease: daratumumab trial launches
Disease control OngoingThis study tests a drug called daratumumab in 40 people with a rare kidney condition called PGNMID, where abnormal proteins damage the kidneys. Participants receive weekly injections for 8 weeks, then every two weeks for another 8 weeks. The goal is to see if the drug can reduce …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Blueberry powder may tame metabolic syndrome by boosting gut bacteria
Disease control OngoingThis study tests whether taking 50 grams of blueberry powder daily for 8 weeks can improve gut bacteria and metabolic health in overweight or obese adults. Researchers will measure changes in blood sugar, cholesterol, and gut microbes. The goal is to see if blueberries can help m…
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could allergy pills calm irritable bowel syndrome?
Disease control CancelledThis trial tests whether a combination of two common antihistamines, cetirizine and famotidine, can reduce symptoms in people with diarrhea-predominant irritable bowel syndrome (IBS-D). Participants take the antihistamines or a placebo for 30 days, then switch, so each person ser…
Phase 3 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Promising drug cocktail targets tough blood cancers
Disease control OngoingThis study tests a combination of two drugs, venetoclax and ASTX727, in people with high-risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) who haven't had treatment before. The goal is to find the safest dose and see if the combo can shrink or control …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a weekly infusion reach the brain to fight a rare childhood disease?
Disease control OngoingThis trial tests an experimental drug called JR-441 in children with mucopolysaccharidosis type IIIA (MPS IIIA), a rare genetic condition that harms the brain and body. Researchers give the drug as a weekly intravenous infusion to see if it is safe and tolerable. They also measur…
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a single injection drug calm the immune attack on kidneys?
Disease control OngoingThis phase 2 trial tests an experimental drug called SGB-9768 in adults with three related kidney diseases: IgA nephropathy, C3 glomerulopathy, and immune complex-mediated membranoproliferative glomerulonephritis. These conditions occur when the immune system deposits proteins in…
Phase 2 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Immune cell reprogramming offers hope for stubborn arthritis and Sjogren's
Disease control OngoingThis early-phase study tests a personalized cell therapy (rapcabtagene autoleucel) in 27 adults with difficult-to-treat rheumatoid arthritis or severe Sjogren's disease. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune system. The…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a single Anti-Inflammatory injection boost jaw joint relief?
Disease control OngoingThis trial tests whether adding a single injection of the anti-inflammatory drug meloxicam to a standard jaw joint washout procedure (arthrocentesis) improves outcomes for people with painful jaw joint problems. Half of the 50 adult participants will receive the combined treatmen…
Sponsor: Hussein Mohammed Ridha • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a weekly infusion slow the toll of a rare genetic disease?
Disease control OngoingThis trial tests whether JR-141, an enzyme replacement therapy given as a weekly IV infusion, can safely manage mucopolysaccharidosis type II (MPS II) over the long term. Researchers will follow about 27 people who completed an earlier JR-141 study, tracking side effects, develop…
Phase 2/3 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Tailored breathing support may reduce lung injury in ECMO patients
Disease control By invitation onlyThis study tests whether personalized ventilator settings can reduce lung injury in adults with severe respiratory failure who are on ECMO (a heart-lung machine). Researchers will use esophageal manometry or electrical impedance tomography to tailor the ventilator's positive pres…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a drug combo boost red blood cells in bone marrow disease?
Disease control OngoingThis phase 3 trial compares two treatments for people with a bone marrow disorder called myelodysplastic syndrome (MDS) who have low red blood cell counts (anemia). One group gets lenalidomide alone, the other gets lenalidomide plus epoetin alfa, a drug that stimulates red blood …
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can an implanted device retrain breathing to treat central sleep apnea?
Disease control OngoingThis study follows 225 adults with moderate to severe central sleep apnea who receive the remedē System, an implanted device that stimulates a nerve to help regulate breathing during sleep. Researchers track serious and non-serious side effects and measure changes in sleep qualit…
Sponsor: Respicardia, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily zinc pill tame insulin resistance in polyendocrine ovarian syndrome?
Disease control By invitation onlyThis trial tests whether taking 50 mg of zinc daily for 12 weeks, alongside standard treatment, improves insulin resistance and other features of polyendocrine metabolic ovarian syndrome (PMOS) in women aged 18 to 45. PMOS is a common hormone condition linked to insulin resistanc…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hip implant aims to cut repeat surgeries
Disease control OngoingThis study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to chec…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Double whammy for AFib: single procedure aims to fix rhythm and prevent strokes
Disease control OngoingThis study tests doing two heart procedures at the same time for people with atrial fibrillation. First, doctors use pulsed field energy to fix the heart's rhythm. Then, they implant a small device to close off a part of the heart where clots can form. The goal is to see if this …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Precision radiation may make stem cell transplants safer for leukemia patients
Disease control OngoingThis study tests a new way to deliver radiation before a stem cell transplant for people with leukemia or myelodysplastic syndrome. Instead of radiating the whole body, the new method targets only the bone marrow and lymph nodes, which may reduce damage to healthy organs. The goa…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control OngoingThis phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Video diet coaching may cut heart risks after spinal cord injury
Disease control OngoingThis trial tests whether nutrition counseling delivered over video calls can help people with spinal cord injury eat healthier and lower their risk of obesity, high cholesterol, and diabetes. Participants, who are at least one year post-injury and overweight, will receive six ses…
Sponsor: Santa Clara Valley Health & Hospital System • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study tests video coaching to help older adults shed pounds and prevent disease
Disease control OngoingThis study tests a video-based healthy lifestyle program for adults aged 50 to 74 who are overweight and have conditions like prediabetes, type 2 diabetes, or high blood pressure. Participants use a tablet, scale, and activity tracker at home, and some get extra support from a co…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for anemia patients: drug may cut need for blood transfusions
Disease control OngoingThis study tests a drug called luspatercept in people with anemia caused by myelodysplastic syndromes (MDS) or beta-thalassemia who need regular blood transfusions. The goal is to see if the drug is safe and can reduce the number of transfusions needed. About 85 participants in I…
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New immunotherapy shows promise against multiple advanced cancers
Disease control OngoingThis study tests a new drug called Cetrelimab (JNJ-63723283) in 234 people with advanced solid tumors like lung, melanoma, bladder, and colorectal cancers. The drug works by blocking PD-1, a protein that stops the immune system from attacking cancer cells. The trial has two parts…
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A sip of science: probiotic milk drink targets gut and metabolism
Disease control By invitation onlyResearchers are testing whether a specially fermented milk drink with probiotic bacteria can improve symptoms of irritable bowel syndrome (IBS) and metabolic syndrome. The study will include 80 adults with IBS or at least one sign of metabolic syndrome, such as high blood pressur…
Sponsor: Warsaw University of Life Sciences • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a disc made from donated tissue ease severe dry eye?
Disease control CancelledThis Phase 3 trial tests whether a disc made from donated human amnion membrane can help people with moderate to severe dry eye disease. The disc is placed on the eye and compared to standard care like lubricating drops and a bandage lens. The study will enroll 40 adults who have…
Phase 4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new drug regimen beat the standard for stem cell transplant complications?
Disease control OngoingThis trial tests whether a drug called cyclophosphamide (PTCY) can prevent graft-versus-host disease (GVHD) better than the current standard, ATG, in patients receiving stem cell transplants from unrelated donors. GVHD is a serious complication where donor immune cells attack the…
Phase 3 • Sponsor: DKMS gemeinnützige GmbH • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Shockwave boost: a new combo for stubborn buttock pain?
Disease control By invitation onlyThis trial compares two non-surgical approaches for deep gluteal syndrome, a condition where the sciatic nerve gets irritated in the buttock area, causing pain and limited movement. About 44 adults aged 25 to 45 will be split into two groups: one receives nerve gliding exercises …
Sponsor: University of Management and Technology Sialkot Pakistan • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a drug duo keep High-Risk blood cancers at bay after transplant?
Disease control OngoingThis early-phase trial is exploring whether combining two drugs, selinexor and azacitidine, can help prevent relapse in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who carry a TP53 mutation and have already undergone a stem cell transplant…
Phase 1/2 • Sponsor: Liping Dou • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Gene therapy hope for toddlers with rett syndrome
Disease control OngoingThis study tests a one-time gene therapy called TSHA-102 in girls aged 2 to 4 with Rett syndrome, a severe genetic disorder. The therapy is given as a single injection into the spine. The main goal is to check if it is safe and tolerable, and to see early signs of whether it help…
Phase 3 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Sjögren's drug ianalumab tested for Long-Term safety in 600-Patient trial
Disease control OngoingThis phase 3 study tests the long-term safety of ianalumab in 612 people with Sjögren's syndrome who already completed a year of treatment in earlier trials. Participants receive ianalumab or placebo injections for up to several more years. The goal is to see if the drug remains …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control By invitation onlyThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each patient. 150 adults will follow a personalized 24-week lifestyle and nutrition plan based on their SMS results. The goal…
Sponsor: Salah Snouda • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Lower drug dose after transplant may cut infections without losing protection
Disease control OngoingThis study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant from a partially matched donor, can reduce serious infections in the first 100 days while still preventing graft-versus-host disease (a common complication where donor cells att…
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy targets high-risk MDS in early trial
Disease control CancelledThis study tests a new two-drug combination (pacritinib plus azacitidine) for people with moderate to very high risk myelodysplastic syndrome (MDS), a bone marrow disorder. The first part finds the safest dose of pacritinib, and the second part checks how well the combination wor…
Phase 1/2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a targeted antibody take on glioblastoma?
Disease control OngoingThis phase 1 trial is testing whether amivantamab, an antibody drug given by IV, is safe and tolerable for people with high-grade malignant brain tumors like glioblastoma. The study enrolls about 12 patients with recurrent glioblastoma or certain molecular subtypes. Participants …
Phase 1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a simple drug tame the dangerous side effects of CAR-T cancer therapy?
Disease control CancelledThis study tests whether giving the drug anakinra early can prevent severe cytokine release syndrome (CRS) in children and young adults with B-cell acute lymphoblastic leukemia (B-ALL) who are receiving CAR-T cell therapy. Participants receive anakinra at the first sign of fever,…
Phase 1/2 • Sponsor: Kevin McNerney • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Ceramic hip resurfacing: a Metal-Free future for joint replacement?
Disease control OngoingThis study is testing a new type of hip resurfacing device made entirely of ceramic, designed for people with hip osteoarthritis, necrosis, or dysplasia. The goal is to see if it is as safe and effective as existing metal-on-metal devices, but without releasing metal ions into th…
Sponsor: Embody Orthopaedic Limited • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Radioactive drug takes on brain cancer in early trial
Disease control OngoingThis early-phase trial is testing a radioactive drug called 131I-TLX101, given alongside standard care, for people newly diagnosed with glioblastoma, an aggressive brain cancer. The study involves 12 participants and aims to find the safest dose and check for side effects. It is …
Phase 1 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a single Immune-Targeting drug quiet an autoimmune kidney disease?
Disease control OngoingThis trial tests whether rituximab, an infusion drug that calms certain immune cells, can help people with idiopathic membranous nephropathy and nephrotic syndrome. Participants receive either rituximab or a placebo, and the study tracks how many achieve a significant reduction i…
Phase 3 • Sponsor: Shoichi Maruyama MD PhD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a sleep machine protect pregnant women from dangerous blood pressure?
Disease control OngoingThis study looks at whether using a CPAP machine during pregnancy can reduce the chance of developing high blood pressure disorders like preeclampsia. About 1,500 pregnant women with mild to moderate sleep apnea will be randomly assigned to use CPAP or not. The goal is to see if …
Sponsor: The George Washington University Biostatistics Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
A new Fast-Track HIV care model aims to Re-Engage those lost to care
Disease control OngoingThis study tests a simplified, accelerated HIV care model called ACCELERATE. It combines rapid telehealth appointments, a pre-approved HIV medication, and a free 30-day starter supply to help people with HIV who have fallen out of care get back on track. The goal is to see if thi…
Phase 4 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
Disease control OngoingThis early-stage trial is testing an experimental oral drug, TYRA-200, in people with advanced bile duct cancer (intrahepatic cholangiocarcinoma) and other solid tumors that have specific changes in the FGFR2 gene. The study aims to find a safe and effective dose and to see wheth…
Phase 1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
A 10-Hour eating window may help reverse early Heart-Kidney-Metabolic syndrome
Disease control OngoingThis trial tests whether a simple 10-hour time-restricted eating schedule, combined with health education, can improve early-stage cardiovascular-kidney-metabolic (CKM) syndrome in adults aged 30–79 who do not yet need medication. Participants in the intervention group eat all th…
Sponsor: Can Tho University of Medicine and Pharmacy • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a Two-Drug combo stop repeat heart attacks?
Disease control OngoingThis study tests whether adding a PCSK9 inhibitor (a powerful cholesterol-lowering drug) to high-intensity statin therapy can prevent future cardiovascular events in people who have recently had a heart attack or unstable angina and underwent a stent procedure. About 1,200 partic…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can pressurized oxygen boost cord blood transplants?
Disease control OngoingThis study tests whether giving patients hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) after an umbilical cord blood stem cell transplant helps the donated stem cells grow faster. The trial enrolls people with blood cancers like leukemia or lymphoma who lack …
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could treating sleep apnea during a COPD hospital stay keep patients out of the hospital?
Disease control CancelledThis study investigates whether diagnosing obstructive sleep apnea (OSA) early and starting CPAP therapy in patients hospitalized for chronic obstructive pulmonary disease (COPD) can reduce the number of patients who are readmitted to the hospital within 30 days. Participants are…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a sleep apnea machine keep heart patients out of the hospital?
Disease control CancelledThis study investigates whether diagnosing and treating obstructive sleep apnea with CPAP therapy early, while patients are still in the hospital for heart problems, can reduce the chance of being readmitted within 30 days. The trial enrolls adults with heart failure, heart attac…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Own stem cells Gene-Hacked to fight rare hurler syndrome
Disease control OngoingThis study tests a one-time gene therapy for children with Hurler syndrome, a severe genetic disorder. Doctors take the child's own blood stem cells, add a working copy of the missing gene, and put them back. The goal is to help the body produce the enzyme it lacks, potentially s…
Phase 1/2 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a single pill help sleep apnea patients breathe easier?
Disease control By invitation onlyThis trial investigates whether a single dose of the experimental drug DAW2020, taken before sleep, can improve how the brain responds to airway blockages in people with moderate-to-severe obstructive sleep apnea. The study measures changes in the arousal threshold—the point at w…
Phase 1/2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Heart attack aftermath: new imaging method may spot hidden danger zones better than standard tests
Disease control OngoingThis trial tests whether using a special camera inside the arteries (optical coherence tomography, or OCT) is better than standard pressure-wire measurements for deciding which non-blocked arteries need stenting in people who have just had a heart attack. About 1,425 participants…
Sponsor: Centro per la Lotta Contro l'Infarto - Fondazione Onlus • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Gene therapy for rare genetic syndrome moves to Long-Term safety check
Disease control By invitation onlyThis study follows children with Phelan-McDermid syndrome (a rare genetic disorder causing developmental delays) who received a single dose of RB001 gene therapy injected into the brain. Researchers will monitor them for up to 5 years to see if the treatment is safe and whether i…
Phase 1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a fiber from agave help tame type 2 diabetes?
Disease control OngoingThis study tests whether taking agave inulin, a natural fiber, for eight weeks can improve blood sugar control and increase healthy gut bacteria in adults with type 2 diabetes. Participants receive either 10 grams of agave inulin or a placebo daily. Researchers measure changes in…
Sponsor: Universidad Autonoma de Queretaro • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Digital assistant aims to close gaps in hereditary cancer care
Disease control By invitation onlyThis trial tests a digital tool that helps doctors and patients manage cancer risks linked to hereditary syndromes like BRCA-related breast/ovarian cancer and Lynch syndrome. The tool provides personalized recommendations during primary care visits. Researchers compare care gaps,…
Sponsor: HealthPartners Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New combo aims to wipe out prostate tumors before surgery
Disease control OngoingThis phase 2 trial is testing whether giving the targeted drug olaparib (Lynparza) along with hormone therapy for 6 months before surgery can shrink or eliminate prostate cancer in men with high-risk disease and specific gene mutations. About 32 men will receive the treatment, th…
Phase 2 • Sponsor: Rana McKay, MD • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug shows promise for shrinking painful NF1 tumors
Disease control OngoingThis study tests a drug called mirdametinib in 114 adults and children with a genetic condition called NF1 that causes nerve tumors (plexiform neurofibromas) that cannot be removed by surgery and cause serious problems. The drug works by blocking a protein that helps tumors grow.…
Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a common nutrient boost brain power in children exposed to alcohol before birth?
Disease control OngoingThis study tests whether choline, a vitamin-like nutrient, can improve memory, thinking, and behavior in children aged 2.5 to 5 years with Fetal Alcohol Spectrum Disorders (FASD). Participants receive choline daily for either 3 or 6 months. Researchers measure changes in memory, …
Phase 2 • Sponsor: Jeff Wozniak • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a 4-Minute chat rival a Dietitian's hour for heart health?
Disease control OngoingThis study tests whether a short, standardized 4-minute heart-healthy talk is as effective as a full 60-minute personalized session with a dietitian for lowering LDL cholesterol and improving diet. Participants are adults aged 30–80 with rheumatoid arthritis, psoriatic arthritis,…
Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a Once-Daily steroid pill improve blood sugar control in Dual-Disease patients?
Disease control CancelledThis trial tests whether taking hydrocortisone once a day (as a dual-release pill) leads to more stable blood sugar levels compared to the standard three-times-a-day regimen in adults who have both insulin-treated diabetes and Addison's disease. Participants will try both schedul…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Engineered t cells with a kill switch aim to make stem cell transplants safer
Disease control OngoingThis study tests a new approach for people receiving a stem cell transplant from a partially matched family donor. The donor's immune cells (T cells) are modified in the lab to include a 'suicide gene' that can be activated by a drug if the cells attack the patient's body, causin…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Suicide Gene-Equipped t cells aim to make stem cell transplants safer
Disease control OngoingThis trial tests whether specially modified T cells from a partially matched donor can help patients recover their immune system faster after a stem cell transplant. The T cells are engineered with a 'suicide gene' that allows doctors to destroy them if they cause graft-versus-ho…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One-Time gene therapy aims to halt rare, fatal brain disease in children
Disease control OngoingThis study tests a single dose of PBGM01, a gene therapy delivered directly into the fluid around the brain and spinal cord, in children with GM1 gangliosidosis. The therapy uses a harmless virus to carry a working copy of the GLB1 gene, which is missing or faulty in these patien…
Phase 1/2 • Sponsor: Gemma Biotherapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a smartphone app replace the gym for heart rehab?
Disease control CancelledThis trial tests whether a home-based tele-rehabilitation program is as effective as traditional center-based cardiac rehabilitation for people who have recently had a heart attack (acute coronary syndrome). Participants will either complete 20 sessions at a rehab center or 20 se…
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Childhood leukaemia trial seeks best chemo cocktail
Disease control OngoingThis trial investigates the best way to treat children with acute myeloid leukaemia (AML) by comparing different chemotherapy drugs and doses. It tests whether adding up to three doses of the targeted drug gemtuzumab ozogamicin to standard chemo is safe and effective. The study a…
Phase 3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy takes on deadly brain cancer
Disease control OngoingThis trial tests a combination of donor immune cells (targeting a common virus) and the drug pembrolizumab (Keytruda) in 58 people with glioblastoma, an aggressive brain cancer. The goal is to see if this approach can shrink tumors and help patients live longer. The study has two…
Phase 1/2 • Sponsor: Queensland Institute of Medical Research • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for rare lung disease: protein infusions may slow emphysema
Disease control OngoingThis study tests whether weekly infusions of Alpha-1 MP (a protein replacement) can slow lung damage in 345 people with emphysema caused by Alpha-1 antitrypsin deficiency. Participants receive one of two doses or a placebo for three years, with lung CT scans tracking changes. The…
Phase 3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could an antioxidant help treat chronic fatigue? new trial tests NAC
Disease control OngoingThis Phase 2 trial tests whether N-Acetylcysteine (NAC), an antioxidant, can help people with ME/CFS (chronic fatigue syndrome). Researchers will give 95 participants different doses of NAC or a placebo for four weeks, then measure brain glutathione levels and markers of oxidativ…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could an HIV drug help treat rett syndrome?
Disease control By invitation onlyThis phase 2 trial tests whether lamivudine, an antiviral drug, can improve symptoms in people with Rett syndrome, a rare genetic disorder that affects movement, communication, and behavior. Ten participants will take the drug by mouth for a set period, and researchers will measu…
Phase 2 • Sponsor: Maria Denise Fernandes Carvalho de Andrade • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Cancer cell therapy trial for brain tumor withdrawn before starting
Disease control CancelledThis study planned to test a new treatment combining CYNK-001 (natural killer cells from donated cord blood) with interleukin-2 in adults whose glioblastoma had returned and could be surgically removed. The goal was to see if this combination was safe and could extend the time be…
Phase 1/2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug aims to plug kidney leaks in multiple diseases
Disease control OngoingThis phase 2 study tests the drug atrasentan in 103 adults with various kidney diseases that cause protein leakage, including IgA nephropathy and FSGS. Participants take a daily tablet to see if it reduces protein in urine, a sign of kidney damage. The goal is to find a new way t…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Fertility drug showdown: which combo helps women get pregnant faster?
Disease control OngoingThis study compares two common fertility treatments—letrozole alone versus clomiphene citrate plus tamoxifen—in 240 women with infertility due to ovulation problems. The goal is to see which approach leads to more ovulations and pregnancies. Participants will be monitored with ul…
Phase 3 • Sponsor: Sana'a University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Balloon or stent? major trial tests safer option for clogged heart arteries
Disease control OngoingThis study tests whether a drug-coated balloon is as safe and effective as a drug-eluting stent for people with large coronary artery disease. About 1,400 participants from multiple countries will be randomly assigned to one of the two treatments. The goal is to see which approac…
Sponsor: B. Braun Medical Industries Sdn. Bhd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for kids with tough kidney disease: obinutuzumab may replace steroids
Disease control OngoingThis study tests a new drug called obinutuzumab in 100 children aged 1-18 with refractory nephrotic syndrome, a kidney condition causing swelling and protein loss. The drug targets immune cells to reduce disease flares and dependence on steroids and other medications. Researchers…
Sponsor: Children's Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to tame Cushing's disease with fewer side effects
Disease control By invitation onlyThis study tests whether adding cabergoline to osilodrostat works better than osilodrostat alone for controlling Cushing's disease. About 50 adults with active Cushing's disease will receive either the combination or the single drug. The goal is to see if the combo can lower cort…
Phase 4 • Sponsor: University of Basrah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising COVID-19 treatment trial pulled before it began
Disease control CancelledThis study was designed to test whether an inhaled drug called ZYESAMI could help people with severe COVID-19 avoid getting worse and needing a ventilator. It was a Phase 3 trial, meaning it was in the final stage of testing. However, the study was withdrawn before any participan…
Phase 3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could less steroid be just as good for kids with kidney disease?
Disease control OngoingThis study tests whether a lower dose of the steroid prednisone can treat relapses of nephrotic syndrome in children as effectively as the standard dose. Fifty children aged 1 to 18 with active relapses will be randomly assigned to either the reduced-dose or standard-dose regimen…
Phase 3 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for hard-to-treat blood cancers: experimental drug imetelstat tested in phase 2 trial
Disease control OngoingThis study tests an experimental drug called imetelstat in 46 adults with high-risk myelodysplastic syndromes or acute myeloid leukemia that did not improve after standard therapy. The goal is to see if the drug can improve blood cell counts and control the disease. Participants …
Phase 2 • Sponsor: GCP-Service International West GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New valve implant offers hope for rare heart condition
Disease control OngoingThis study is testing a custom-made artificial heart valve, called TRICENTO, in 15 people with carcinoid heart disease who have severe leakage of the tricuspid valve and cannot have surgery. The valve is delivered through a catheter, avoiding open-heart surgery. The goal is to se…
Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Cash and prizes boost HIV pill taking in uganda trial
Disease control OngoingThis study tests whether offering small prizes (phone credit) can encourage young people aged 15-30 with HIV to take their medication every day. 560 participants in Uganda are split into groups with different reward rules. The goal is to see if these low-cost incentives improve a…
Sponsor: RAND • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy aims to shrink Hard-to-Treat lung tumors before surgery
Disease control OngoingThis phase 2 trial tests giving chemotherapy (carboplatin and paclitaxel) plus the immunotherapy drug nivolumab before surgery for people with Pancoast tumors, a rare type of lung cancer. After surgery, additional treatment is tailored based on whether the tumor was fully removed…
Phase 2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail shows promise for rare blood cancer
Disease control OngoingThis study tests whether adding the drug venetoclax to standard azacitidine treatment helps people with a severe form of myelodysplastic syndrome (MDS) live longer. MDS is a bone marrow disorder that can lead to leukemia. About 500 adults with newly diagnosed high-risk MDS will r…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a targeted drug beat standard care for shock in liver patients?
Disease control OngoingThis study tests whether a drug called Angiotensin II can raise blood pressure more effectively than standard medications in people with liver cirrhosis who have septic shock. Researchers will measure how well the heart and blood vessels work together over 24 hours. The trial inv…
Early phase 1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to tame deadly brain tumors
Disease control OngoingThis study tests whether adding the targeted drug pazopanib to standard chemotherapy (temozolomide) can safely control glioblastoma, an aggressive brain cancer. About 51 adults who had surgery and chemoradiation will receive the combination. The main goal is to find the best dose…
Phase 1/2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for older blood cancer patients: smarter transplants aim to cut relapse
Disease control OngoingThis clinical trial is testing different treatment strategies to improve outcomes for older adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) who are getting a stem cell transplant. The study compares a new pre-transplant drug (Vyxeos) with stan…
Phase 2/3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New radioactive therapy targets hard-to-treat thyroid cancer
Disease control OngoingThis early-phase study tests a radioactive drug (177Lu-PP-F11N) that seeks out and attaches to cancer cells in people with advanced medullary thyroid cancer and certain other neuroendocrine tumors. The goal is to see if the drug can help image tumors and deliver targeted radiatio…
Phase 1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug shows promise for rare blood vessel disease
Disease control OngoingThis study tests a drug called tezepelumab in 42 adults with EGPA, a rare disease that causes inflammation in blood vessels and can damage organs. The goal is to see if the drug helps patients reach remission, meaning no active disease and low steroid use. Participants receive ei…
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New eye drop combo aims to soothe dry eyes fast
Disease control By invitation onlyThis study tests whether using two eye drops together—Vevye (cyclosporine) and Flarex (a steroid)—can safely improve symptoms in adults with moderate to severe dry eye disease. Sixty participants will use Vevye twice daily and Flarex four times daily for one month. The goal is to…
Phase 4 • Sponsor: Canyon City Eyecare • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New lifestyle program aims to boost fitness in older adults at heart risk
Disease control OngoingThis study tests whether a program combining exercise, diet advice, and behavioral support can improve fitness and health in adults aged 60-75 who are at high risk for heart disease. Participants in the program receive supervised high-intensity exercise and counseling, while all …
Sponsor: University of Tromso • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Exercise program aims to boost health in severe mental illness
Disease control OngoingThis study tests whether a 6-week exercise program, done twice a week, can improve physical and mental health in 100 adults with severe mental illness. Participants are randomly assigned to either usual care or usual care plus the exercise program. The goal is to see if exercise …
Sponsor: Universidad Pública de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Should sarcoidosis patients stay on infliximab? new trial aims to find out
Disease control OngoingThis phase 3 trial looks at whether people with severe sarcoidosis who are in remission should stop or continue taking infliximab. 32 adults who have been on infliximab for at least 6 months and are stable on low-dose steroids will be randomly assigned to stop or continue the dru…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common vitamin tame a rare gut disease?
Disease control By invitation onlyThis study tests whether taking vitamin B1 tablets for a year can reduce the size and number of colon polyps in people with familial adenomatous polyposis (FAP), a genetic condition that raises colon cancer risk. Ten adults with FAP who still have their colon will take vitamin B1…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blocking stomach blood flow to fight obesity: a new approach?
Disease control CancelledThis study planned to test a procedure called bariatric embolization for people with morbid obesity who cannot have standard weight-loss surgery. The procedure involves injecting tiny particles into blood vessels near the stomach to reduce blood flow, which may lower hunger hormo…
Sponsor: IHU Strasbourg • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo treatment aims to save hips from collapse
Disease control OngoingThis study tests a procedure for people with early-stage osteonecrosis (bone death) of the hip. Doctors drill into the hip bone, inject a concentrated sample of the patient's own bone marrow, and add a special bone graft material called Genex. The goal is to see if this helps bon…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New implant could help sleep apnea sufferers ditch the CPAP mask
Disease control OngoingThis study tests a device that stimulates a nerve in the neck to keep the airway open during sleep. It is for adults with moderate to severe obstructive sleep apnea who cannot use a CPAP machine. The goal is to see if the device is safe and improves breathing and sleep quality.
Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New blood filter could save lives in septic shock
Disease control OngoingThis study tests a new blood filtering therapy for adults in the ICU with septic shock, a life-threatening condition caused by severe infection. The treatment aims to remove harmful substances from the blood to help patients recover faster. The trial includes 15 participants and …
Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain pacemaker shows promise for rare childhood epilepsy
Disease control OngoingThis pilot study tests whether deep brain stimulation (DBS) of specific brain pathways can safely reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy. Five participants receive the electrical stimulation as an add-on to their usual treatment. The goa…
Sponsor: Liankun_Ren • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Ultrasound device opens brain barrier to attack deadly tumors
Disease control OngoingThis trial tests an implantable ultrasound device that temporarily opens the blood-brain barrier, allowing chemotherapy to reach brain tumors. It includes 57 adults with recurrent glioblastoma who have already tried 1-2 treatments. The goal is to find a safe dose and see if this …
Phase 1/2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Withdrawn study: could hydroxychloroquine help High-Risk pregnancies?
Disease control CancelledThis study was designed to see if adding hydroxychloroquine to standard treatment (aspirin and heparin) could help women with antiphospholipid syndrome have a healthy full-term pregnancy. It planned to enroll pregnant women before 14 weeks of gestation. However, the trial was wit…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Stem cell shot into ovaries aims to tame perimenopause symptoms
Disease control By invitation onlyThis study looks at whether injecting special stem-like cells called Muse cells directly into the ovaries can help women aged 28 to 70 who are in perimenopause. The cells may repair tissue, reduce inflammation, and improve hormone balance. Researchers will track safety, hormone l…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Blood filter aims to pull toxins from septic shock patients
Disease control OngoingThis study tests whether a device called the PMX cartridge, which filters endotoxins from the blood, can improve survival in people with septic shock. About 150 adults with severe infections and low blood pressure will receive either standard care alone or standard care plus the …
Sponsor: Spectral Diagnostics (US) Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug shows promise for controlling rare kidney disorders
Disease control OngoingThis study tests the long-term safety and effectiveness of pegcetacoplan in 100 people with two rare kidney diseases, C3 glomerulopathy and IC-MPGN. Participants previously completed a one-year trial and saw benefit from the drug. The goal is to see if pegcetacoplan can keep redu…
Phase 3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could freezing dangerous heart plaque stop a heart attack?
Disease control OngoingThis early study tests a new freezing treatment for people who recently had a heart attack or unstable chest pain. The treatment uses a special balloon to freeze high-risk plaque in the heart's arteries that could rupture and cause another heart attack. The goal is to stabilize t…
Sponsor: Cryotherapeutics SA • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug aims to stop hip bone death from steroids
Disease control OngoingThis study tests a new drug called RAB001 in people with early-stage hip bone damage caused by long-term steroid use. About 160 participants will receive either a low, medium, or high dose of RAB001, or a standard bone drug (alendronate). The goal is to see if RAB001 can reduce t…
Phase 2 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart monitor could make blood thinners safer for heart attack patients
Disease control OngoingThis study tests whether an implantable heart monitor with remote follow-up can help doctors decide when to prescribe blood thinners to patients who have had a heart attack and developed new atrial fibrillation. The goal is to reduce bleeding complications compared to the standar…
Phase 4 • Sponsor: Centre Hospitalier de PAU • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Space suit that zaps muscles could keep astronauts fit on mars missions
Disease control By invitation onlyThis study tests a special body suit that uses gentle electric pulses to stimulate muscles, helping astronauts exercise more efficiently in space. Twelve astronauts on the International Space Station will wear the suit during their workouts. Researchers will measure muscle stiffn…
Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for blood cancer patients: using mismatched donors for transplants
Disease control OngoingThis study tests a stem cell transplant using donors who are not a perfect match for patients with blood cancers like leukemia and lymphoma. Doctors give special drugs after the transplant to help prevent the donor cells from attacking the patient's body. The goal is to see if th…
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New trial aims to slash COVID-19 deaths and ventilator use
Disease control OngoingThis study tests several experimental treatments at once in critically ill COVID-19 patients who need high-flow oxygen or a ventilator. The goal is to quickly find which treatments can reduce deaths and shorten the time patients need breathing support. About 1,500 adults in the h…
Phase 2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Heart rhythm showdown: ablation may beat drugs for ventricular tachycardia
Disease control OngoingThis trial tests whether a procedure called catheter ablation works better than anti-arrhythmic drugs for people with structural heart disease who have had a dangerous fast heart rhythm (ventricular tachycardia). About 162 participants will be randomly assigned to either ablation…
Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Virus therapy takes on brain cancer in early trial
Disease control OngoingThis early-stage study tests a genetically engineered virus (rQNestin34.5v.2) that is injected directly into recurrent brain tumors to see if it is safe and what dose works best. About 62 adults with certain types of brain cancer that have come back or worsened are taking part. T…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could keytruda tame tough prostate cancers?
Disease control OngoingThis phase 2 study tests pembrolizumab (Keytruda) in 40 men with metastatic castration-resistant prostate cancer that has specific genetic flaws (mismatch repair deficiency or CDK12 inactivation). The goal is to see if the drug can shrink tumors or slow the cancer. Researchers wi…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vitamin e in knee implants: a Long-Term showdown
Disease control OngoingThis study looks at two kinds of plastic used in total knee replacement surgery: one with vitamin E and one without. The goal is to see which one lasts longer, causes less wear, and helps patients move better. About 605 adults with knee arthritis or similar problems took part, an…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sound waves instead of surgery: new device tested for vein disease
Disease control OngoingThis study tests whether a device called Sonablate can safely use high-intensity focused ultrasound (HIFU) to treat vein problems like varicose veins, leg ulcers, and certain birth defects. About 30 adults with these conditions will receive the treatment, which does not involve c…
Sponsor: Sonablate • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug aims to tame rare artery disease
Disease control OngoingThis phase 3 trial tests whether upadacitinib (Rinvoq) can help people with Takayasu arteritis, a rare disease that inflames large arteries. About 56 adults who have had a recent relapse despite steroids will receive either upadacitinib or a placebo, along with a steroid taper. T…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Heart clot showdown: new blood thinner vs. old standard in major trial
Disease control OngoingThis study tests whether a newer type of blood thinner (DOA) works better than the standard one (VKA) for dissolving dangerous blood clots inside the heart. About 340 adults with such clots will be randomly assigned to one of the two treatments. The goal is to see which drug redu…
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New stent under observation for heart attack patients
Disease control OngoingThis study looks at how well the GENOSS stent works in real-world patients who have had a heart attack or unstable chest pain (acute coronary syndrome). Researchers are tracking heart-related events like death, heart attacks, and the need for repeat procedures. The study involves…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Which weight loss surgery works best? major trial launches
Disease control OngoingThis study compares two weight loss surgeries for people with severe obesity: sleeve gastrectomy with transit bipartition (SG+TB) and Roux-en-Y gastric bypass (RYGB). About 320 participants will be followed for two years to see which surgery leads to greater weight loss and fewer…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a ketogenic diet help fight brain tumors?
Disease control OngoingThis pilot study tests whether an energy-restricted ketogenic diet (ERKD) can help control glioblastoma, an aggressive brain cancer. Sixteen adults with newly diagnosed glioblastoma will follow the diet while receiving standard radiation and chemotherapy. The goal is to see if th…
Sponsor: Michigan State University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New program aims to close cancer screening gaps for rural families
Disease control By invitation onlyThis study tests a two-year follow-up program for 200 adults with hereditary cancer syndromes like BRCA or Lynch syndrome. Participants get personalized care plans and regular check-ins with a genetics doctor to help them follow cancer prevention and screening guidelines. The goa…
Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a single drug free PMR patients from steroids?
Disease control OngoingThis phase 3 trial tests whether rituximab, a drug that calms certain immune cells, can help people with polymyalgia rheumatica (PMR) stop taking steroids without their symptoms returning. The study includes 174 adults who are currently experiencing a PMR relapse and cannot lower…
Phase 3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New pill targets aggressive tumors with genetic flaw
Disease control OngoingThis early-phase study tests an experimental oral drug (GSK4418959) in adults with advanced solid tumors that have specific genetic changes (dMMR or MSI-H). The drug works by blocking a protein (WRN) that these tumors need to survive. The study aims to see if the drug, alone or w…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for rare blau syndrome: tofacitinib under the microscope
Disease control By invitation onlyThis study is looking at how well the drug tofacitinib works for people with Blau syndrome, a rare genetic condition that causes inflammation in the joints, eyes, and skin. Researchers will review medical records from 24 participants to see if tofacitinib helps control the diseas…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may cut bleeding risk for heart patients on strong meds
Disease control OngoingThis study tests whether a blood test can help doctors safely lower the dose of strong blood thinners (P2Y12 inhibitors) in people who recently had a heart attack or stent. The goal is to reduce bleeding complications without raising the risk of another heart attack or stroke. Ab…
Phase 4 • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Sleep apnea device may keep heart rhythm in check
Disease control OngoingThis study looks at whether using a CPAP machine at night can reduce the chance of atrial fibrillation (an irregular heartbeat) returning in people who have both sleep apnea and a history of AF. Researchers will follow 91 adults for 12 months, tracking how often they use CPAP and…
Sponsor: Medical University of Sofia • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Stem cell therapy for COVID-19 lung damage trial pulled before it began
Disease control CancelledThis early-stage study aimed to test whether infusing donor stem cells could help people recover from acute respiratory distress syndrome (ARDS) caused by COVID-19. The trial was withdrawn before enrolling any participants, so no results are available. The approach was based on e…
Phase 1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New device aims to stop aneurysm growth without open surgery
Disease control OngoingThis study tests a new device called the Nectero EAST System in 46 people with abdominal aortic aneurysms (AAA). The goal is to see if it is safe and can stop the aneurysm from growing, reducing the need for major surgery. Participants receive the device through a catheter, and d…
Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a One-Stop clinic solve the mystery of functional disorders?
Diagnosis OngoingFunctional somatic disorders cause persistent physical symptoms that doctors cannot explain by other diseases. The DISTRESS trial evaluates a new clinic where internal medicine doctors, trained to recognize these disorders, examine patients and provide guidance to their general p…
Sponsor: Regionshospitalet Silkeborg • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI plus ultrasound could catch heart and lung decline before it turns critical
Diagnosis By invitation onlyResearchers are testing whether artificial intelligence can combine ultrasound images with routine health data to track changes in a person's physiology over time. The study enrolls adults with heart, lung, kidney, or blood vessel conditions, as well as healthy volunteers. The go…
Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
A portable sleep test could unmask hidden sleep apnea in millions with high blood pressure
Diagnosis OngoingThis trial tests whether a portable home sleep apnea test can be as effective as an in-laboratory sleep study for diagnosing obstructive sleep apnea in people with high blood pressure. Participants are randomly assigned to either the home test or the lab test, and researchers com…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThis study tests an AI tool called AIDP that analyzes MRI scans to help diagnose Parkinson's disease and two similar conditions (MSA and PSP). Researchers at 21 sites will compare the AI's diagnosis to that of movement disorder specialists. The goal is to see if the tool can impr…
Sponsor: University of Florida • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
New imaging tools put to the test for measuring dry eye treatment effects
Diagnosis OngoingThis study tests whether two specialized eye imaging devices—the LipiView II and Keratograph 5M—can detect changes in tear film stability after using Miebo eye drops in people with dry eye. Twenty adults with normal tear film will have their eyes measured before and at several ti…
Phase 4 • Sponsor: The Eye Care Institute • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Pocket-Sized ECG could spot heart attacks in minutes
Diagnosis OngoingThis study tests whether a compact 3-lead ECG device can accurately detect acute coronary syndrome (heart attack) in adults arriving at the emergency department with chest pain. Participants receive a HeartBeam ECG recording within 10 minutes of the standard 12-lead ECG. The goal…
Sponsor: HeartBeam, Inc. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Sepsis diagnosis study withdrawn before it began
Diagnosis CancelledThis study planned to compare a newer blood test (presepsine) with a standard one (lactate) for diagnosing severe sepsis and septic shock in emergency department patients. The goal was to see if presepsine could detect these life-threatening infections more accurately. However, t…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
10-Minute Finger-Prick test could revolutionize heart attack diagnosis
Diagnosis OngoingThis study is testing a new finger-prick blood test that measures troponin levels in about 10 minutes, compared to the usual 2-hour lab test. Researchers hope it will help diagnose heart attacks faster and reassure patients who are not having one, allowing them to be discharged s…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
AI reads your Heart's electrical signals to find hidden blockages
Diagnosis OngoingThis study enrolls 800 patients having heart attacks to test an artificial intelligence model that reads standard 12-lead ECGs. The AI aims to detect which artery is blocked and how severely blood flow is reduced, at the moment of a heart catheterization. If accurate, this could …
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Parents' phone videos may spot sleep apnea in kids with down syndrome
Diagnosis OngoingThis study explores whether parents can use their smartphones to record short videos of their child sleeping to screen for obstructive sleep apnea (OSA). Children with Down syndrome are at higher risk for OSA, but standard sleep studies can be hard to access. Parents will rate th…
Sponsor: Children's Hospital of Eastern Ontario • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New stool test could cut unnecessary colonoscopies
Diagnosis By invitation onlyThis study checks if a new stool test can better tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) compared to current tests. About 300 adults and teens will give a stool sample and have a colonoscopy as part of their regular care. If…
Sponsor: DiaSorin Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Could a mouthpiece replace sleep lab tests for apnea?
Diagnosis OngoingThis study checks if a special mouthpiece that measures oxygen levels during sleep is as accurate as the standard sleep lab test. Thirty adults with obstructive sleep apnea will wear the device overnight in a sleep lab. If it works well, it might offer a simpler way to track oxyg…
Sponsor: ProSomnus Sleep Technologies • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Could your mattress detect sleep apnea?
Diagnosis OngoingThis study tests whether a non-contact device placed under the mattress can accurately detect sleep apnea. Researchers will compare the device's readings to standard sleep tests in 200 adults suspected of having sleep apnea. If proven reliable, this could offer a simple, low-cost…
Sponsor: Withings • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New magnetic heart test could speed up heart attack diagnosis in ER
Diagnosis By invitation onlyThis study is testing whether a device called magnetocardiography (MCG) can quickly and accurately tell if chest pain is caused by a heart attack. Researchers at Mayo Clinic will use the MCG scanner on 1,000 emergency room patients with chest pain and compare its accuracy to stan…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Brain wave test may unlock secrets of chronic pain
Diagnosis OngoingThis study uses a device that combines magnetic stimulation and brain wave recording (TMS-EEG) to find biological markers for chronic pain. Researchers will measure brain responses in 100 adults with chronic pain and see if these signals can help diagnose pain types and predict h…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Aspirin shows promise in blocking ovarian cancer for High-Risk women
Prevention OngoingThis study tests whether taking aspirin can prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations, who are at high risk. About 117 participants will take either aspirin or a placebo daily for up to 2 years before their scheduled risk-reducing surgery. Researchers wil…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can diet and exercise programs cut cancer risk? new study tests lifestyle changes
Prevention OngoingThis study tests different programs to help people at high risk for cancer (such as those with BRCA or Lynch syndrome) or cancer survivors increase their physical activity and eat healthier. The goal is to see which programs work best to reduce cancer risk. About 337 participants…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a common antiplatelet drug replace warfarin after APS-Related stroke?
Prevention OngoingAntiphospholipid syndrome (APS) raises the risk of blood clots and strokes, and doctors often prescribe warfarin to prevent another stroke. Warfarin requires frequent blood tests and carries bleeding risks, especially for younger patients. This trial compares clopidogrel-based an…
Phase 4 • Sponsor: Seoul National University Hospital • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
A new care routine aims to shield aging hearts and minds in the ICU
Prevention OngoingThis trial tests whether a structured prevention bundle can reduce delirium in adults aged 70 and older admitted to a cardiac intensive care unit (CICU). Participants are randomly assigned to either usual care or the bundle, which includes daily pain checks, avoiding sedatives wh…
Sponsor: Tel Aviv Medical Center • Aim: Prevention
Last updated Aug 23, 2026 00:00 UTC
-
Bollywood dance and fitness trackers: a new weapon against breast cancer?
Prevention OngoingThis study tests whether a 6-month program combining Bollywood-style dance classes and a fitness tracker can increase physical activity and improve metabolic health in South Asian Indian immigrant women aged 40-65 who are not very active. The goal is to see if this culturally tai…
Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Eye surgery trial to prevent blindness in stickler syndrome pulled before start
Prevention CancelledThis study aimed to see if a surgical procedure called scleral buckling could prevent retinal detachment in people with Stickler syndrome, a genetic condition that raises the risk of vision loss. The plan was to treat one eye in patients aged 5 to 35 who had already lost vision i…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can a digital coach help you avoid heart disease? new study aims to find out
Prevention By invitation onlyThis study is testing a digital health platform called STELA that creates personalized lifestyle plans to reduce risk factors for heart disease, like obesity, high cholesterol, and insulin resistance. About 100 adults without existing heart disease will use the platform for a yea…
Sponsor: Nemocnice AGEL Trinec-Podlesi a.s. • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
New surgery may prevent ovarian cancer without removing ovaries
Prevention OngoingThis study tests a surgery called radical fimbriectomy in women with BRCA mutations who are at high risk for pelvic cancer but want to keep their ovaries. The procedure removes the fallopian tubes, where many of these cancers start, while leaving the ovaries to produce natural ho…
Sponsor: Centre Oscar Lambret • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Could a simple drug stop deadly organ failure after surgery?
Prevention OngoingThis study tests if a drug called dalargin can prevent serious organ problems like kidney injury, lung failure, or heart damage after major abdominal surgery. About 200 adults having high-risk surgery will get either dalargin or a placebo for 3 days. The goal is to see if dalargi…
Phase 3 • Sponsor: Botkin Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Digital screening may boost HIV prevention in Women's health visits
Prevention OngoingThis study tests whether collecting sexual health information electronically during routine gynecologic visits can increase the use of PrEP, a medication that prevents HIV. About 1,170 women aged 15-65 who are not living with HIV will participate. The goal is to see if this appro…
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Online course aims to boost diet and Self-Care for MS and fatigue patients
Symptom relief OngoingThis study is testing whether an online course can help people with multiple sclerosis, long COVID, fibromyalgia, or cancer-related fatigue adopt healthier diets and self-care habits. Researchers will measure changes in quality of life, fatigue, and mental health. The goal is to …
Sponsor: Terry L. Wahls • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a robotic exoskeleton rebuild arm strength after Guillain-Barré?
Symptom relief OngoingGuillain-Barré syndrome can leave people with weak arms and hands, making daily tasks hard. This trial tests whether adding robot-assisted arm training to usual therapy helps adults in the sub-acute phase of recovery. Participants use the Armeo Power 2 exoskeleton for 20 sessions…
Phase 4 • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Mindfulness program aims to ease lung cancer breathlessness
Symptom relief OngoingThis study tests a 6-week mindfulness-based program for lung cancer patients struggling with breathlessness, cough, and fatigue. The program combines mindful breathing, relaxation, cough control, acupressure, and light exercise. Researchers will check if it's practical and liked …
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could peppermint oil be a natural pain reliever for fibromyalgia?
Symptom relief By invitation onlyThis study is testing whether applying peppermint oil to the skin can reduce chronic pain and improve daily function in people with fibromyalgia. Researchers will also look at whether this treatment is cost-effective compared to standard care. About 175 adults with fibromyalgia w…
Sponsor: Bilecik Seyh Edebali Universitesi • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Hands-On nerve technique ease Fibromyalgia's grip?
Symptom relief By invitation onlyResearchers in Chile are testing whether adding neural mobilization, a physical therapy technique that targets nerve movement, to standard fibromyalgia care improves daily function and reduces pain more than standard care alone. The trial enrolls 20 women aged 18 and older with a…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Laughing gas vs. oxygen for easier labor induction
Symptom relief CancelledThis study was designed to see if giving nitrous oxide (laughing gas) helps pregnant women feel less pain when a balloon is placed to start labor. It planned to compare nitrous oxide with plain oxygen. However, the study was withdrawn before any participants were enrolled, so no …
Phase 3 • Sponsor: Jefferson Drapkin • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can pedaling during dialysis make red blood cells more flexible?
Symptom relief CancelledResearchers are testing whether supervised exercise can change how red blood cells behave in people with end-stage kidney disease who receive hemodialysis. About 180 participants will cycle during dialysis sessions three times a week for six months, then exercise at home for thre…
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a Job-Focused rehab program keep arthritis patients employed?
Symptom relief OngoingPeople with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis often struggle to stay in work. This trial tests a 6-month vocational rehabilitation program called WORK-ON, which includes a coordinating occupational therapist, group sessions with peers, and ind…
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New hope for IBS sufferers: allergy drug may beat standard treatment
Symptom relief OngoingThis study tests whether ebastine, an allergy medication, works better than mebeverine, a common IBS drug, for reducing belly pain and improving daily life. About 200 adults with non-constipated IBS will take one of the two pills for 12 weeks. The goal is to see if ebastine provi…
Phase 3 • Sponsor: Guy Boeckxstaens • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can starting anemia drug sooner keep MDS patients off transfusions?
Symptom relief OngoingResearchers are testing whether starting epoetin alfa early, as soon as anemia appears, works better than waiting until a person needs blood transfusions. The trial enrolls adults with lower risk myelodysplastic syndromes (MDS) who have mild anemia and are not yet dependent on re…
Phase 3 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
A personal nurse and a plan: could this ease the daily burden of arthritis?
Symptom relief OngoingThis trial tests a six-month program where a coordinating rheumatology nurse helps people with inflammatory arthritis set goals and plan actions to manage their condition. Participants also get access to physiotherapy, occupational therapy, and social work support as needed. The …
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can a Nine-Week group program help blood cancer patients grow through trauma?
Symptom relief OngoingResearchers in Greece are testing a nine-session group program called TRANSFORM for people who have finished treatment for blood cancers such as leukemia, lymphoma, and myeloma. The program combines teaching, reflection, coping exercises, and mindfulness to see whether it can spa…
Sponsor: University of West Attica • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Eye drops take aim at dry eye: phase 2 trial puts TJO-087 to the test
Symptom relief OngoingResearchers are testing an experimental eye drop called TJO-087 in adults with dry eye syndrome. The trial enrolls about 90 people who have dry eye symptoms and signs of corneal damage. Participants receive either TJO-087 or a placebo drop for 3 months. The main measure is whethe…
Phase 2 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a smarter oxygen device help lung disease patients move more?
Symptom relief By invitation onlyThis study tests whether using a portable oxygen concentrator (a lightweight, battery-powered device) during walking or exercise helps people with interstitial lung disease (ILD) or COPD feel less breathless and be more active in their daily lives. Twenty-four participants will t…
Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New fibromyalgia drug shows promise in Long-Term safety trial
Symptom relief By invitation onlyThis study tests the long-term safety and effectiveness of an experimental drug called AXS-14 for people with fibromyalgia, a condition causing widespread pain and fatigue. About 300 adults who previously took part in a related study will receive AXS-14 for 52 weeks. Researchers …
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Oxygen chamber treatment tested for long COVID fatigue relief
Symptom relief OngoingThis study is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms like fatigue and brain fog in people with post-COVID syndrome. About 40 adults with long COVID will receive the treatment. The main goal is to see if a la…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Writing as medicine: can words soothe chronic pain?
Symptom relief CancelledThis study looks at whether a guided therapeutic writing program can help adult women with chronic pain and co-occurring mental health conditions. Participants will complete writing exercises focused on emotional processing and meaning-making over four weeks, then share their exp…
Sponsor: Toni Salikka • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Eye workouts while on dialysis: a new way to prevent falls?
Symptom relief By invitation onlyThis pilot study will test whether a short eye-exercise program done during dialysis sessions can improve physical function, balance, and fear of falling in people with kidney failure. Thirty adults on maintenance hemodialysis will be randomly assigned to do the exercises or rece…
Sponsor: Pardis Specialized Wellness Institute • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New hope for kids with rare liver disease: long-term drug study launched
Symptom relief OngoingThis study looks at the long-term safety and effectiveness of odevixibat in 70 people with Alagille syndrome, a rare genetic condition that affects the liver and other organs. The drug aims to reduce severe itching and improve bile flow. Participants who completed a prior 24-week…
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Zapping the brain to fight teen pain: a new hope?
Symptom relief By invitation onlyThis trial tests whether transcranial electrical stimulation (tES) — a safe, non-invasive technique that sends a mild electrical current through the scalp — can reduce pain and improve quality of life in children and adolescents aged 10 to 21 with juvenile fibromyalgia or other n…
Sponsor: Istituto Giannina Gaslini • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can adding shockwaves boost bowen therapy for buttock pain?
Symptom relief By invitation onlyThis trial tests whether adding extracorporeal shockwave therapy (ESWT) to the Bowen Technique, a gentle manual therapy, improves outcomes for people with deep gluteal pain syndrome. Forty-six adults aged 25 to 45 with buttock pain will be randomly assigned to receive either Bowe…
Sponsor: University of Management and Technology Sialkot Pakistan • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Massage showdown: which therapy eases piriformis pain best?
Symptom relief By invitation onlyThis study compares two types of hands-on therapy—Stecco Fascial Manipulation and Rolfing Structural Integration—for people with piriformis syndrome, a condition that causes buttock and leg pain. Forty-two adults aged 25 to 45 with at least four weeks of pain will receive four we…
Sponsor: Danyal Ahmad • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could zapping the brain ease fibromyalgia pain?
Symptom relief By invitation onlyThis early study tests whether a non-invasive brain stimulation technique called TMS can help reduce pain, fatigue, and brain fog in people with fibromyalgia. About 30 adults will receive multiple TMS sessions and undergo MRI scans to see how the brain changes. The goal is to gat…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can robot legs help Non-Walking kids join in at school?
Symptom relief By invitation onlyThis pilot study explores whether robot-assisted walking devices can be used in schools to help children who cannot walk independently. The devices attach to a walker and power leg movements, allowing children to stand and walk upright. The study aims to identify the best ways to…
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Mouth rinse could ease painful radiation side effects for head and neck cancer patients
Symptom relief OngoingThis trial tests Gelclair, a mouth rinse that forms a protective coating over the mouth's lining, to see if it eases the painful mouth sores (oral mucositis) caused by radiation therapy for head and neck cancer. The study enrolls adults with squamous cell carcinoma who will recei…
Phase 4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Teaching the brain about pain may boost exercise benefits for chronic pain sufferers
Symptom relief By invitation onlyThis study tests whether combining pain neuroscience education (teaching people how the brain processes pain) with therapeutic exercise helps people with fibromyalgia or chronic low back pain. Participants attend exercise sessions three times a week and one education session week…
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Could a tiny dose of naltrexone calm CRPS pain? new study aims to find out.
Symptom relief By invitation onlyThis study tests whether a very low dose of naltrexone, a drug usually used for addiction, can reduce pain and other symptoms in people with Complex Regional Pain Syndrome (CRPS). Forty adults with CRPS will receive either the drug or a placebo for six months. The main goal is to…
Phase 4 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Lifting weights, lifting hope: exercise trial targets brain cancer decline
Symptom relief By invitation onlyThis study explores whether a supervised, circuit-based resistance training program can help glioblastoma patients maintain muscle mass and perform daily tasks more easily. Researchers will enroll 24 adults with glioblastoma who are currently on treatment. Participants will exerc…
Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study tests if guided exercise beats simple advice for fibromyalgia fatigue
Symptom relief OngoingThis study looks at whether supervised physical activity helps people with fibromyalgia stay active longer than just getting advice. Fibromyalgia causes pain and fatigue, and inactivity can make symptoms worse. The study involves 330 adults who are currently sedentary. Researcher…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can an online course keep arthritis patients working?
Symptom relief OngoingThis study tests an online program designed to help people with inflammatory arthritis remain employed. The program includes eLearning modules, group video sessions, and consultations with an occupational therapist and vocational counselor. About 528 participants from three Canad…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a 30-Minute infusion be as safe as an hour for kids with IBD?
Symptom relief OngoingThis study compares giving the drug infliximab over 30 minutes versus the standard 60 minutes in children with inflammatory bowel disease (IBD). The goal is to see if the shorter infusion causes just as few allergic reactions and improves patient and nurse satisfaction. Sixty chi…
Sponsor: University Hospital, Akershus • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple muscle zap boost pain relief for back pain sufferers?
Symptom relief By invitation onlyThis study looks at whether adding a daily 30-minute muscle stimulation session can improve pain control and quality of life for people who already have a spinal cord stimulator (BurstDR) for chronic back pain. Sixty adults with failed back surgery syndrome or persistent spinal p…
Sponsor: Jessa Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can remote rehab beat home workouts for piriformis pain?
Symptom relief By invitation onlyThis study compares two exercise programs—asynchronous telerehabilitation (remote guidance) and a standard home exercise plan—for people with piriformis syndrome, a condition causing buttock and leg pain. About 46 adults aged 18-45 with confirmed diagnosis will participate. The g…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Tailored team approach shows promise for IBS sufferers
Symptom relief OngoingThis study tests a personalized treatment plan for adults with moderate-to-severe IBS. Participants receive a combination of medical care, dietary guidance, psychological therapy, and physical therapy, chosen in an order that suits them. The goal is to reduce IBS symptoms by at l…
Sponsor: Linkoeping University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could a sleep apnea drug boost brain power in kids with down syndrome?
Symptom relief OngoingThis study tests a combination of two medicines (atomoxetine and oxybutynin) given at bedtime for 6 months to children aged 6-17 with Down syndrome and obstructive sleep apnea. The goal is to see if the treatment improves sleep quality and thinking skills. About 36 children will …
Phase 2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Can remote rehab help lung patients breathe easier?
Symptom relief OngoingThis pilot study tests whether home-based or video-supervised exercise programs are acceptable and helpful for people with chronic lung diseases like IPF, sarcoidosis, bronchiectasis, asthma, and other interstitial lung diseases. Fifty participants will be randomly assigned to on…
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New combo treatment aims to quiet jaw pain for TMD sufferers
Symptom relief OngoingThis study tests whether wearing a custom mouth splint and getting a granisetron injection into the jaw muscle reduces pain from temporomandibular disorders (TMD) better than the splint alone or with lidocaine. About 48 adults with jaw muscle pain will be followed for 6 months. T…
Phase 4 • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Online support groups and telemedicine aim to ease Parkinson's and dementia burden
Symptom relief OngoingThis study looks at whether online community support and telemedicine can improve quality of life for people with Parkinson's disease, Lewy body dementia, and related conditions, as well as their caregivers. About 632 participants will receive palliative care training for their d…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Which letrozole schedule boosts ovulation best in PCOS?
Symptom relief OngoingThis study looks at two ways of taking the drug letrozole to help women with PCOS ovulate and get pregnant. One group takes 5 mg daily for 10 days, the other takes 10 mg daily for 5 days. Researchers will track follicle growth and ovulation to see which schedule is more effective…
Sponsor: Mst.Sumyara Khatun • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New oxygen device may make endoscopy safer for High-Risk patients
Symptom relief By invitation onlyThis study tests whether high-flow oxygen therapy can prevent low oxygen levels (hypoxemia) in patients at higher risk during sedated digestive endoscopy. The trial includes 326 adults with obesity, sleep apnea, or stable lung or heart conditions. Researchers will compare high-fl…
Phase 4 • Sponsor: Outcomes'10 • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
PCOS treatment showdown: metformin vs. birth control for older women
Symptom relief CancelledThis study aimed to see if metformin or birth control pills were more satisfying for treating PCOS in women aged 40-49. It planned to use a quality-of-life questionnaire to measure patient satisfaction. However, the study was withdrawn before any participants were enrolled, so no…
Early phase 1 • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Parents as Co-Therapists: new study aims to help kids with language delays
Symptom relief By invitation onlyThis study tests whether training parents to use specific communication strategies, alongside standard speech therapy, helps children aged 3-5 with Developmental Language Disorder improve their language skills and behavior. Researchers will compare outcomes like language developm…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gaming therapy aims to reduce repetitive hand movements in rett syndrome
Symptom relief OngoingThis study tests whether personalized computer games can help people with Rett syndrome use their arms more purposefully and reduce repetitive hand movements. Fourteen participants will play games that reward them for separating their hands and reaching for targets. The training …
Sponsor: Georgetown University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
App-Based mouth exercises aim to quiet snoring
Symptom relief OngoingThis study tests whether doing simple mouth, tongue, and throat exercises using a mobile app can improve snoring and sleep apnea better than following a paper guide. The 34 participants are adults with mild to severe obstructive sleep apnea who could not or would not use a CPAP m…
Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Clean air trial hopes to ease breathing for rare lung disease patients
Symptom relief By invitation onlyThis study is testing whether using HEPA air purifiers at home can reduce respiratory symptoms and improve lung function in children and adults with Cystic Fibrosis (CF) or Primary Ciliary Dyskinesia (PCD). Participants will have two purifiers installed in their home and will und…
Sponsor: University of Cyprus • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Breathe easy, move better: slow breathing may ease fibromyalgia pain
Symptom relief By invitation onlyThis study looks at whether slow breathing techniques can help women with fibromyalgia improve their heart rate control and exercise performance. About 159 women will be randomly assigned to breathe slowly (with or without a visual guide) or normally before doing arm curls. Resea…
Sponsor: University of Malaga • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief By invitation onlyThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Virtual reality games could make dialysis less miserable
Symptom relief OngoingThis study tests a virtual reality platform designed for people on hemodialysis. The platform includes games to encourage exercise, plus nutritional advice and psychological support. Researchers hope it will improve patients' walking ability, quality of life, and overall well-bei…
Sponsor: Cardenal Herrera University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a zapping the brain ease fibromyalgia pain?
Symptom relief OngoingThis study looks at whether a single session of mild electrical brain stimulation (tDCS) over the cerebellum can help reduce pain in women with fibromyalgia. About 92 right-handed women aged 18-65 with confirmed fibromyalgia and moderate-to-severe pain will receive the stimulatio…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Light mask may soothe dry eyes in Graves' patients
Symptom relief By invitation onlyThis study tests a low-level light therapy mask for dry eye disease in people with Graves' eye disease who haven't improved with standard treatments. Thirty adults will receive either the real light therapy or a sham device. The goal is to see if the treatment improves tear film …
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New exercise combo aims to ease PCOS symptoms without drugs
Symptom relief By invitation onlyThis study tests whether combining senobi exercises with aerobic workouts can help women with polycystic ovary syndrome (PCOS) lose weight, feel less tired, and improve their quality of life. Thirty-two women aged 18 to 35 with PCOS will be split into two groups: one doing both s…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could simple breathing exercises ease fibromyalgia symptoms?
Symptom relief OngoingThis study looks at whether pranayama breathing exercises can help people with fibromyalgia feel less pain, anxiety, and sleep better. About 54 adults with fibromyalgia will practice these breathing techniques. The goal is to see if this gentle, low-cost approach can improve qual…
Sponsor: Ondokuz Mayıs University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New study aims to find the best Weight-Loss surgery for fewer side effects
Symptom relief OngoingThis study compares two types of weight-loss surgery—sleeve gastrectomy alone versus sleeve gastrectomy with transit bipartition—to see which leads to fewer cases of dumping syndrome (nausea, diarrhea, dizziness after eating) and better quality of life. Researchers will follow 20…
Sponsor: Mina Kamal Gergis Erian • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Does concentrating change your breathing? study probes Brain-Breath link in opioid users
Knowledge-focused By invitation onlyResearchers at UC San Diego want to know whether doing a mental task changes breathing differently in people who take opioid pain medicine every day, people with obstructive sleep apnea, and healthy adults. The study compares three groups of 40 adults in total. Each participant v…
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
500 COVID survivors tracked to uncover lingering health mysteries
Knowledge-focused OngoingThis study follows 500 adults who had COVID-19 to see what health problems they face months later. Researchers will track symptoms like tiredness, breathing trouble, and lung damage. The goal is to learn how common these long-term issues are and who is most likely to have them.
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists dig into tissue samples to unravel lung scarring mystery
Knowledge-focused OngoingThis study collects and analyzes blood, DNA, and tissue samples from 315 adults with pulmonary fibrosis, their relatives, and healthy volunteers. The goal is to learn more about the disease's causes, not to test a new treatment. Researchers hope the findings will guide future the…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New program aims to boost genetic testing in cancer families
Knowledge-focused OngoingThis study looks at whether a website and a genetic family navigator can help more relatives of people with hereditary cancer get genetic testing. About 205 participants will use the online hub and work with a navigator to learn about their cancer risk. The goal is to see if this…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study probes Mitapivat's inner workings in sickle cell
Knowledge-focused OngoingThis observational study will examine how the drug mitapivat changes red blood cells in 6 people with sickle cell disease. Researchers will measure oxygen binding and cell survival markers from blood samples and muscle oxygen tests. The goal is to understand the drug's effects, n…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track flu antibodies for years to build better vaccines
Knowledge-focused By invitation onlyThis study follows 200 people who have had the flu to see how their immune system changes over two years. Participants give blood and nasal samples every three months. The goal is to learn how long antibodies last and how they change, which could help create more effective flu va…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can tongue exercises unlock better sleep? new study investigates
Knowledge-focused By invitation onlyThis study looks at whether special mouth and throat exercises can improve sleep apnea by strengthening the muscles that keep the airway open. Thirty adults with sleep apnea will use myofunctional therapy devices for three months. Researchers will measure muscle pressure in the t…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
500-Person study aims to crack the code of personalized weight loss
Knowledge-focused By invitation onlyThis study follows 500 obese adults to see how different factors like diet, exercise, stress, and sleep affect weight loss. Researchers collect blood tests, measurements, and questionnaires at the start and during follow-up. The goal is to find patterns that could lead to more pe…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study hopes to outsmart pancreatic cancer by gathering clues
Knowledge-focused OngoingThis study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
2000 volunteers needed to test Next-Gen MRI scans
Knowledge-focused OngoingThis study aims to test new MRI sequences in 2000 adults (patients and healthy volunteers) to see if they can produce better images than current methods. Participants will undergo additional scans during their regular MRI. The goal is to improve diagnostic capabilities without di…
Phase 4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Researchers track rare thyroid cancer to uncover its secrets
Knowledge-focused OngoingThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but part…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Sound waves may replace X-Rays for dental implant timing
Knowledge-focused OngoingThis study at the University of Michigan is testing whether ultrasound can monitor bone graft healing after tooth extraction, potentially replacing more invasive scans. About 140 adults needing a tooth extraction and bone graft for a future dental implant will have their healing …
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Could a simple leg massage boost brain health in sleep apnea patients?
Knowledge-focused By invitation onlyThis early study at Mayo Clinic tests whether using a device that massages the legs at night can help the brain clear waste products better in people with obstructive sleep apnea. The study involves 12 adults aged 50 and older who already use CPAP therapy. Researchers will measur…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Registry maps the return of a stubborn heart condition
Knowledge-focused OngoingResearchers are building a registry to follow adults with recurrent pericarditis, a condition where inflammation around the heart keeps coming back. The registry collects information over time on how often flare-ups happen, what treatments patients receive, and whether they are h…
Sponsor: Eurasian Association of Therapists • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Spinal fluid and blood may reveal how the brain suffers after cardiac arrest
Knowledge-focused OngoingResearchers at Chungnam National University Hospital are studying blood and cerebrospinal fluid from adults who had an out-of-hospital cardiac arrest and received post-resuscitation care. The goal is to map molecular changes over time and see how they relate to the severity of br…
Sponsor: Chungnam National University Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Braces breakthrough? study tests which wire moves teeth faster
Knowledge-focused By invitation onlyThis study compares stainless steel and titanium-molybdenum alloy wires for moving canine teeth in people with braces. Sixteen participants will have one type of wire on each side of their upper jaw to see which works better. The goal is to find out which wire moves teeth more ef…
Sponsor: Tanzila Rafique • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood test could spot hidden tumors in NF1 patients
Knowledge-focused By invitation onlyThis study aims to find blood-based biomarkers that signal the presence and size of plexiform neurofibromas in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI to compare biomarker levels in 200 participants with different …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New study aims to uncover hidden heart risks in women
Knowledge-focused OngoingThis pilot study is testing whether it's possible to run a larger study that focuses on heart disease in women. Researchers will gather information from 176 women aged 25-55 in Ontario who have had certain female-specific health issues like pre-eclampsia, gestational diabetes, or…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Hidden muscle loss in Sjögren's syndrome: a new study looks for answers
Knowledge-focused OngoingThis study examines whether women with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth, also experience muscle loss, a condition called sarcopenia. Researchers will measure muscle strength, muscle mass, and physical performance in 120 participants…
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Heart rate secrets: new study tracks diabetes Drug's hidden effects
Knowledge-focused OngoingThis study monitors heart rate variability in 150 adults with type 2 diabetes who also have heart failure, chronic kidney disease, or both. Participants will wear a 24-hour heart monitor before and after starting a standard SGLT2 inhibitor medication. The goal is to understand ho…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New software aims to cut ventilator complications in ICUs
Knowledge-focused OngoingThis study tests whether a software tool called the Respiratory Knowledge Portal (RKP) can help ICU teams reduce complications in patients on breathing machines. Researchers will collect data from 875 patients to see if the tool improves how alarms are set, helps wean patients of…
Sponsor: The University of Texas Medical Branch, Galveston • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Florida launches brain disease biobank to fuel future discoveries
Knowledge-focused OngoingThis study is creating a statewide collection of blood samples and medical information from people with various brain blood vessel diseases, such as stroke and dementia. The goal is to build a resource that scientists can use in future research to better understand and potentiall…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New blood test could spot cancer return after transplant
Knowledge-focused OngoingThis study is testing a new blood test called AlloHeme that measures how much of a patient's own cells remain after a bone marrow transplant. The goal is to see if this test can predict whether the cancer (acute leukemia or myelodysplastic syndrome) will come back. About 307 adul…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Diet soda showdown: stevia vs. aspartame – which is better for your gut?
Knowledge-focused OngoingThis study looked at 41 healthy adults who regularly drink sugary sodas. Researchers replaced their sugary drinks with either stevia-sweetened or aspartame-sweetened beverages for 10 weeks. The goal was to see how these alternatives affect metabolism and gut bacteria. The results…
Sponsor: Laval University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study analyzes Odevixibat's impact on rare liver disease outcomes
Knowledge-focused OngoingThis study looks at a rare liver disease called PFIC, which causes severe itching and liver damage. Researchers compare patients who took the drug odevixibat to those who did not, using data from past studies and a patient registry. The goal is to see if odevixibat helps avoid li…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can explicit grammar lessons help kids with language disorder?
Knowledge-focused OngoingThis study compares two teaching methods for children aged 5-9 with developmental language disorder. One method uses only traditional implicit teaching (like imitation and practice), while the other adds explicit rule explanations. Over 111 children will receive 32 sessions targe…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
50,000 samples to unlock secrets of hereditary tumors
Knowledge-focused CancelledThis study will collect blood and tumor tissue from up to 50,000 adults with hereditary or genetic-linked cancers. Researchers will use these samples to create lab-grown tumor models, like mini-tumors, to study how these cancers work and test new treatments. The goal is to better…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can tracking ambulance ventilators improve emergency breathing care?
Knowledge-focused By invitation onlyThis study tracks how paramedics use the ZOLL 731 ventilator when helping people with serious conditions like cardiac arrest, sepsis, or heart failure before they reach the hospital. Researchers will record which ventilator modes and settings are used, and how often alarms go off…
Sponsor: Zoll Medical Corporation • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Smart sensors could revolutionize rett syndrome monitoring
Knowledge-focused OngoingThis study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The go…
Sponsor: Rett Syndrome Research Trust • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists collect skin cells to pave way for future immune disease cures
Knowledge-focused By invitation onlyThis study collects small skin samples from people with primary immunodeficiency or immune regulation disorders, as well as from healthy volunteers. Researchers will use these cells to create cell lines for laboratory research. The goal is to better understand immune diseases and…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
500 cancer Patients' records reviewed to tame immunotherapy side effects
Knowledge-focused OngoingThis study looks back at the medical records of 500 children and adults with cancer who received immunotherapy at the National Cancer Institute. The goal is to understand the side effects, like inflammation and immune reactions, that can happen with these treatments. By learning …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Blood test could spot rare nerve tumors years earlier in NF1 patients
Knowledge-focused By invitation onlyThis study is testing whether a blood test (liquid biopsy) can detect a rare but serious nerve tumor called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will compare the timing of tumor detection by the blood test versus standard i…
Sponsor: David Miller • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Sniffing out Parkinson's: new study uses nose, blood, and urine to catch disease early
Knowledge-focused OngoingThis study aims to find early markers of Parkinson's disease, multiple system atrophy, and Lewy body dementia by analyzing samples from the nose, blood, and urine. Researchers will compare results from 180 people with these conditions and healthy volunteers. The goal is to improv…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Wearable ECG patch could unlock hidden heart risks
Knowledge-focused By invitation onlyThis study is testing whether a wearable ECG patch, combined with AI analysis, can help doctors identify a wide range of heart conditions and risks from a single recording. The Cor360 system looks at many aspects of heart health at once, such as heart failure, rhythm problems, an…
Sponsor: Peerbridge Health, Inc • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Do complex heart procedures expose patients to more harmful radiation and contrast?
Knowledge-focused OngoingThis study is looking at people hospitalized for a heart attack (STEMI or NSTEMI) who undergo a procedure to open blocked heart arteries, called percutaneous coronary intervention (PCI) or angioplasty. It compares two groups: those having a standard (non-complex) PCI and those ha…
Sponsor: Centre Cardiologique du Nord • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Are Europe's heart patients getting the right prevention care? a massive survey aims to find out
Knowledge-focused OngoingThis observational study will enroll about 8,000 adults across Europe who have coronary heart disease or are at high risk for it, including those with diabetes or chronic kidney disease. Researchers will check whether doctors are following European guidelines for lifestyle advice…
Sponsor: European Society of Cardiology • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Could a simple blood test predict clot risk in PCOS?
Knowledge-focused OngoingThis study looks at whether different types of polycystic ovary syndrome (PCOS) have different blood clotting profiles. Researchers will measure several biological markers in blood samples from women with PCOS and compare them based on the presence of insulin resistance. The goal…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Counting the uncounted: a nationwide look at two rare epilepsies
Knowledge-focused CancelledThis observational study aims to measure how many people in Portugal have Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS), two rare and severe forms of epilepsy. Researchers will review existing medical records from about three public hospitals to estimate the percentage of…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Could a mouthpiece replace the CPAP machine for sleep apnea?
Knowledge-focused OngoingThis registry study follows 500 adults with obstructive sleep apnea who are prescribed a mandibular advancement device (MAD) — a dental appliance worn at night to keep the airway open. Researchers will track how the device is prescribed, how often patients actually use it, and wh…
Sponsor: ResMed • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Could a brain disease change behavior years before diagnosis?
Knowledge-focused OngoingThis study investigates whether people with neurodegenerative diseases—like Alzheimer's, Parkinson's, or ALS—show changes in behavior, social circumstances, or health before and after their diagnosis. Researchers will compare the records of over 61,000 patients with those of matc…
Sponsor: Kuopio University Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Sleep apnea study to reveal how CPAP alters body signals
Knowledge-focused OngoingThis study looks at how continuous positive airway pressure (CPAP) therapy affects body signals like oxygen levels, heart rate, and breathing in adults with obstructive sleep apnea. Researchers will analyze data from 160 people who completed a previous trial, comparing signals be…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a biologic drug tame juvenile arthritis in kids?
Knowledge-focused CancelledThis study follows children aged 6 to 17 with active juvenile enthesitis-related or psoriatic arthritis who are being treated with secukinumab. Researchers will track how long children stay on the drug, how much their symptoms improve, and whether they achieve remission. The goal…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Beyond BRCA: new gene panel could sharpen cancer risk prediction
Knowledge-focused OngoingThis study is investigating whether testing for a panel of 24 genes, in addition to the well-known BRCA1 and BRCA2 genes, can better estimate the risk of breast and ovarian cancer. Researchers will analyze genetic samples from people with a family history of these cancers, as wel…
Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can tracking PCOS over time unlock better care?
Knowledge-focused OngoingThis study aims to create a large, long-term research cohort of women with polycystic ovary syndrome (PCOS). By systematically collecting follow-up data, researchers hope to understand how the condition evolves across different life stages and identify key factors that influence …
Sponsor: Guangdong Women and Children Hospital • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New bedside heart test could slash ER wait times for chest pain
Knowledge-focused OngoingThis study looks at whether a quick, point-of-care blood test for heart damage can give results faster than standard lab tests for people with chest pain in the emergency room. Researchers will compare the time it takes to get test results and how long patients stay in the ER. Th…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Wearable tech puts hormone health to the test
Knowledge-focused OngoingThis trial tests whether wearable devices can measure how the body responds to everyday challenges like changes in salt intake, meals, fasting, and exercise in adults with endocrine or metabolic disorders. Participants wear home monitoring devices and follow different diet and ac…
Sponsor: Felix Beuschlein • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Eye disease study aims to pave way for future treatments
Knowledge-focused OngoingThis study follows 127 people with a genetic eye condition called USH2A-related retinal degeneration, which can cause vision loss and hearing problems. Researchers measure changes in vision, retinal sensitivity, and mobility over several years. The goal is to understand how the d…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can mapping a rare Gene's effects pave the way to targeted epilepsy therapies?
Knowledge-focused OngoingThis study follows children aged 6 to 21 who have a CNKSR2 gene mutation, which can cause epilepsy, language difficulties, and intellectual disability. Researchers will use brain scans, EEGs, and developmental tests to track how the condition changes over time. The goal is to cre…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New tool aims to unmask why sleep apnea patients abandon their breathing machines
Knowledge-focused OngoingThis study tests a questionnaire called the PAP Problems Triaging Tool, designed to identify why people with obstructive sleep apnea struggle to use their positive airway pressure (PAP) machines. Researchers will ask adults newly prescribed PAP therapy to complete the questionnai…
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Simple tests could revolutionize chronic pain diagnosis
Knowledge-focused OngoingThis study aims to improve how doctors diagnose and treat chronic muscle and joint pain by using simple questionnaires and pain sensitivity tests. Researchers will study 250 adults with conditions like osteoarthritis, fibromyalgia, chronic low back pain, or inflammatory arthritis…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Can a simple glucose monitor unlock PCOS secrets?
Knowledge-focused OngoingThis study aims to learn more about blood sugar patterns in women with Polycystic Ovary Syndrome (PCOS) using a continuous glucose monitor (CGM). Researchers will compare women with and without PCOS to see how their blood sugar differs in daily life. They will also test whether w…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Brain scans aim to unlock mysteries of muscle disease
Knowledge-focused By invitation onlyThis study looks at how myotonic dystrophy types 1 and 2 affect the brain. About 100 adults aged 30-65 will have MRI scans, thinking and movement tests, and blood draws. Some will also have a spinal tap. The goal is to find brain changes that could be used as markers in future tr…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Scientists map the hidden timeline of a deadly hantavirus
Knowledge-focused OngoingThis observational study follows people who have been exposed to Andes virus, a hantavirus that can cause severe respiratory illness. Researchers collect blood samples and monitor symptoms at key points from exposure through infection and recovery. The goal is to understand how t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New study tracks kids on life support to see how timing affects their brains
Knowledge-focused OngoingThis study follows 550 children who need ECMO (a machine that does the work of the lungs) after sudden, severe breathing failure. Researchers will track their abilities and quality of life for a year after leaving the ICU. They will also compare two groups: one that received ECMO…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Could less heart screening be safer for kidney transplant patients?
Knowledge-focused OngoingThis trial investigates whether kidney transplant candidates on dialysis can safely skip routine heart screening after being placed on the waiting list. Participants are randomly assigned to either no further screening or regular annual screening for hidden coronary artery diseas…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Blood test may predict aneurysm surgery need in marfan patients
Knowledge-focused OngoingThis study looks for biological markers in the blood and tissue of adults with Marfan syndrome that could signal when an aortic aneurysm is dangerous enough to require surgery. Researchers will compare three groups of Marfan patients: those without aortic aneurysms, those with st…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans may predict recovery from ICU delirium in lung failure patients
Knowledge-focused CancelledThis study investigates cognitive problems in intensive care patients with acute respiratory distress syndrome (ARDS) who develop delirium (sudden confusion). Researchers use a non-invasive EEG cap and auditory tests to measure brain activity at the bedside. The goal is to identi…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Flat feet may be tied to a common cause of hip pain, study suggests
Knowledge-focused OngoingThis study looks at whether people with flat feet (pes planus) are more likely to have piriformis syndrome, a condition that causes pain in the hip and lower back. Researchers will compare foot posture and pain in adults aged 18-65 who have piriformis syndrome with those who do n…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Cushing's disease study in western france withdrawn before starting
Knowledge-focused CancelledThis study was designed to look back at the health of people with Cushing's disease in Western France between 1990 and 2015. The goal was to find out how many patients went into remission and how many had their disease come back after their first surgery. However, the study was w…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
ECMO Patients' hidden infection risk under the microscope
Knowledge-focused OngoingThis study follows 200 adults on ECMO (a heart-lung machine) for severe breathing problems. Researchers track how many get hospital-acquired infections and measure antibiotic levels in their blood and lungs. The goal is to learn more about infections and drug dosing in these crit…
Sponsor: Policlinico Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Do blood transfusions help at the end of life? a study asks patients and staff
Knowledge-focused OngoingThis study looks at how patients with advanced blood cancers (like acute myeloid leukemia) who are not eligible for a cure, along with their nurses and doctors, feel about the benefits of blood transfusions. Researchers will give questionnaires before each transfusion to compare …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Dentists in the dark? study probes sleep training gaps in italian dental schools
Knowledge-focused OngoingThis study will survey directors of dental programs at Italian universities to find out if sleep medicine is part of the curriculum. The goal is to understand how much future dentists learn about sleep-disordered breathing like sleep apnea. About 70 program directors will answer …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for clues to diagnose Parkinson's earlier
Knowledge-focused OngoingThis study aims to identify biomarkers—biological clues in the body—that can help distinguish between Parkinson's disease and similar conditions like progressive supranuclear palsy and multiple system atrophy. Researchers will follow people with early-stage parkinsonism and healt…
Sponsor: Non-profit organization for scientific research in Parkinson's disease and related disorders • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingThis study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such a…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain leak clue to chronic fatigue and long COVID brain fog?
Knowledge-focused By invitation onlyThis Johns Hopkins study looks at whether a leaky blood-brain barrier and immune changes contribute to cognitive problems in people with ME/CFS (chronic fatigue syndrome), both those who got sick before the pandemic and those who developed it after COVID-19. Researchers will use …
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Gut check: 4,000-Person study links diet, genes, and stomach troubles
Knowledge-focused By invitation onlyThis study looks at how diet, genetics, and gut bacteria work together to cause digestive problems like IBS, IBD, and celiac disease. Researchers will follow about 4,000 adults with and without these conditions to find patterns. The goal is to understand why some people get sick …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists hunt for genes behind kidney disease
Knowledge-focused OngoingThis study aims to find the genetic causes of kidney diseases like FSGS and nephrotic syndrome. Researchers will collect saliva and urine samples from up to 2,050 participants, including patients and their family members, as well as healthy volunteers. The goal is to understand w…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Ground-Level vision test could help retinitis pigmentosa patients walk better
Knowledge-focused CancelledThis study was designed to see if a new method of measuring the visual field—by projecting vision zones on the ground—helps people with retinitis pigmentosa understand their remaining sight and improve their walking rehabilitation. The trial was withdrawn before enrolling any par…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Why do women have heart attacks without blocked arteries? new study investigates
Knowledge-focused OngoingThis study looks at women who have had a heart attack or unstable angina but do not have major blockages in their heart arteries. Doctors will use special imaging techniques, like IVUS and MRI, to find hidden causes such as cholesterol plaque in artery walls or problems with tiny…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can a website bring BRCA testing to more people?
Knowledge-focused OngoingThis study is testing a digital health tool to help more people of Ashkenazi Jewish descent get tested for BRCA gene mutations, which increase cancer risk. Over 5,400 participants will use a web portal to learn about testing and decide whether to proceed. The goal is to see if th…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
What happens to severe COVID-19 survivors after the ICU?
Knowledge-focused OngoingThis study follows 90 people who survived severe COVID-19 pneumonia and needed intensive care. Researchers will check their physical health, mental health, and quality of life at 3 months, 6 months, 1 year, and 5 years after leaving the ICU. The goal is to better understand the l…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New MRI study seeks hidden stroke causes in rare blood disorder
Knowledge-focused By invitation onlyThis study looks at why people with antiphospholipid syndrome (APS) — a condition that raises blood clot risk — may have narrowed brain arteries. Researchers will use advanced MRI scans on 60 APS patients to check for artery narrowing and plaque buildup. The goal is to better und…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood pressure clues may predict early death after heart attack
Knowledge-focused OngoingThis study examines whether a low pulse pressure (the difference between top and bottom blood pressure numbers) in the first hours after a cardiac arrest is linked to early death. Researchers will analyze data from 3500 patients who had a cardiac arrest outside the hospital and a…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain scans reveal diabetes link to cognitive decline in rare disease
Knowledge-focused OngoingThis study looks at whether diabetes or blood sugar problems can worsen thinking and memory issues in people with myotonic dystrophy type 1. Researchers will use MRI brain scans and thinking tests over 4 years to track changes. The goal is to understand why some patients have mor…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a blood test predict who will get diabetes from steroids?
Knowledge-focused OngoingThis study aims to find genetic and metabolic markers that explain why some people develop diabetes, high blood pressure, or bone loss from glucocorticoids while others do not. Researchers will analyze blood and urine samples from up to 600 participants, including those with exce…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
AI could help heart surgery patients get the right Anti-Inflammatory drug
Knowledge-focused OngoingThis study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can treating sleep apnea fix blood sugar problems?
Knowledge-focused PausedThis study looks at why sleep apnea raises the risk of diabetes. Overweight adults with and without sleep apnea will have their blood sugar control measured. Some will receive CPAP, some will get extra oxygen at night, and others will get a sham treatment. The goal is to find out…
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Global experts unite to tackle abdominal pressure crisis
Knowledge-focused By invitation onlyThis study brings together 60 international experts to agree on clear definitions and management strategies for intra-abdominal hypertension and abdominal compartment syndrome, serious conditions where pressure builds dangerously in the abdomen. Using a structured online survey, …
Sponsor: Medical University of Lublin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Sjögren's study dives deep into immune clues in spit and blood
Knowledge-focused OngoingThis study looks at immune system markers in the saliva and blood of 80 people with primary Sjögren's syndrome, a chronic disease causing dry eyes and mouth. Researchers will check for antibodies that may block a key enzyme and see how gum disease affects symptoms. The goal is to…
Sponsor: University of Sao Paulo General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Brain zap aftermath: can we map and avoid memory loss?
Knowledge-focused OngoingThis study tracks 80 patients with brain tumors (metastases or meningiomas) who receive stereotactic radiosurgery. Researchers use memory tests and quality-of-life questionnaires before treatment and every 3 months for a year to see if and how brain function changes. By comparing…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
450 babies help scientists unlock secrets of healthy eating
Knowledge-focused OngoingThis study follows 450 infants and their families from birth to age 12 to learn how a child's biology and home environment work together to shape eating habits and growth. Researchers collect samples, measurements, and surveys at regular visits. The goal is to understand what inf…
Sponsor: University of Illinois at Urbana-Champaign • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Massive global heart study launches to see what really works
Knowledge-focused By invitation onlyThis study is a large international registry that will collect data from up to 130,000 people who have had a heart attack or unstable chest pain. Researchers will track treatments, outcomes, and safety to understand what works best in real-world care. No new drugs or devices are …
Sponsor: University of Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Why do some blind people see things that Aren't there? new study aims to find out
Knowledge-focused By invitation onlyThis study looks at how common Charles Bonnet Syndrome (CBS) is in people with vision loss from conditions like macular degeneration or glaucoma. CBS causes complex visual hallucinations without mental illness. Researchers will survey 640 participants to measure how often it happ…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Severe asthma drug may boost daily steps, study hopes
Knowledge-focused OngoingThis study looks at whether mepolizumab, a drug already used to reduce asthma attacks, can also improve physical activity and exercise tolerance in people with severe asthma. Researchers will track daily steps and activity levels in 62 adults over six months. The goal is to see i…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New test could forecast COVID-19 Patients' future health
Knowledge-focused OngoingThis study aims to create a test that predicts how hospitalized COVID-19 patients will fare in the short and long term (up to one year). Researchers will enroll 600 adults from hospitals and Veterans' facilities, using medical records and lab data to forecast risks like frailty, …
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to spot hidden heart attack risks with High-Tech imaging
Knowledge-focused OngoingThis study looks at 40 people who recently had a heart attack and had one blockage treated. Researchers will use special pressure wires and optical imaging to examine other blockages that were not treated. The goal is to see how many of these leftover blockages are actually dange…
Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New tool aims to measure how chronic pain affects sex life
Knowledge-focused By invitation onlyThis study is testing a Turkish version of a questionnaire that looks at how chronic pain conditions like fibromyalgia and back pain affect sexual function and satisfaction. Researchers will ask 170 people with chronic pain and a stable partner to fill out the survey. The goal is…
Sponsor: Kutahya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New study digs into how mepolizumab changes nose bacteria and genes in asthma patients
Knowledge-focused OngoingThis study tracks 40 people with nasal polyps and severe asthma who are taking mepolizumab, a drug that reduces inflammation. Researchers collect nose, blood, and sputum samples before treatment and at 3, 6, and 12 months to see how the drug affects symptoms, nose bacteria, and g…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Withdrawn study sought to test amino Acid's effect on insulin sensitivity
Knowledge-focused CancelledThis study was designed to see if adding the amino acid isoleucine to a healthy, low-isoleucine diet would change how the body responds to insulin in people with obesity and prediabetes. It planned to enroll adults with a BMI of 30 or higher who also had metabolic syndrome. The s…
Sponsor: Jean L. Fry • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could your phone camera replace blood tests? new study explores
Knowledge-focused OngoingThis study follows 60 people with lower-risk myelodysplastic neoplasms (MDS) who need regular red blood cell transfusions. Over 6 months, participants use a smartphone app to answer weekly quality-of-life questions and take photos of their fingernails or eyelids. Researchers aim …
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New computer model aims to predict fractures in rare bone disorder patients
Knowledge-focused OngoingThis study is testing whether a computer tool called MEKANOS can better predict the risk of hip fractures in people with Fibrous Dysplasia or McCune-Albright Syndrome. Researchers will take CT scans of the femur and use the tool to calculate bone strength. The goal is to improve …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Swimming study tests gentle exercise for chronic fatigue sufferers
Knowledge-focused PausedThis pilot study looks at whether light, self-paced swimming is a tolerable activity for people with ME/CFS and related conditions like Long COVID and fibromyalgia. Participants will swim for 15-30 minutes at their own pace and track symptoms and heart rate variability using an a…
Sponsor: Simon Fraser University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
11,000 volunteers help unlock genetic secrets of heart valve disease
Knowledge-focused OngoingThis study is looking for the genetic causes of bicuspid aortic valve disease, a common heart condition where the aortic valve has two flaps instead of three. Researchers will analyze DNA from 11,000 participants, including patients and their relatives, to find gene changes linke…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Brazilian study to reveal how well medical cannabis really works in daily life
Knowledge-focused By invitation onlyThis observational study will follow 384 patients in Brazil who are using cannabis-based products (like CBD or THC oils) prescribed by their own doctors for chronic pain, anxiety, or depression. Researchers will not provide the medication but will track patients' quality of life,…
Sponsor: Santa Catarina Federal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can ovarian freezing help girls with turner syndrome have children later?
Knowledge-focused OngoingThis study looks at freezing ovarian tissue in girls with Turner syndrome, a condition that often causes early ovary failure and infertility. Researchers want to find out which patients are most likely to have healthy eggs in their tissue by checking their genes, hormones, and me…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Hidden heart and kidney disease: 16,660 people screened in major spanish study
Knowledge-focused OngoingThis study screened over 16,600 adults aged 45-70 with at least one risk factor (like high blood pressure or smoking) but no known heart disease. Researchers used ultrasound and simple blood and urine tests to find hidden signs of atherosclerosis, pre-diabetes, and kidney disease…
Sponsor: Institut de Recerca Biomèdica de Lleida • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Sleep apnea treatment may help blood pressure, especially in the very sleepy
Knowledge-focused OngoingThis study looks at whether treating obstructive sleep apnea (OSA) with a breathing device (CPAP) lowers blood pressure more in people who are very sleepy compared to those who are not. Researchers will analyze data from about 10,000 adults with OSA from previous studies. The goa…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused CancelledThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Practice makes perfect? study tests if simulator skills save lives in delivery room
Knowledge-focused OngoingThis study looks at whether healthcare providers can use skills learned on mannequins when helping real newborns breathe. About 120 respiratory therapists will be observed in both a simulation lab and the delivery room. The goal is to see if their ability to manage a baby's mask …
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Gene study aims to solve wolfram syndrome mystery
Knowledge-focused OngoingThis study looks at 45 people with certain changes in the WFS1 gene to figure out if they have a milder, dominant form of wolfram-like syndrome instead of the more severe recessive form. Researchers will use eye scans (OCT) to see if the gene changes are linked to specific eye pr…
Sponsor: Hôpital Necker-Enfants Malades • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can a Low-Carb diet tame insulin and testosterone in overweight women?
Knowledge-focused OngoingThis study is testing whether a Mediterranean-style low-carb diet that reduces calories can lower insulin and testosterone levels in overweight or obese women with insulin resistance. Eight premenopausal women aged 21-45 will follow the diet to lose about 5% of their body weight.…
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New Light-Based monitor could help protect newborn brains
Knowledge-focused OngoingThis study is observing brain oxygen levels in two groups of newborns at high risk of brain injury: full-term babies undergoing cooling treatment for oxygen deprivation, and extremely premature babies. Researchers use a non-invasive light sensor (near-infrared spectroscopy) to me…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Study on COVID-19 and blood cancer connection pulled before starting
Knowledge-focused CancelledThis study was designed to learn how the protein calprotectin might change blood stem cells in people with severe COVID-19 or certain blood cancers. Researchers planned to compare cells from patients and healthy donors in the lab. However, the study was withdrawn before any parti…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New national registry aims to improve care for rare genetic polyposis syndromes
Knowledge-focused OngoingThis study is a national registry collecting data from 1500 people with familial adenomatous polyposis (FAP) and related conditions across 28 Italian centers. It aims to better understand how these diseases progress, how they are currently managed, and what factors influence outc…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Massive PT study mines 4 million records to find what works best
Knowledge-focused OngoingThis study looks back at the medical records of about 4 million people who had physical or occupational therapy for muscle and joint problems. Researchers want to see if different ways of giving therapy lead to different results. No new treatments are tested—the goal is to learn …
Sponsor: ATI Holdings, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Can a phone call and online tools save lives? new study aims to boost cancer screening in High-Risk patients
Knowledge-focused By invitation onlyThis study tests two simple, scalable methods to help people with inherited cancer risk follow through on recommended screenings. Researchers will provide online educational resources and personalized phone outreach to 900 participants. The goal is to see if these approaches impr…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Gut leak study seeks clues in lactose intolerant adults
Knowledge-focused By invitation onlyThis study looks at how lactose intolerance affects the gut's barrier and inflammation in 200 adults with IBS-like symptoms. Researchers will measure markers in stool samples to see if they relate to symptom severity. The goal is to better understand the link between lactose into…
Sponsor: Bezmialem Vakif University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Could bile acids cause baby lung issues? new study investigates
Knowledge-focused By invitation onlyThis study looks at babies born to mothers with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and high bile acid levels. Researchers want to see if these bile acids can lead to breathing problems in newborns. They will compare 120 babies—some …
Sponsor: Carol Davila University of Medicine and Pharmacy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
500 patients join study to unravel recurrent heart inflammation
Knowledge-focused OngoingThis study follows 500 children and adults with recurrent pericarditis (repeated inflammation of the heart lining) to better understand the disease. Researchers will track which treatments patients use, how the disease affects quality of life, and the economic costs. The goal is …
Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists use chili peppers and ice water to unlock headache secrets
Knowledge-focused By invitation onlyThis study looks at how headaches work by using capsaicin (the spicy part of chili peppers) and ice water to trigger mild, temporary pain in people with and without headache disorders. Researchers measure changes in pain signals and tear production to better understand conditions…
Phase 1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Spine surgery spark: could a jolt of electricity help patients regain bladder control?
Knowledge-focused OngoingThis study explores whether a short burst of electrical stimulation applied during and after spine surgery can help nerves recover in people with cauda equina syndrome, a condition that can cause bladder, bowel, and sexual problems. About 40 adults having emergency surgery will r…
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can a video call replace a nurse's home visit for sleep apnea patients?
Knowledge-focused OngoingThis study looks at whether remote video visits (tele-visits) work as well as in-person home visits for people using a CPAP machine to treat sleep apnea. About 320 adults who have been using CPAP for at least a year will take part. The main goal is to see if tele-visits help peop…
Sponsor: AGIR à Dom • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Real-world heart procedure blood thinner patterns under the microscope
Knowledge-focused OngoingThis study tracks how doctors in Spain use injectable blood thinners (cangrelor or GPIs) during heart procedures like stent placement. It includes 717 patients and will look at short-term outcomes like death, heart attack, stroke, and bleeding within 48 hours. The goal is to unde…
Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New digital tool aims to tame uncontrolled asthma in GP practices
Knowledge-focused OngoingThis study tests a digital tool called AsthmaOptimiser that helps doctors assess asthma control and find ways to improve treatment during a single visit. About 746 adults with asthma who have had recent flare-ups will take part. The goal is to see if the tool can identify better …
Sponsor: General Practitioners Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New breathing test for newborns could improve lung care
Knowledge-focused OngoingThis study uses a non-invasive breathing test called forced oscillometry to measure lung function in 600 newborn infants, both full-term and premature, with and without lung conditions like respiratory distress or bronchopulmonary dysplasia. The goal is to better understand how t…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
COVID lung damage: who gets scarred?
Knowledge-focused OngoingThis study follows 200 ICU patients with severe COVID-19 to see how often they develop lung scarring (pulmonary fibrosis). Researchers will use blood tests and CT scans to find early signs of scarring and identify risk factors. The goal is to understand how scarring affects recov…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Longer breathing tube after surgery may cut risks for sleep apnea patients
Knowledge-focused By invitation onlyThis study looks at whether leaving a breathing tube in for 24-48 hours after gastric cancer surgery can lower complications in patients who also have severe obstructive sleep apnea. Researchers will compare two groups of 240 patients: one with standard tube removal and one with …
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Amputation for pain: how long until patients walk again?
Knowledge-focused OngoingThis study reviews the medical records of 20 adults who had a limb amputated to relieve severe, long-lasting pain from complex regional pain syndrome (CRPS). Researchers want to measure how many days pass between the amputation and when patients first use a functional prosthetic …
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Pulse power: beans and lentils may reshape your gut bacteria
Knowledge-focused OngoingThis study looks at how eating a diet rich in pulses—like beans, lentils, and peas—affects the gut microbiome, feelings of fullness, and appetite hormones. Researchers are enrolling 44 overweight or obese adults who will follow a high-pulse diet for four weeks. The goal is to see…
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Proteomics may unlock key clues to mepolizumab success in rare lung disease
Knowledge-focused By invitation onlyThis study aims to find biological markers in blood, saliva, and sputum that can predict how well patients with EGPA (a rare inflammatory disease) and severe asthma respond to the drug mepolizumab. Researchers will analyze proteins in these samples before and after treatment to u…
Phase 4 • Sponsor: Azienda Ospedaliero Universitaria di Cagliari • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study seeks better ways to track rare lung disease
Knowledge-focused OngoingThis study follows 286 adults with Alpha-1 Antitrypsin Deficiency, a genetic condition that can damage the lungs and liver. Researchers use CT scans and blood tests over three years to see how lung density changes. The goal is to find biological markers that could help design bet…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Sleep apnea nerve stimulation study pulled before starting
Knowledge-focused CancelledThis study was designed to see if stimulating both sides of a tongue nerve during sleep could improve airway collapse in people with obstructive sleep apnea who already have an Inspire device. It was withdrawn before enrolling anyone, so no results are available.
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Massive 10,000-person study to reveal how sleep apnea treatment affects heart health
Knowledge-focused OngoingThis study follows 10,000 people with both obstructive sleep apnea and high blood pressure over many years. Researchers will track how well patients use CPAP machines and blood pressure medications, and whether this reduces the chance of heart attacks, strokes, heart failure, or …
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Diabetes and liver danger: new study follows 317 patients to uncover hidden risks
Knowledge-focused By invitation onlyThis study follows 317 adults with type 2 diabetes who were first examined between 2019 and 2023. Researchers will repeat advanced liver scans, blood tests, and body composition measurements to see how liver fat and scarring change over time. The goal is to find out who is most a…
Sponsor: Linkoeping University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC